Last updated: Dec 10, 2020 - 02:00 GMT
| Ampligen in Chronic Fatigue Syndrome |
Chronic fatigue syndrome, Coronavirus disease 19 infection |
rintatolimod alone |
2,5-Oligoadenylate synthetase stimulator, Interferon type I receptor agonist, Ribonuclease stimulator, TLR-3 agonist |
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
AIM ImmunoTech Inc |
|
US |
|
|
AMP 511, NCT00215813 |
Phase 3 Clinical |
Recruiting |
2 |
|
|
Ann Marie Coverly, Charles Lapp, MD, Charles W. Lapp, M.D., Daniel Peterson, M.D., Daniel Peterson, MD, Diane Young |
2020-10-27 |
| A phase III trial to evaluate CoviSafe for the detection of COVID-19 |
Coronavirus disease 19 infection |
CoviSafe alone |
|
|
Kannaba Technologies Inc |
Therma Bright Inc |
|
|
|
|
Phase 3 Clinical |
Planned |
0 |
|
|
|
2020-12-09 |
| A phase II trial to evaluate CoviSafe for the detection of COVID-19 |
Coronavirus disease 19 infection |
CoviSafe alone |
|
|
Kannaba Technologies Inc |
Therma Bright Inc |
|
|
|
|
Phase 2 Clinical |
Planned |
0 |
|
|
|
2020-12-09 |
| A phase I trial to evaluate CoviSafe for the detection of COVID-19 |
Coronavirus disease 19 infection |
CoviSafe alone |
|
|
Kannaba Technologies Inc, Therma Bright Inc |
|
|
|
|
|
Phase 1 Clinical |
Planned |
0 |
|
|
|
2020-12-09 |
| Brief Mindfulness-Based Intervention to Improve Psychological Wellbeing |
Acute stress disorder, Anxiety disorder, Coronavirus disease 19 infection, Psychiatric disorder |
virtual brief mindfulness session alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Imam Abdulrahman Bin Faisal University |
|
Saudi Arabia |
2020-07-07 |
2020-09-05 |
MINDFULLNESS during COVID19, NCT04656626 |
Phase Not Applicable |
Completed |
0 |
1 Month |
146 |
Amani al-qurni, BOARD |
2020-12-09 |
| Disinfection & cross infection tests on sports equipment in covid-19 |
Coronavirus disease 19 infection |
a cross-infection test alone, disinfectants alone, test gloves alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
St Marianna University School of Medicine |
|
Japan |
2020-10-28 |
|
UMIN000042270 |
Phase Not Applicable |
Not yet recruiting |
0 |
|
41 |
Hiroto Fujiya, Kanaka Yatabe |
2020-12-09 |
| NgT-NAFOGA(NATION) Study: Phase I clinical trial to investigate the safety, tolerability and pharmacokinetics of NewGenNafamostat in healthy male subjects |
Coronavirus disease 19 infection |
nafamostat (COVID-19 infection), Institut Pasteur Korea alone |
Serine protease inhibitor, Transmembrane serine protease 2 inhibitor |
Male, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) |
NewGen Therapeutics Inc |
NewGen Therapeutics Inc |
South Korea |
2020-12-05 |
|
KCT0005647, NgT-NAFOGA(NATION), NgT-NAFOGA(NATION) Study |
Phase 1 Clinical |
Not yet recruiting |
0 |
|
32 |
Hyun Chul Kim, Seung Hwan Lee |
2020-12-09 |
| MORPH-II: Revisiting A Mobile Intervention to Reduce Pain and Improve Health |
Coronavirus disease 19 infection, Pain |
caloric restriction intervention alone, movement restriction intervention alone |
|
Healthy volunteers accepted, Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Wake Forest University |
|
US |
2021-01-31 |
2022-10-31 |
IRB00023965, MORPH-II, NCT04655001 |
Phase Not Applicable |
Not yet recruiting |
0 |
21 Months |
100 |
Amber Brooks, MD, Charlotte Crotts, BS, Jason Fanning, PhD |
2020-12-09 |
| Urine Alkalinization to Prevent AKI in COVID-19 |
Coronavirus disease 19 infection, Renal injury |
sodium bicarbonate alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Guy's & St Thomas' Hospital NHS Trust |
|
UK |
2021-02-01 |
2022-03-30 |
283852, NCT04655716 |
Phase 3 Clinical |
Not yet recruiting |
0 |
13 Months |
80 |
Marlies Ostermann |
2020-12-09 |
| Hospitalization or Outpatient Management of Patients With SARS-CoV-2 Infection - Revised HOME-CoV Score Study |
Coronavirus disease 19 infection |
revised HOME-CoV score alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University Hospital, Angers |
|
France |
2020-12-08 |
2021-06-08 |
2020-A03067-32, NCT04657471 |
Phase Not Applicable |
Not yet recruiting |
0 |
6 Months |
1300 |
Alexandre GHUYSEN, Andrea PENALOZA, Anyhony CHAUVIN, Caroline SOULIE, Christian BRICE, Coralie CAYEUX, David DALL'ACQUA, Delphine DOUILLET, Emmanuel MONTASSIER, Esma OUMMAMAR, Florent FREMY, Francis COUTURAUD, Frédéric BALEN, Henri Hani KARAM, Henrinjatovo ANDRIANJAFY, Julie PERNET, Kasarra BEN HAMMOUDA, Laure ABENSUR VUILLAUME, Marc ANDRONIKOF, Marc NOIZET, Mathieu VIOLEAU, Medhi TAALBA, Meïssa KARE, Mustapha SEBBANE, Nicolas PESCHANSKI, Ombeline SUSONG, Pascal BISSOLOKELE, Pierre-Clément THIEBAUD, Romain BLONDET, SCHMIDT Jeannot, Sonja CURAC, Stéphane GENNAI, Séverine GOSSELIN, Yann-Erick CLAESSENS |
2020-12-09 |
| Multiple Interactive With Nutrition and Exercise Strategies in Frailty Cancer Patients |
Coronavirus disease 19 infection, Muscle weakness |
cycle exercise alone, online nutrition consultation alone, routine nutrition consultation alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Tzu Chi University |
|
Taiwan |
2020-11-01 |
2023-11-30 |
NCT04654637, TCU-CHHUANG |
Phase Not Applicable |
Recruiting |
0 |
37 Months |
128 |
Chu Hou Huang, PhD, Chun Hou Huang, Chun Hou Huang, Phd |
2020-12-09 |
| SARS-CoV-2/COVID-19 Prevalence Study |
Coronavirus disease 19 infection |
|
|
Healthy volunteers accepted, Newborn Infants (up to 5 months), Infants (6-23 months), Preschool Children (2-5 yrs), Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
COVID-19 Prevention Network |
|
Puerto Rico, US |
2020-12-15 |
2021-03-30 |
COVPN 5002, NCT04658121 |
Phase Not Applicable |
Not yet recruiting |
0 |
3 Months |
3920 |
Ayana Moore, PhD, Jessica Justman, MD, Laura Mkumba |
2020-12-09 |
| Impact of Postoperative Telemedicine Visit versus In-person Visit on Patient Satisfaction During the COVID-19 Pandemic: A Prospective, Randomized Trial |
Coronavirus disease 19 infection |
Telemedicine visit alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Cedars-Sinai Medical Center |
|
US |
2020-09-28 |
2021-06-30 |
NCT04652674, STUDY00000944 |
Phase Not Applicable |
Recruiting |
0 |
9 Months |
70 |
Karen Zaghiyan, MD, Lucille Yao, MD, Phillip Fleshner, MD |
2020-12-09 |
| COLDSTER: Comparison of Two Corticosteroid Regimens for Post-COVID Diffuse Lung Disease |
Coronavirus disease 19 infection, Lung disease, Viral pneumonia |
prednisolone alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Postgraduate Institute of Medical Education and Research |
|
India |
2020-12-10 |
2021-12-09 |
COLDSTER, INT/IEC/2020/SPL-1528, NCT04657484 |
Phase 2 Clinical |
Recruiting |
0 |
12 Months |
100 |
Ritesh Agarwal, MD, DM, Sahajal Dhooria, Sahajal Dhooria, MD, DM |
2020-12-09 |
| Edtech-HPV: A Community Approach Using Education and Technology to Increase HPV Vaccination |
Coronavirus disease 19 infection, Papillomavirus infection |
Text messaging reminder alone, parental HPV vaccine education alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Memorial Sloan-Kettering Cancer Center |
|
US |
2017-06-28 |
2022-06-30 |
17-336, Edtech-HPV, NCT03209713 |
Phase Not Applicable |
Recruiting |
0 |
60 Months |
800 |
Abraham Aragones, MD, MS, Ester Corpuz, Eva Moya, PhD, Francesca Gany, MD, MS, Rebeca Aceves Zaragoza |
2020-12-09 |
| A clinical trial of peginterferon alfa-2b follow-on-biologic, Zydus-Cadila for the treatment of Coronavirus disease 19 infection |
Coronavirus disease 19 infection |
|
|
|
Zydus Cadila Healthcare Ltd |
|
US |
|
|
|
Phase Not Applicable |
Planned |
0 |
|
|
|
2020-12-09 |
| Reducing Food Insecurity During COVID-19 |
Coronavirus disease 19 infection |
Fresh Connect produce prescription program alone, grocery store gift cards alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Boston Medical Center Corp |
Krupp Family Foundation, Patient Centered Outcome Research Institute, US Department of Agriculture, Waldron Charitable Fund |
US |
2021-01-31 |
2022-10-31 |
6007145, H-41052, NCT04652596, PENDING |
Phase Not Applicable |
Not yet recruiting |
0 |
21 Months |
250 |
Erin Ashe, MPH, Jocelyn Antonio, BS, Michael Silverstein, MD MPH, Michael Silverstein, MD, MPH |
2020-12-09 |
| PRINCESS: Pronation in COVID-19 Patients Undergoing Non Invasive Respiratory Support |
Coronavirus disease 19 infection, Viral pneumonia |
awake prone position alone, non invasive respiratory support alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University of Modena and Reggio Emilia |
|
Italy |
2020-03-01 |
2020-11-30 |
NCT04649658, PRINCESS, UMODENAREGGIO10 |
Phase Not Applicable |
Completed |
0 |
9 Months |
93 |
Roberto Tonelli |
2020-12-09 |
| COVID-RIC1: Seroprevalence Study of CoV-2-SARS Infection in Patients With Chronic Inflammatory Rheumatic Diseases |
Coronavirus disease 19 infection, Psoriatic arthritis, Rheumatoid arthritis, Spondylarthritis |
routine care alone, serological testing alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University Hospital, Montpellier |
|
France |
2020-12-01 |
2021-07-30 |
COVID-RIC1, NCT04655612, RECHMPL20_0624 |
Phase Not Applicable |
Recruiting |
0 |
7 Months |
5000 |
Jacques MOREL, MD, PhD, Jacques Morel, MD, PhD, Thao Pham, MD, PhD |
2020-12-09 |
| Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast Surgery |
Breast tumor, Coronavirus disease 19 infection |
mastectomy alone |
|
Female, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
MD Anderson Cancer Center |
National Cancer Institute |
US |
2019-05-21 |
2022-03-31 |
NCI-2019-07463, NCT04169542, PA18-1077 |
Phase Not Applicable |
Recruiting |
0 |
34 Months |
600 |
Anaeze Offodile, Elizabeth FitzSullivan, Makesha V. Miggins, Richard A. Ehlers |
2020-12-09 |
| Cov-activity: Physical Activity Program Implementation in Hospitalized Positive Covid-19 Older Adults |
Coronavirus disease 19 infection |
physical activity program alone |
|
Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Centre Hospitalier Universitaire de Toulouse |
|
France |
2020-11-01 |
2021-12-31 |
Cov-activity, NCT04647682, RC31/20/0145 |
Phase Not Applicable |
Recruiting |
0 |
14 Months |
30 |
Laurine ANDRE, MD |
2020-12-09 |
| SPUTNIK-UAE: A Phase III Clinical Trial of the Immunogenicity and Safety of the Gam-COVID-Vac Vaccine Against COVID-19 in the UAE |
Coronavirus disease 19 infection |
Sputnik V alone |
COVID19 Spike glycoprotein modulator |
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Gamalei Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation Collaborator |
PDC-CRO |
Saudi Arabia, United Arab Emirates |
2020-12-31 |
2021-12-31 |
06-GAM-COVID-VAC-2020, NCT04656613, SPUTNIK-UAE |
Phase 3 Clinical |
Not yet recruiting |
0 |
12 Months |
1000 |
Ahmed Al Hammadi, Mohamed Mostafa |
2020-12-09 |
| Addressing Anxiety in 2 to 3-Year Olds: A Pilot, Intervention Study |
Anxiety disorder, Coronavirus disease 19 infection, Generalized anxiety disorder, Phobia, Social phobia |
being brave protocol based-cognitive behavioral therapy alone |
|
Healthy volunteers accepted, Infants (6-23 months), Preschool Children (2-5 yrs) |
Massachusetts General Hospital |
|
US |
2019-09-27 |
2022-09-01 |
2018P000376, NCT04039243 |
Phase Not Applicable |
Recruiting |
0 |
35 Months |
90 |
Dina Hirshfeld-Becker, PhD, Jordan Holmen, BA |
2020-12-09 |
| COVID-HIGH: HFNT Versus COT in COVID-19 |
Coronavirus disease 19 infection, Hypoxia, Respiratory failure, Respiratory tract infection, Viral pneumonia |
High Flow Nasal Therapy alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo |
Azienda Ospedaliero - Universitaria Policlinico - Vittorio Emanuele |
Italy |
2021-01-10 |
2022-03-01 |
1TH DEC 2020, COVID-HIGH, NCT04655638 |
Phase Not Applicable |
Not yet recruiting |
0 |
13 Months |
364 |
Alberto Noto, Alessio Mattei, Andrea Cortegiani, Andrea Cortegiani, MD, Annalisa Carlucci, Antonino Giarratano, Cesare Gregoretti, Claudia Crimi, Claudia Crimi, MD, Enrico Clini, Nicola Scichilone, Raffaele Scala |
2020-12-09 |
| RLX0120: Trial to study efficacy and safety of two doses of raloxifene in adult paucisymptomatic COVID-19 patients |
Coronavirus disease 19 infection |
raloxifene alone |
Estrogen receptor modulator |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Dompe Farmaceutici SpA |
|
Italy |
2020-10-31 |
|
2020-003936-25, RLX0120, RLX0120 |
Phase 2/Phase 3 Clinical |
Recruiting |
1 |
|
150 |
Flavio Mantelli |
2020-12-09 |
| Physical Activity During Covid-19 Lockdown |
Coronavirus disease 19 infection |
Physical Activity alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Hospital Tengku Ampuan Afzan, University Malaya Medical Centre |
|
Malaysia |
2020-12-02 |
2021-03-17 |
55434, NMRR-20-2607-55434 |
Phase Not Applicable |
Status not specified |
2 |
3 Months |
|
Dr Lim Zhuang Li, Dr. Choong Wai Kwong |
2020-12-08 |
| Phase II/III Study of COVID-19 DNA Vaccine (AG-0302-COVID19) |
Coronavirus disease 19 infection |
AG-0301-COVID19 alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
AnGes MG Inc |
Japan Agency for Medical Research and Development |
Japan |
2020-11-23 |
2022-03-31 |
AG0302-COVID19-JN-02, NCT04655625 |
Phase 2/Phase 3 Clinical |
Recruiting |
0 |
16 Months |
500 |
AnGes, Inc. Clinical Development |
2020-12-09 |
| COVIDEYE: Prevalence of SARS-CoV-2 Genome in Tears of Asymptomatic and Moderately Symptomatic COVID-19 Patients |
Coronavirus disease 19 infection |
PCR alone, conjunctival swab test alone, nasopharyngeal swab test alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Assistance Publique Hopitaux de Paris |
|
France |
2020-12-31 |
2021-12-31 |
2020-A02996-33, APHP201268, COVIDEYE, NCT04654325 |
Phase Not Applicable |
Not yet recruiting |
1 |
12 Months |
1280 |
Antoine ROUSSEAU, PhD, Antoine Rousseau, PhD, Christelle Vauloup-Fellous, PhD |
2020-12-09 |
| Efficacy of prebiotic products on admitted patients with Covid-19 |
Coronavirus disease 19 infection |
probiotic intake alone, hydroxychloroquine plus remdesivir |
COVID19 non structural protein 8 modulator, COVID19 replicase polyprotein 1ab inhibitor, RNA polymerase modulator |
|
Shaheed Beheshti Medical University |
|
Iran |
2020-09-22 |
|
IR.SBMU.RETECH.REC.1399.562, IRCT20161206031255N4 |
Phase 3 Clinical |
Recruiting |
1 |
|
60 |
Afshin Zerghi, Roshanak Mokaberinejad |
2020-12-09 |
| Clinical Outcome of Patients With COVID-19 Pneumonia Treated With Corticosteroids and Colchicine |
Coronavirus disease 19 infection, Viral pneumonia |
dexamethasone alone, colchicine plus dexamethasone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Clínica Medellín - Comprometidos con tu Salud |
|
Colombia |
2020-03-20 |
2020-08-20 |
04-2020, NCT04654416 |
Phase Not Applicable |
Completed |
1 |
5 Months |
301 |
Miguel Alejandro Pinzón |
2020-12-09 |
| A multi-center, double-blind, placebo-controlled, adaptive design, phase III clinical trial to evaluate the efficacy and safety of fostamatinib in adult, hospitalized COVID-19 patients |
Coronavirus disease 19 infection |
fostamatinib disodium alone |
Syk tyrosine kinase inhibitor |
|
Rigel Pharmaceuticals Inc |
|
|
2020-12-31 |
|
|
Phase 3 Clinical |
Planned |
0 |
|
|
|
2020-12-08 |
| Prevalence of burnout, its associated factors among Dr and nurse of JB DHO during COVID-19 pandemic |
Coronavirus disease 19 infection |
|
|
Healthy volunteers accepted |
Universiti Sains Malaysia |
|
Malaysia |
2021-01-01 |
2021-05-31 |
57271, NMRR-20-2579-57271 |
Phase Not Applicable |
Not yet recruiting |
1 |
5 Months |
|
Dr NUR SUJAIHAH BINTI HANAFI |
2020-12-09 |
| A large-scale surveillance study of OneDraw Blood Collection Device to assess the prevalence of previous infection with COVID-19 |
Coronavirus disease 19 infection |
OneDraw device alone |
|
|
Drawbridge Health Inc, University of Cambridge |
|
UK |
|
|
|
Phase Not Applicable |
Recruiting |
1 |
|
4000 |
Professor Nick Wareham |
2020-12-08 |
| Awareness, Knowledge and Attitudes of Obstetricians towards the use of Telemedicine in Antenatal Care: A Cross-sectional study in a Tertiary Government Hospital in the Philippines during the COVID-19 Pandemic |
Coronavirus disease 19 infection |
Telemedicine alone |
|
|
Philippine General Hospital |
|
Philippines |
2020-10-20 |
2020-11-30 |
PHRR201201-003180 |
Phase Not Applicable |
Completed |
1 |
1 Month |
|
Dominique Joyce M. Concepcion, Izabelle Julienne Figueras-Prieto, Regina Rosario M. Panlilio |
2020-12-08 |
| COVID-19 Cure Using Integrative Treatment |
Coronavirus disease 19 infection |
Integrative treatment alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
Knowledge Research and Innovation Center, |
|
Pakistan |
2020-03-17 |
2020-06-30 |
ChiCTR2000040632 |
Phase 1 Clinical |
Completed |
1 |
3 Months |
34 |
Muhammad Yahya Qureshi, Umber Nawaz |
2020-12-09 |
| Treatment With Pirfenidone for COVID-19 Related Severe ARDS |
Coronavirus disease 19 infection, Respiratory distress syndrome |
pirfenidone alone, standard of care alone |
PDGF receptor antagonist, TGF beta receptor antagonist, p38 MAP kinase inhibitor |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Soroka University Medical Center |
Roche Holding AG |
Israel |
2020-11-08 |
2021-12-31 |
NCT04653831, SCRC20007 |
Phase 2 Clinical |
Recruiting |
1 |
13 Months |
100 |
Ori Galante, MD, Yasmeen Abu Fraiha, Yasmeen Abu Fraiha, MD |
2020-12-09 |
| Efficacy of barley water (Hordeum vulgare) in clinical outcome of COVID-19 patients |
Coronavirus disease 19 infection, Viral pneumonia |
barley water intake alone, current medication alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Shiraz University of Medical Sciences |
|
Iran |
2020-11-15 |
|
IR.SUMS.REC.1399.216, IRCT20150830023823N3 |
Phase 2 Clinical |
Recruiting |
1 |
|
50 |
Abbas Rezaianzadeh, Ali Tavakoli |
2020-12-09 |
| To compare the effect of lying in face down position along with oxygen therapy given through high-flow nasal cannula device versus lying face down with oxygen given by non-rebreathing face mask in COVID-19 patients |
Coronavirus disease 19 infection, Hypoxia, Respiratory failure |
awake prone positioning alone, high-flow nasal cannula alone, oxygen alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
All India Institute of Medical Sciences Patna |
|
India |
2020-12-15 |
|
CTRI/2020/12/029587 |
Phase 2 Clinical |
Not yet recruiting |
1 |
|
60 |
Rajnish Kumar |
2020-12-09 |
| Effects of PPE among Healthcare Workers |
Coronavirus disease 19 infection, Psychiatric disorder |
personal protective equipment alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Sri Ramachandra Medical College, Hospital & Research institute |
Sri Ramachandra University |
India |
2020-12-15 |
|
CTRI/2020/12/029584 |
Phase Not Applicable |
Not yet recruiting |
1 |
|
150 |
Dr Swathy Moorthy, DrSPThiagarajan |
2020-12-07 |
| CADE: Cardiac Assessment After Covid-19 Disease in Elite Altheltic Population |
Coronavirus disease 19 infection, Heart injury |
MRI alone, echocardiography alone, electrocardiogram alone |
|
Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) |
University Hospital, Montpellier |
Centre Hospitalier Universitaire de Nimes, Centre Hospitalier de Perpignan, Clinique du Millénaire, Rennes University Hospital, ligue nationale de Basket |
France |
2020-04-01 |
2021-01-01 |
CADE, NCT04653857, RECHMPL20_0648 |
Phase Not Applicable |
No longer recruiting |
1 |
9 Months |
250 |
Christophe HEDON, MD, Stéphane CADE, MD |
2020-12-09 |
| Effectiveness of Unani add-on therapy in preventing the disease severity of COVID-19 infection |
Coronavirus disease 19 infection |
Variable regimens including Behidana, Unnab and Sapistan-unani decoction , Joshanda tea , Tiryaq-e-Arba , azithromycin , hydroxychloroquine , vitamin C , zinc |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
Central Council for Research in Unani Medicine |
Ministry of Ayush |
India |
2020-12-04 |
|
CTRI/2020/12/029575 |
Phase 3 Clinical |
Not yet recruiting |
1 |
|
100 |
Dr Jugal Kishore, Dr Rohit Kumar, Dr Tamanna Nazli, Prof Jugal Kishore |
2020-12-09 |
| Study of the safety of hyperimmune bovine milk and colostrum against COVID-19 |
Coronavirus disease 19 infection |
bovine Colostrum plus bovine milk |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Isfahan University |
Isfahan Oil Refinery |
Iran |
2020-11-10 |
2020-11-25 |
IR.MUI.MED.REC.1399.672, IRCT20200927048849N1 |
Phase 1 Clinical |
Completed |
1 |
|
40 |
Hassan Niliahmadabadi, Rasoul Roknizadeh, Somayeh Sadeghi |
2020-12-08 |
| A study of cyclophosphamide outcomes in patients with COVID-19 |
Coronavirus disease 19 infection, End stage renal disease, Respiratory distress syndrome, Vasculitis |
cyclophosphamide plus prednisone |
|
|
Metropolitan Hospital Center |
|
|
|
|
|
Phase Not Applicable |
Status not specified |
0 |
|
3 |
|
2020-12-07 |
| GraphealNpas: Feasibility and Analytical Performance of TestNPass (IVDMD) for COVID-19 Diagnosis on Saliva Sample |
Coronavirus disease 19 infection |
TestNPass diagnotic medical device (Grapheal SAS) alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University Hospital, Grenoble |
Grapheal SAS |
France |
2020-12-15 |
2021-03-15 |
2020-A03087-32, 38RC20.378, GraphealNpas, NCT04654442 |
Phase Not Applicable |
Not yet recruiting |
1 |
3 Months |
60 |
Benjamin Némoz, MD, Benjamin Némoz, Némoz, Marion Le Maréchal, MD, Pierre AUDOIN, MS |
2020-12-09 |
| NIVHOC: A clinical trial to compare the effect of non-invasive ventilation with high-flow nasal oxygen therapy versus only high flow nasal oxygen therapy in COVID 19 patients with respiratory failure |
Coronavirus disease 19 infection, Respiratory failure |
face mask alone, non-invasive ventilation based high flow nasal oxygen therapy alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
All India Institute of Medical Sciences Patna |
|
India |
2020-12-12 |
|
CTRI/2020/12/029585, NIVHOC |
Phase Not Applicable |
Not yet recruiting |
1 |
|
100 |
Kunal Singh |
2020-12-09 |
| ROCD: A study of kidney Problems with covid 19 in admitted patients at a teritiary care hospital |
Coronavirus disease 19 infection, Renal disease |
|
|
Newborn Infants (up to 5 months), Infants (6-23 months), Preschool Children (2-5 yrs), Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Yenepoya Medical college |
|
India |
2020-12-21 |
|
CTRI/2020/12/029581, ROCD |
Phase Not Applicable |
Not yet recruiting |
1 |
|
300 |
Dr Santhosh Pai, Dr Santhosh pai |
2020-12-09 |
| Various Blood Parameters Affecting outcome in ICU Patients |
Coronavirus disease 19 infection, Vitamin D deficiency |
|
|
Male, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
JSS University |
|
India |
2020-12-15 |
|
CTRI/2020/12/029586 |
Phase Not Applicable |
Not yet recruiting |
1 |
|
150 |
DR AKSHAY, DR Rajalakshmi R |
2020-12-09 |
| Aerosol Particle Concentrations Among Different Oxygen Devices for Spontaneous Breathing Patients With Tracheostomy |
Coronavirus disease 19 infection, Respiratory disease |
Airvo2 (Fisher and Paykel Healthcare Ltd) alone, high-flow high humidity oxygen therapy alone, tracheostomy alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Rush University Medical Center |
|
US |
2021-01-31 |
2021-05-31 |
HFOT-TRACH-AEROSOL, NCT04654754 |
Phase Not Applicable |
Not yet recruiting |
1 |
4 Months |
10 |
Jie Li, Jie Li, PhD |
2020-12-07 |
| Study of AffloVest in At-Risk Respiratory Patients During COVID-19 Pandemic |
Chronic obstructive pulmonary disease, Coronavirus disease 19 infection, Cough |
Afflovest device alone, Standard Care alone, digital thermometer alone, high frequency chest wall oscillation (HFCWO) therapy alone, pulse oximeter alone, spirometer alone, telehealth training alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Mount Sinai Medical Center |
International Biophysics Corporation, SPARK Healthcare |
US |
2020-12-31 |
2021-11-30 |
GCO 20-2667, ISMMS-AFF-20, NCT04654481 |
Phase Not Applicable |
Recruiting |
1 |
11 Months |
30 |
Elinor L Schwind, MS, Patricia Walker, MD, Teresa Demarco, PTA |
2020-12-09 |
| Serial sero-epidemiological surveillance study to monitor the trend of SARS-CoV-2, Dengue and Chikungunya infection transmission in the Vellore Demographic Health Surveillance System (HDSS) |
Chikungunya virus infection, Coronavirus disease 19 infection, Dengue virus infection |
neutralization assay alone |
|
Healthy volunteers accepted, Preschool Children (2-5 yrs), Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Christian Medical College, Vellore, India |
Biotechnology Industry Research Assistance Council, National BioPharma Mission |
India |
2020-12-10 |
|
CTRI/2020/12/029564 |
Phase Not Applicable |
Not yet recruiting |
1 |
|
5000 |
Winsley Rose |
2020-12-08 |
| ReCOV: RT-PCR Database Analysis for COVID-19 Infections and Re-infection |
Coronavirus disease 19 infection |
RT-PCR alone |
|
|
University Hospital, Montpellier |
Centre Hospitalier Universitaire de Nimes, Centre National de la Recherche Scientifique (CNRS), Laboratoire Pasteur-Cerba, MIVEGEC, MPL Analysis Laboratoires |
France |
2020-02-01 |
2021-03-30 |
NCT04653844, RECHMPL20_0640, ReCOV |
Phase Not Applicable |
No longer recruiting |
1 |
13 Months |
7000000 |
Vincent Foulongne, PhD |
2020-12-09 |
| A case report study of severe encephalopathy or focal brain lesions in children with multisystem inflammatory syndrome associated with COVID-19 |
Brain disease, Coronavirus disease 19 infection, Inflammatory disease |
Variable regimens including IV immunoglobulin , anakinra , methylprednisolone |
Type I IL-1 receptor antagonist |
Male, Preschool Children (2-5 yrs), Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Columbia University Irving Medical Center |
|
|
|
|
|
Phase Not Applicable |
Status not specified |
0 |
|
1 |
|
2020-12-07 |
| AtemNHK: Effects of Integrative Medicine on Infectious Respiratory Diseases Including COVID-19 |
Coronavirus disease 19 infection, Respiratory tract infection |
protective lifestyle intervention alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Charite University |
|
Germany |
2020-12-31 |
2021-12-31 |
ATEMNHK, AtemNHK, NCT04653727 |
Phase Not Applicable |
Not yet recruiting |
1 |
12 Months |
3000 |
Andreas Michalsen |
2020-12-09 |
| Evaluation of prophylaxis induced by ivermectin in populations exposed to COVID-19 patients |
Coronavirus disease 19 infection |
ivermectin alone |
Chloride channel modulator |
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
Akam Tejarat Fartak Farasoo |
|
Iran |
2020-11-30 |
|
IR.QUMS.REC.1399.261, IRCT20200408046987N3 |
Phase 3 Clinical |
Recruiting |
3 |
|
800 |
Abbas Allami, Alireza Mehralian, Morteza Shakhsi Niaee, Nematollah Gheibi, fatemeh samieerad |
2020-12-08 |
| Effect of GRAPEX in treatment of COVID-19 |
Coronavirus disease 19 infection |
Grapex alone, Standard country protocol drug therapy alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Abadan University of Medical Sciences |
|
Iran |
2021-01-08 |
|
IR.ABADANUMS.REC.1399.098, IRCT20200921048783N1 |
Phase 3 Clinical |
Not yet recruiting |
1 |
|
80 |
Hoda Mojiri-Forushani, Hoda Mojjiri-Forushani, Sara Mobarak |
2020-12-08 |
| A phase II study to evaluate PIC1-01 for the treatment of patients with hypoxic ischemic encephalopathy (HIE) |
Brain hypoxia-ischemia, Coronavirus disease 19 infection |
PIC1-01 alone |
Complement C1s subcomponent inhibitor |
|
ReAlta Life Sciences Inc |
|
Europe |
|
|
|
Phase 2 Clinical |
Planned |
0 |
|
|
|
2020-12-07 |
| The effect of Helichrysum pseudoplicatum syrup on clinical manifestations of patients with COVID-19 |
Coronavirus disease 19 infection, Respiratory tract infection |
Helichrysum pseudoplicatum syrup (Shahid Beheshti, Arak University of Medical Sciences) alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
Arak University of Medical Sciences and Health Services |
|
Iran |
2020-05-18 |
|
IR.ARAKMU.REC.1399.003, IRCT20180610040049N6 |
Phase 3 Clinical |
No longer recruiting |
1 |
|
60 |
Alireza Kamali, Hosein Sarmadian, Mohammad KamaliNejad, Seied Amirhosein Latifi |
2020-12-08 |
| A pivotal, phase II/III clinical trial to evaluate SCB-2019 in combination with Dynavax’s advanced CpG 1018 adjuvant plus alum for the prevention of SARS-CoV-2 infection |
Coronavirus disease 19 infection |
Variable regimens including CpG 1018 adjuvant , SCB-2019 , alum |
COVID19 Spike glycoprotein modulator |
|
Clover Biopharmaceuticals AUS Pty Ltd |
|
|
2021-06-30 |
|
|
Phase 2/Phase 3 Clinical |
Planned |
0 |
|
|
|
2020-12-07 |
| Serological investigations of blood donors from the city and area around Magdeburg for antibodies against SARS-CoV-2 (COVID-19) |
Coronavirus disease 19 infection |
serological examination alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
Institut fUr Medizinische Mikrobiologie und Krankenhaushygiene |
Institut fur Sozialmedizin und Gesundheitssystemforschung, Ministerium für Wirtschaft, Wissenschaft und Digitalisierung des Landes Sachsen-Anhalt |
Germany |
2021-01-15 |
|
163/20, DRKS00023263 |
Phase 4 Clinical |
Not yet recruiting |
1 |
|
4500 |
Heuft Hans-Gert, Stephan Kramer |
2020-12-08 |
| A retrospective, case series study to describe clinical outcomes associated with tocilizumab compared with those not receiving tocilizumab in critically ill patients with severe COVID-19 |
Coronavirus disease 19 infection |
tocilizumab alone |
|
|
Atrium Health |
|
|
|
|
|
Phase Not Applicable |
Status not specified |
0 |
|
49 |
|
2020-12-07 |
| A follow-up study of long-term prognosis in patients with novel coronavirus pneumonia (COVID-19) |
Coronavirus disease 19 infection |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Xi'an Children's Hospital |
|
China |
2020-02-02 |
2021-05-31 |
ChiCTR2000040628 |
Phase Not Applicable |
Recruiting |
1 |
15 Months |
430 |
Guo Yaling, Xu You, Yang Mingb, Yang Puye |
2020-12-07 |
| Novel coronavirus pneumonia (COVID-19) treated with different antiviral regimens: a medical records based study for analysis of therapeutic effect and length of stay of hospitalization |
Coronavirus disease 19 infection |
hormone therapy alone, Variable regimens including Lianhua Qingwen , abidol , interferon , oseltamivir , ribavirin |
|
Infants (6-23 months), Preschool Children (2-5 yrs), Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
People's Hospital of Shapingba District, Chongqing City |
|
China |
2020-12-01 |
2022-11-30 |
2020SQKWLH016, ChiCTR2000040571 |
Phase Not Applicable |
Not yet recruiting |
1 |
24 Months |
180 |
Huang Zi Yang |
2020-12-07 |
| Impact of COVID-19 pandemic on post graduate medical trainees in India |
Coronavirus disease 19 infection |
|
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) |
Post Graduate Institute of Dental Sciences (PGIMS) |
|
India |
2020-12-06 |
|
BREC/20/204, CTRI/2020/12/029515 |
Phase Not Applicable |
Not yet recruiting |
1 |
|
1000 |
Jyoti Khanna |
2020-12-07 |
| An exploratory, phase II, physician-initiated clinical trial investigating the efficacy and safety of TM-5614 in patients with novel coronavirus pneumonia |
Coronavirus disease 19 infection, Viral pneumonia |
TM-5614 alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Japan Agency for Medical Research and Development |
|
Japan |
2020-07-20 |
2021-01-31 |
jRCT2021200018 |
Phase 2 Clinical |
Recruiting |
1 |
6 Months |
30 |
Fumio Sakamaki, Harigae Hideo, Hideo Zhang, Hisatoshi Sugiura, Isao Ito, Keisuke Tomii, Koichiro Asano, Sakurako Tajiri, Yasunari Miyazaki |
2020-12-07 |
| MeDiCo- health Study: Eating habits during the Covid-19 pandemic |
Coronavirus disease 19 infection |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Technical University of Munich |
EIT Food iVZW, Personalized nutrition and vitamins - LOEWI |
Germany |
2020-12-03 |
|
655/20 S, DRKS00022514, MeDiCo- health Study |
Phase Not Applicable |
Not yet recruiting |
1 |
|
200 |
Laura Mengel, Thomas Skurk |
2020-12-07 |
| CHDR2044: Healthy volunteers blood sampling |
Coronavirus disease 19 infection |
flow cytometry alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
Leyden Laboratories BV |
|
Netherlands |
2020-11-03 |
2021-01-31 |
CHDR2044, NL75505.058.20, NL9045 |
Phase Not Applicable |
Not yet recruiting |
1 |
2 Months |
20 |
I.M.C. de Visser-Kamerling |
2020-12-08 |
| DF in COVID19: A Single-Arm Safety and Feasibility Study of Defibrotide for the Treatment of Severe COVID-19 |
Coronavirus disease 19 infection, Viral pneumonia |
defibrotide (iv, veno-occlusive disease), Gentium alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Brigham & Women's Hospital |
Jazz Pharmaceuticals plc |
US |
2021-01-01 |
2023-11-01 |
2020P003203, DF in COVID19, NCT04652115 |
Phase 2 Clinical |
Not yet recruiting |
1 |
34 Months |
42 |
Paul G Richardson, MD, Paul G. Richardson |
2020-12-08 |
| Exploratory research on severity indicators for COVID-19 patients |
Coronavirus disease 19 infection, Viral pneumonia |
Body motion sensor alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Japan Agency for Medical Research and Development |
|
Japan |
2020-07-30 |
2020-12-31 |
jRCT1052200041 |
Phase Not Applicable |
Not yet recruiting |
1 |
5 Months |
40 |
Eiji Asanoi, Naho Fujiwara, Shigeru Miyagawa, Sho Saito, Yoshiki Sawa, Yukio Abe, sawa Yoshiki |
2020-12-07 |
| Effect of the COVID-19 Public Health Crisis on the Mental Health and Physical Well-Being of Cancer Patients, the Coping With COVID Study |
Acute stress disorder, Coronavirus disease 19 infection, Psychiatric disorder |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
MD Anderson Cancer Center |
National Cancer Institute |
US |
2020-07-13 |
2021-03-31 |
2020-0451, NCI-2020-06556, NCT04652505 |
Phase Not Applicable |
Recruiting |
1 |
8 Months |
700 |
Tamara E Lacourt, Tamara E. Lacourt |
2020-12-08 |
| CoronaVac3CL: Efficacy, Safety, and Immunogenicity of an Inactivated Vaccine Against COVID-19 in High Infection Risk Adults |
Coronavirus disease 19 infection |
CoronaVac alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Pontificia Universidad Catolica De Chile |
Ministry of Health, Sinovac Research & Development Co Ltd |
Chile |
2020-11-27 |
2022-03-31 |
200708006, CoronaVac3CL, NCT04651790 |
Phase 3 Clinical |
Recruiting |
1 |
16 Months |
2300 |
Alvaro Rojas, MD, Carolina Iturriaga, Nurse, Katia Abarca, MD, María Soledad Navarrete, Nurse |
2020-12-09 |
| An observational, single-center study to evaluate the prevalence of major bleeding events in patients with COVID-19 receiving intensive thromboprophylaxis |
Bleeding, Coronavirus disease 19 infection |
enoxaparin alone, heparin alone |
|
|
Università della Svizzera italiana |
|
Switzerland |
|
|
|
Phase Not Applicable |
Status not specified |
1 |
|
270 |
|
2020-12-04 |
| WAYRA: Home-based Respiratory Physiotherapy and Telephone-Based Psychological Support in Severe COVID-19 Patients |
Coronavirus disease 19 infection |
home-based respiratory physiotherapy alone, telephone-based psychological support alone |
|
Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
Universidad Peruana Cayetano Heredia |
Johns Hopkins University, London School of Hygiene and Tropical Medicine |
Peru |
2020-10-26 |
2021-03-30 |
202852, NCT04649736, WAYRA |
Phase Not Applicable |
Recruiting |
1 |
5 Months |
108 |
Anderson N. Soriano-Moreno, MD, Andres G Lescano, PhD, MHS, Germán Málaga, MD, MSc, Stella M Hartinger, MSc, PhD, William Checkley, MD, PhD |
2020-12-07 |
| CovExc: Muscular Rehabilitation by Eccentric Exercise After Severe COVID-19 Infection |
Coronavirus disease 19 infection |
rehabilitation by eccentric exercises alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University Hospital Clermont-Ferrand |
GIRCI Auvergne Rhône-Alpes, Ministry of Health, France |
France |
2020-06-05 |
2021-12-05 |
2020-A01201-38, CovExc, NCT04649086, PHRCI 2020 COSTE (COVEXC) |
Phase Not Applicable |
Recruiting |
5 |
18 Months |
120 |
Dominic PERENNOU, MD, PhD, Emmanuel COUDEYRE, MD, PhD, Emmanuelle CHALEAT-VALAYER, MD, PhD, Lise Laclautre, PharmD, Léonard FEASSON, MD, PhD, Nicolas COSTE, MD, MSc, Paul ORNETTI, MD, PhD |
2020-12-07 |
| Packaging and Disseminating the JOIN for ME Program in Low-Income Settings |
Coronavirus disease 19 infection, Obesity |
JOIN for ME program alone |
|
Healthy volunteers accepted, Children (6-12 yrs) |
Miriam Hospital |
Brandeis University, Brown University, Tufts University, University of North Carolina |
US |
2021-01-31 |
2023-02-28 |
5U18DP006429-02, NCT04647760 |
Phase Not Applicable |
Not yet recruiting |
1 |
25 Months |
128 |
Andrea M Grenga, BA, Elissa Jelalian, PhD |
2020-12-07 |
| SHYCOV: Silent Hypoxia and Awake Proning in COVID-19 Patients |
Coronavirus disease 19 infection, Hypoxia |
physiotherapy alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Ostfold Hospital Trust |
|
Norway |
2020-11-30 |
2021-12-31 |
NCT04647747, SHYCOV, SHYCOV2020 |
Phase Not Applicable |
Not yet recruiting |
1 |
13 Months |
40 |
Hans Joakim Myklebust-Hansen |
2020-12-07 |
| Rapid Development and Implementation of a Remote ECG-monitored, Prospective, Randomized Clinical Trial During a Pandemic: Hydroxychloroquine Prophylaxis in COVID-19 Household Contacts |
Coronavirus disease 19 infection |
hydroxychloroquine alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Bryn Mawr Hospital |
Sharpe-Strumia Foundation |
US |
2020-05-27 |
2020-11-15 |
BM02332, NCT04652648 |
Phase 4 Clinical |
Completed |
3 |
5 Months |
54 |
Luciano kapelusznik |
2020-12-07 |
| PCR Cycle Threshold Values and COVID-19 Outcomes |
Coronavirus disease 19 infection |
real-time polymerase chain reaction alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University Hospitals of North Midlands NHS Trust |
|
UK |
2020-11-24 |
2021-03-31 |
286389, NCT04651413 |
Phase Not Applicable |
Recruiting |
1 |
4 Months |
800 |
Keira Watts, Robert Bowler, Robert J Bowler, Timothy Kemp |
2020-12-08 |
| The Protective Potential of Exercise Training on the Cardiopulmonary Morbidity After COVID-19 |
Coronavirus disease 19 infection |
high intensity interval training alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Rigshospitalet |
|
Denmark |
2021-01-01 |
2021-12-31 |
H-20033733 V.2, NCT04647734 |
Phase Not Applicable |
Not yet recruiting |
1 |
12 Months |
40 |
Regitse Christensen, MD, PhD, Ronan Berg, DMSc, MD |
2020-12-08 |
| COMBO: Camostat With Bicalutamide for COVID-19 |
Coronavirus disease 19 infection |
Standard of care alone, camostat mesylate alone, bicalutamide plus camostat mesylate |
Androgen receptor antagonist, Serine protease inhibitor, Transmembrane serine protease 2 inhibitor, Trypsin inhibitor |
Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Sidney Kimmel Comprehensive Cancer Center |
|
US |
2021-01-31 |
2023-01-31 |
COMBO, COV2005, IRB00254142, NCT04652765 |
Phase 1 Clinical |
Not yet recruiting |
1 |
24 Months |
60 |
Aliya Lalji, MD, Catherine H Marshall, MD/MPH |
2020-12-08 |
| LYT-100 in Post-acute COVID-19 Respiratory Disease |
Coronavirus disease 19 infection, Fibrosis, Inflammatory disease, Viral pneumonia |
deupirfenidone alone |
PDGF receptor antagonist, TGF beta receptor antagonist, p38 MAP kinase inhibitor |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
PureTech Health Plc |
Clinipace Worldwide, Novotech (Australia) Pty Ltd |
US, Romania |
2020-12-31 |
2021-12-31 |
LYT-100-2020-02, NCT04652518 |
Phase 2 Clinical |
Recruiting |
2 |
12 Months |
168 |
Adrian Streinu-Cercel, MD, PhD, Barry Sigal, MD, FCCP, Heather Paden, Site Coordinator, Toby Maher, MD |
2020-12-08 |
| Testing the effectiveness of almitrine bismesylate in the treatment of COVID-19 |
Coronavirus disease 19 infection, Hypoxia, Viral pneumonia |
almitrine bismesylate alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University of Oxford |
LifeArc |
UK |
2020-04-30 |
2021-09-30 |
2020-002567-57, CPMS 47241, IRAS 282381, ISRCTN11713182 |
Phase 2 Clinical |
Recruiting |
3 |
17 Months |
116 |
Dr Talbot |
2020-12-08 |
| FSC19-KN: Single-Center, Prospective, Controlled, Follow-up Study of COVID-19 Patients District Konstanz |
Coronavirus disease 19 infection |
|
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Hegau-Bodensee-Klinikum |
Deutsche Forschungsgemeinschaft (DFG), German Federal Ministry of Education and Research |
Germany |
2021-01-01 |
|
20-1020, DRKS00022409, FSC19-KN |
Phase Not Applicable |
Not yet recruiting |
1 |
|
400 |
Marc Kollum |
2020-12-08 |
| Observational, Retrospective Study to Evaluate Coagulation Changes and the Influence of Antithrombin III Treatment in Patients With Severe COVID-19 Infection |
Blood clotting disorder, Coronavirus disease 19 infection |
antithrombin III alone |
|
|
Octapharma AG |
|
Austria, Germany, France |
2020-10-19 |
2021-01-31 |
ATN01, NCT04651400 |
Phase Not Applicable |
Recruiting |
5 |
3 Months |
300 |
Mikaela Raymond |
2020-12-08 |
| A retrospective study to evaluate the effects of tocilizumab in the treatment of critical COVID-19 pneumonia |
Coronavirus disease 19 infection, Pneumonia |
Mechanical ventilation alone, tocilizumab alone, Variable regimens including Standard hospital protocol |
|
|
Stony Brook University Hospital |
|
US |
|
|
|
Phase Not Applicable |
Status not specified |
1 |
|
115 |
|
2020-12-04 |
| HOO-COVID: Efficacy and Safety of Ozonized Oil (HOO) in COVID-19 Patients |
Coronavirus disease 19 infection |
ozonized oil alone, routine standard treatment alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Istituto Neurologico Mediterraneo NEUROMED |
|
Italy |
2021-01-31 |
2021-08-31 |
DEP_052020, HOO-COVID, NCT04651387 |
Phase Not Applicable |
Not yet recruiting |
1 |
7 Months |
74 |
Licia Iacoviello, MD, PhD |
2020-12-07 |
| CAGE: COVID-19 And geko Evaluation |
Coronavirus disease 19 infection |
geko T3 device alone, peroneal nerve neuromuscular electrical stimulation alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Lawson Health Research Institute |
|
Canada |
2020-12-31 |
2021-04-30 |
CAGE, ISS-COV-002, NCT04651374 |
Phase Not Applicable |
Not yet recruiting |
1 |
4 Months |
40 |
Jessica Sturt-Smith, Tina Mele, Tina Mele, MD PhD FRCSC |
2020-12-07 |
| A retrospective, observational study to evaluate the treatment responses of criteria-based tocilizumab therapy for COVID-19 respiratory infection in ICU and non-ICU patients |
Coronavirus disease 19 infection, Respiratory tract infection |
tocilizumab alone |
|
|
Jefferson Health (US) |
|
|
|
|
|
Phase Not Applicable |
Status not specified |
0 |
|
170 |
|
2020-12-04 |
| A study to evaluate the efficacy of DeepCOVID-XR, the machine-learning algorithm, to detect COVID-19 by analyzing X-ray images of the lungs |
Coronavirus disease 19 infection |
DeepCOVID-XR alone |
|
|
Northwestern University |
|
US |
|
|
|
Phase Not Applicable |
Status not specified |
1 |
|
|
|
2020-12-04 |
| Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (BNT-162b2) in Chinese Healthy Population |
Coronavirus disease 19 infection, Viral pneumonia |
BNT-162b2 alone |
COVID19 Spike glycoprotein modulator |
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over), Asian Ancestry |
BioNTech SE, Jiangsu Province Centers for Disease Control and Prevention |
Shanghai Fosun Pharmaceutical Industry Development Co Ltd |
China |
2020-12-31 |
2021-12-31 |
BNT162-06, ChiCTR2000040044, NCT04649021 |
Phase 2 Clinical |
Not yet recruiting |
4 |
12 Months |
960 |
BioNTech Responsible Person, BioNTech clinical trial information desk, Wang Wei, Zhu Fengcai |
2020-12-09 |
| Serological Profile of Children and Young Adolescents With at Least One COVID-19 Diagnosed Family Member |
Coronavirus disease 19 infection |
|
|
Healthy volunteers accepted, Preschool Children (2-5 yrs), Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Universita degli Studi di Milano |
|
Italy |
2020-12-05 |
2021-12-31 |
GMT_CD_CT_LG_EB_10_2020, NCT04649944 |
Phase Not Applicable |
Not yet recruiting |
1 |
12 Months |
40 |
Giampietro Farronato, DDS, Gianluca Martino Tartaglia, DDS PhD, Gianluca Tartaglia, Professor, Marco Farronato, |
2020-12-08 |
| The effect of Steroid on the outpatient treatment of COVID-19 |
Coronavirus disease 19 infection |
prednisolone alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Isfahan University of medical Sciences |
|
Iran |
2020-12-21 |
|
IR.MUI.MED.REC.1399.781, IRCT20171219037964N2 |
Phase 3 Clinical |
Not yet recruiting |
3 |
|
70 |
Babak Amra, Dr. Babak Amra, Dr. Forough Soltaninejad, Dr. Mehrdad Salahi, Shaghayegh Haghjoo |
2020-12-08 |
| SAVID: Serum Amyloid A as a prognostic marker for disease severity and mortality in COVID-19 |
Coronavirus disease 19 infection |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Franciscus Gasthuis & Vlietland |
Siemens Healthcare GmbH |
Netherlands |
2021-01-01 |
2021-12-31 |
NL9082, SAVID |
Phase Not Applicable |
Planned |
1 |
12 Months |
400 |
Nadine Pouw |
2020-12-07 |
| High-Flow Nasal Cannula for severe COVID-19, a multicenter, prospective, cohort study |
Coronavirus disease 19 infection |
High-Flow Nasal Cannula alone |
|
|
Franciscus Gasthuis & Vlietland |
|
|
2020-12-01 |
2021-12-31 |
NL9067 |
Phase Not Applicable |
Planned |
0 |
13 Months |
200 |
Yasemin Türk |
2020-12-04 |
| SHARP-COVID: COVID-19 pandemic impact on severe asthma patients care in Europe |
Asthma, Coronavirus disease 19 infection |
|
|
|
Amsterdam University Medical Center |
|
Netherlands |
2020-11-22 |
2021-01-31 |
NL9063, SHARP-COVID |
Phase Not Applicable |
Not yet recruiting |
1 |
2 Months |
900 |
Katrien Eger |
2020-12-04 |
| Estimation of Dynamics of Humoral and Cellular Immunity in COVID-19 Patients |
Coronavirus disease 19 infection, Viral pneumonia |
Humoral and cellular immunity test alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus |
Belarusian State Medical University, Belarussian Research Institute for Epidemiology and Microbiology |
Belarus |
2020-10-01 |
2021-12-31 |
IBCE-COVID19-IMMUNITY, NCT04649840 |
Phase Not Applicable |
Recruiting |
1 |
15 Months |
60 |
Andrei Hancharou, MD, PHD |
2020-12-04 |
| A retrospective study on clinical outcome of tocilizumab in relation to respiratory status improvements and to analyze the association between initial inflammatory markers and treatment outcomes in patients with COVID-19 |
Coronavirus disease 19 infection |
tocilizumab alone |
|
|
Saint Barnabas Health Care Systems |
|
|
|
|
|
Phase Not Applicable |
Status not specified |
0 |
|
84 |
|
2020-12-09 |
| The Impact of COVID-19 on Surgical Practice in Jordan During the Second Outbreak |
Coronavirus disease 19 infection |
|
|
|
Yarmouk University |
|
Jordan |
2020-11-01 |
2020-11-10 |
NCT04650035, THE IMPACT OF COVID-19 JORDAN |
Phase Not Applicable |
Completed |
1 |
|
60 |
Raed M Ennab |
2020-12-04 |
| VR Baby, a virtual reality learning environment - does it help medical students to learn about complex topics in obstetrics and gynecology? |
Coronavirus disease 19 infection |
Brightspace eLearning University platform alone, VR Baby virtual reality learning environment intervention alone |
|
Healthy volunteers accepted |
University College Dublin |
|
Ireland |
2020-01-27 |
2021-03-31 |
ISRCTN19845486 |
Phase Not Applicable |
No longer recruiting |
1 |
14 Months |
40 |
Prof Fionnuala McAuliffe |
2020-12-08 |
| AirFLO2 Treatment for Hypoxia and/or Tachypnea in Patients With COVID-19 (AirFLO2) |
Coronavirus disease 19 infection, Hypoxia, Tachypnea |
AirFLO2 device alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Duke University |
Medex Inc |
US |
2020-12-04 |
2021-06-30 |
NCT04649775, PRO00105246 |
Phase Not Applicable |
Not yet recruiting |
1 |
6 Months |
50 |
Catherine M Foss, BS, Loretta Que, MD, Maria A Santoro, MA |
2020-12-04 |
| SOLIDARITY: WHO COVID-19 Solidarity Trial for COVID-19 Treatments |
Coronavirus disease 19 infection |
acalabrutinib alone, interferon beta-1a alone, remdesivir alone |
Btk tyrosine kinase inhibitor, COVID19 non structural protein 8 modulator, COVID19 replicase polyprotein 1ab inhibitor, RNA polymerase modulator |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
The University of The West Indies-Mona |
|
Jamaica |
2020-12-01 |
2021-12-31 |
NCT04647669, SOLIDARITY, SRD/ETH/20 |
Phase 3 Clinical |
Not yet recruiting |
1 |
13 Months |
100 |
Marvin E Reid, MB BS PhD, Marvin Reid, Naydenne Williams, MBBS DM, Tomlin Paul |
2020-12-04 |
| TeenCove: A Study to Evaluate the Safety, Reactogenicity and Effectiveness of mRNA-1273 Vaccine in Adolescents 12 to < 18 Years Old to Prevent COVID-19 |
Coronavirus disease 19 infection |
mRNA-1273 alone |
COVID19 Spike glycoprotein modulator |
Healthy volunteers accepted, Children (6-12 yrs), Adolescents (13-17 yrs) |
ModeRNA Therapeutics |
Biomedical Advanced Research and Development Authority (BARDA) |
US |
2020-11-30 |
2022-06-30 |
MRNA-1273-P203, NCT04649151, TeenCove |
Phase 2/Phase 3 Clinical |
Not yet recruiting |
7 |
19 Months |
3000 |
Moderna Clinical Trials |
2020-12-08 |
| Profiling Recovery of Those Discharged Into the Community With COVID-19 |
Coronavirus disease 19 infection |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University of Derby |
Sheffield Hallam University, University Hospitals Of Derby and Burton NHS Foundation Trust |
UK |
2021-01-04 |
2021-12-17 |
COVID-19-UOD&RDH20/21, NCT04649957 |
Phase Not Applicable |
Not yet recruiting |
1 |
11 Months |
100 |
Amanda Baxendale, PhD, Mark A Faghy, PhD, Ruth Ashton, PhD, Tom Bewick, MD, Tom Maden-Wilkinson, PHD |
2020-12-07 |
| Well-being in Cancer Patients With Neuropathy During COVID-19 Who Participated in Prior Clinical Trials |
Coronavirus disease 19 infection, Neuropathic pain |
|
|
|
MD Anderson Cancer Center |
National Cancer Institute |
US |
2020-05-26 |
2021-07-01 |
2020-0508, 2020-0508, NCI-2020-06014, NCT04650178 |
Phase Not Applicable |
Recruiting |
1 |
13 Months |
274 |
Sarah Prinsloo |
2020-12-04 |
| Differences in Exhaled Breath by Using Ion Mobility Spectrometry (IMS) in Subjects Tested for SARS-CoV-2 Infection (COVID-19 Disease) |
Coronavirus disease 19 infection |
Ion Mobility Spectrometry (IMS) alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
B Braun Melsungen AG |
CeGaT |
Germany |
2020-12-31 |
2021-05-31 |
HC-N-H-2006, NCT04649931 |
Phase Not Applicable |
Not yet recruiting |
1 |
5 Months |
400 |
Juergen Schaefer, Prof. Dr., Study Manager |
2020-12-04 |
| Perception of the COVID-19 Pandemic in Patients With Hematological or Solid Neoplasias |
Acute stress disorder, Coronavirus disease 19 infection, Hematological neoplasm, Solid tumor |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Medizinische Universität Innsbruck |
|
Austria |
2020-11-23 |
2020-12-31 |
1264/2020, NCT04649320 |
Phase Not Applicable |
Recruiting |
1 |
1 Month |
300 |
Reinhard Stauder, M.D. |
2020-12-04 |
| COVID-19 Nasal Swab Trial |
Coronavirus disease 19 infection |
CanSwab alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Orthopaedic Innovation Center Inc |
|
Canada |
2020-12-31 |
2021-02-28 |
B2020:121, NCT04649424 |
Phase Not Applicable |
Not yet recruiting |
1 |
2 Months |
72 |
Anand Kumar, MD, Gloria Vasquez-Grande, MD, Kerry Dust, MD, Paul Van Caeseele, MD, Sarah Tran, Trevor Gascoyne |
2020-12-04 |
| ResCOVID: A Clinical Trial for Hospitalized Patients With COVID-19 in Ceara |
Coronavirus disease 19 infection |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Escola de Saúde Pública do Ceará |
|
Brazil |
2020-04-02 |
2021-12-30 |
3.948.100, NCT04649827, ResCOVID |
Phase Not Applicable |
Recruiting |
1 |
20 Months |
3000 |
Jadson A' Franco, Marcelo A Holanda, PHD |
2020-12-04 |
| Convalescent Plasma for Treatment of COVID-19: An Open, Randomized, Controlled Trial |
Coronavirus disease 19 infection |
SARS-CoV-2 convalescent plasma alone, steroid therapy alone, SARS-CoV-2 convalescent plasma plus betamethasone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Karolinska University Hospital |
Danderyd Hospital, Falu Hospital, Karolinska Institutet |
Sweden |
2020-12-03 |
2022-02-01 |
CP3, NCT04649879 |
Phase 2/Phase 3 Clinical |
Not yet recruiting |
3 |
13 Months |
920 |
Alexandre Bonnard, MD, Anne Börjesson Hanson, Hanna Sahlgren, MD, Joakim Dillner, Joakim Dillner, MD, PhD, Johan Rudling, MD, Johan Ursing, MD, PhD, Karin Norlin, Karl Hagman, MD, Lena Flod, Magnus Hedenstierna, MD, PhD, Maria Eriksdotter, Miia Kivipelto, Ulf Öhlund |
2020-12-07 |
| COVID-19 Thrombosis Prevention Trials: Post-hospital Thromboprophylaxis |
Coronavirus disease 19 infection, Deep vein thrombosis, Ischemic stroke, Lung embolism, Myocardial infarction, Thromboembolism |
apixaban alone |
Factor Xa antagonist |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Duke University |
National Heart Lung and Blood Institute |
US |
2020-12-31 |
2021-09-30 |
NCT04650087, PRO00107078 |
Phase 3 Clinical |
Not yet recruiting |
1 |
9 Months |
5320 |
Thomas L. Ortel, MD, PhD, Thomas Ortel, M.D., Ph.D, Tracy Wang, MD |
2020-12-04 |
| Effect of Favipiravir on outpatient treatment of COVID-19 |
Coronavirus disease 19 infection |
favipiravir alone |
RNA polymerase inhibitor |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Isfahan University of medical Sciences |
|
Iran |
2020-12-21 |
|
IR.MUI.MED.REC.1399.780, IRCT20171219037964N3 |
Phase 3 Clinical |
Not yet recruiting |
3 |
|
70 |
Babak Amra, Dr. Babak Amra, Dr. Forough Soltaninejad, Dr. Mehrdad Salahi, Shaghayegh haghjooy Javanmard |
2020-12-04 |
| Variation in Acute Appendicitis During COVID-19 Pandemic in Italy |
Appendicitis, Coronavirus disease 19 infection |
appendectomy alone |
|
|
University of Milano-Bicocca |
|
Italy |
2020-09-01 |
2020-11-30 |
APPENDICITE-COVID, Appendicitis-pandemic, NCT04649996 |
Phase Not Applicable |
Completed |
6 |
3 Months |
532 |
|
2020-12-07 |
| A multiple-ascending dose study to evaluate RP-7214 in Covid-19 patients |
Coronavirus disease 19 infection |
RP-7214 alone |
Dihydroorotate dehydrogenase inhibitor |
|
Rhizen Pharmaceuticals SA |
|
US |
|
|
|
Phase Not Applicable |
Planned |
1 |
|
|
|
2020-12-03 |
| ABDALA: ABDALA Clinical Study |
Coronavirus disease 19 infection |
CIGB-66 alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Center for Genetic Engineering and Biotechnology |
|
Cuba |
2020-07-12 |
2021-05-31 |
ABDALA, IG / CIGB-66I / CVD19 / 2002, RPCEC00000346 |
Phase 1/Phase 2 Clinical |
Not yet recruiting |
1 |
10 Months |
132 |
Francisco Hernandez Bernal, Maria Carmen Ricardo Cobas |
2020-12-04 |
| Efficacy and Safety of TY-027, a Treatment for COVID-19, in Humans |
Coronavirus disease 19 infection |
TY-027, Tychan alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Tychan Pte Ltd |
|
Singapore |
2020-12-04 |
2021-12-30 |
NCT04649515, SCT-301 |
Phase 3 Clinical |
Not yet recruiting |
1 |
12 Months |
1305 |
Anjali Baglody, MSc, Jenny Low, MBBS, Justin Ng, PhD |
2020-12-04 |
| A first-in-man, single ascending dose study to evaluate RP-7214 in healthy subjects |
Coronavirus disease 19 infection |
RP-7214 alone |
Dihydroorotate dehydrogenase inhibitor |
Healthy volunteers accepted |
Rhizen Pharmaceuticals SA |
|
US |
|
|
|
Phase 1 Clinical |
Not yet recruiting |
1 |
|
|
|
2020-12-03 |
| Curmeric-Prevention-COVID-19-Health Personnel-General Calixto Garcia University Hospital |
Coronavirus disease 19 infection |
curmeric alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Center for Technological Applications and Nuclear Development (CEADEN) |
Calixto Garcia Hospital, Ministerio de Salud Publica |
Cuba |
2020-03-19 |
2020-04-18 |
RPCEC00000344 |
Phase Not Applicable |
No longer recruiting |
1 |
1 Month |
199 |
Tania Valdes González, Yanet Morejon Diaz |
2020-12-07 |
| COVID-19 and Sports - an Online Survey on the Impact of the Pandemic and Possible Preventive Measures |
Coronavirus disease 19 infection |
|
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Medizinische Universität Innsbruck |
Universitat Innsbruck |
Austria |
2020-06-15 |
2020-08-31 |
20200609, NCT04649333 |
Phase Not Applicable |
Completed |
1 |
2 Months |
1336 |
|
2020-12-08 |
| STEPCO: Short and Medium-term Effects of Pulmonary Rehabilitation in Mild to Critical Post-acute COVID-19 |
Coronavirus disease 19 infection |
pulmonary rehabilitation program alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Schön Klinik Berchtesgadener Land |
|
Germany |
2020-11-25 |
2021-03-31 |
COVID-REHAB, NCT04649918, STEPCO |
Phase Not Applicable |
Recruiting |
1 |
4 Months |
50 |
Andreas R Koczulla, MD, Rainer Gloeckl, PhD |
2020-12-07 |
| Surfactant Protein Genetic Variants in COVID-19 Infection |
Coronavirus disease 19 infection |
genetic test alone |
|
Newborn Infants (up to 5 months), Infants (6-23 months), Preschool Children (2-5 yrs), Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Milton S. Hershey Medical Center |
|
US |
2020-03-01 |
2021-12-31 |
15456, NCT04650191 |
Phase Not Applicable |
Recruiting |
1 |
22 Months |
300 |
Chintan Gandhi, Chintan K Gandhi, MD, MBBS |
2020-12-04 |
| A retrospective study to evaluate the epidemiological and clinical characteristics of older patients with COVID-19 outside Wuhan |
Coronavirus disease 19 infection |
epidemiological and clinical analysis alone |
|
|
National Natural Science Foundation of China |
|
China |
|
|
|
Phase Not Applicable |
Status not specified |
1 |
|
788 |
|
2020-12-03 |
| Sharing Stories: a digital intervention for caregivers with young children in the COVID-19 era to promote child social, emotional and language development, responsive parenting and parental mental wellbeing in Zambia, Tanzania and Uganda |
Coronavirus disease 19 infection, Psychiatric disorder |
Sharing Stories digital group-based parenting intervention alone |
|
|
University of Stellenbosch |
The LEGO Foundation |
Uganda, Zambia, Tanzania |
2020-06-01 |
2021-05-31 |
ISRCTN77689525 |
Phase Not Applicable |
No longer recruiting |
4 |
12 Months |
720 |
Prof Sarah Skeen |
2020-12-04 |
| A retrospective study to evaluate the therapeutic effects of adenosine in high flow 21% oxygen aereosol in patients with Covid19-pneumonia |
Coronavirus disease 19 infection, Pneumonia |
adenosine alone |
|
|
Universita degli Studi di Roma La Sapienza |
|
|
|
|
|
Phase Not Applicable |
Status not specified |
0 |
|
66 |
|
2020-12-03 |
| Types of drugs used and their side effects in COVID-19 patients |
Coronavirus disease 19 infection |
|
|
Infants (6-23 months), Preschool Children (2-5 yrs), Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Maulana Azad Medical College |
|
India |
2020-12-07 |
|
CTRI/2020/12/029463 |
Phase Not Applicable |
Not yet recruiting |
1 |
|
1000 |
Dr Bhupinder Singh, Dr Bhupinder Singh Kalra |
2020-12-04 |
| How COVID-19 affected MAHE students diet and lifestyle practices |
Coronavirus disease 19 infection |
|
|
Healthy volunteers accepted, Young Adults (18-44 yrs) |
Welcomgroup Graduate School of Hotel Administration |
|
India |
2020-12-03 |
|
CTRI/2020/12/029456 |
Phase Not Applicable |
Not yet recruiting |
1 |
|
294 |
Asha Moideen, Aswindev, Aswindev J, Dr Meenakshi Garg |
2020-12-04 |
| Study of COVID-19 infection in hemodialysis and post-renal transplant patients |
Coronavirus disease 19 infection, End stage renal disease, Kidney dialysis, Kidney transplantation |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Shree Krishna Hospital, The Healing Tree |
|
India |
2020-12-11 |
|
CTRI/2020/12/029478 |
Phase Not Applicable |
Not yet recruiting |
1 |
|
80 |
Dr Maulin Shah |
2020-12-04 |
| HBOTpCOVID: Hyperbaric Oxygen Therapy for Post-COVID-19 Syndrome |
Cognitive disorder, Coronavirus disease 19 infection |
hyperbaric oxygen therapy alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Assaf-Harofeh Medical Center |
|
Israel |
2021-01-01 |
2023-01-01 |
332-20-ASF, HBOTpCOVID, NCT04647656 |
Phase Not Applicable |
Not yet recruiting |
1 |
24 Months |
70 |
Shai Efrati, Prof., Shani Zilberman-Itskovich, Dr. |
2020-12-04 |
| MAMBISA study: Adaptive phase I/II clinical trial, randomized, of parallel-groups, to evaluate the safety and immunogenicity in adults of two vaccine candidates, based on recombinant RBD subunits for the prevention of COVID-19 in regimens that use the nasal route of administration. (COVID-19) |
Coronavirus disease 19 infection |
CIGB-66 alone, CIGB-669 alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) |
Center for Genetic Engineering and Biotechnology |
|
Cuba |
2020-12-07 |
2021-05-31 |
IG / VPIN / CVD19 / 2001, MAMBISA study, RPCEC00000345 |
Phase 1/Phase 2 Clinical |
Not yet recruiting |
1 |
5 Months |
88 |
Carlos Alberto Gonzalez Delgado, Zurina Cinza estevez |
2020-12-04 |
| Clinical Characteristics and Outcomes of Patients with COVID-19 Admitted in the ICU of a Tertiary Public Hospital and COVID-19 Referral Center in the Philippines |
Coronavirus disease 19 infection |
|
|
|
Philippine General Hospital |
|
Philippines |
2020-04-01 |
2020-06-01 |
PHRR201125-003177 |
Phase Not Applicable |
No longer recruiting |
1 |
2 Months |
|
Aprille Anne O. Octaviano, Blessie Marie B. Perez, Jubert P. Benedicto, MD |
2020-12-03 |
| MAC VITAL: Implementing Peri-operative Mobile Application for Contactless Vital Signs |
Coronavirus disease 19 infection |
Anura Research app alone, standard vital sign measurement device alone, vital sign measurement alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
The University Health Network |
|
Canada |
2020-12-15 |
2024-12-15 |
MAC VITAL, NCT04648111, PROTOCOL VERSION: OCT 29, 2020 |
Phase Not Applicable |
Not yet recruiting |
1 |
48 Months |
200 |
|
2020-12-02 |
| Effect of medical mask on maternal oxygen saturation and fetal non-stress test during late third trimester of pregnancy in the COVID-19 era |
Coronavirus disease 19 infection |
surgical mask alone |
|
Healthy volunteers accepted, Female, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Native American Ancestry |
Srinakarinwirot University |
|
Thailand |
2020-12-01 |
|
TCTR20201124002 |
Phase 0 Clinical |
Not yet recruiting |
1 |
|
70 |
Tharangrut Hanprasertpong |
2020-12-08 |
| Exploratory Study: COVID-19 and Pregnancy |
Coronavirus disease 19 infection |
SARS-CoV-2 serology test alone |
|
Healthy volunteers accepted, Female, Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) |
Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo |
|
Brazil |
2020-09-21 |
2022-06-13 |
30270820.3.0000.0068, NCT04647994 |
Phase Not Applicable |
Recruiting |
1 |
20 Months |
500 |
Ana CS Farche, PhD, Ana Claudia S Farche, PhD, Rossana P Francisco, PhD |
2020-12-03 |
| Re_Co: Medical Rehabilitation after Coronavirus Disease (Covid-19)/ Re_Co |
Acute stress disorder, Coronavirus disease 19 infection |
pneumological rehabilitation alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
University of Lubeck |
Deutsche Rentenversicherung Bund |
Germany |
2021-02-01 |
|
20-391, DRKS00023642, Re_Co |
Phase Not Applicable |
Not yet recruiting |
2 |
|
580 |
Ruth Deck |
2020-12-03 |
| COVER-Studie: Investigation of factors that may influence the course of a SARS-CoV-2 infection (COVID-19): A study of the University Medical Center Greifswald |
Coronavirus disease 19 infection |
questionnaire alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University Medicine Greifswald |
|
Germany |
2020-04-30 |
|
BB 059/20, COVER-Studie, DRKS00021672 |
Phase Not Applicable |
Recruiting |
1 |
|
400 |
Eik Schäfer, Klaus Hahnenkamp, Wolfgang Hoffmann |
2020-12-03 |
| A cohort study to evaluate the clinical and laboratory features and short-term outcomes of patients with coronavirus disease 2019 (COVID-19) |
Coronavirus disease 19 infection |
antimicrobial alone, clinical and laboratory features analysis alone, glucocorticoid alone |
|
|
Chinese Academy of Medical Sciences |
|
China |
|
|
|
Phase Not Applicable |
Status not specified |
1 |
|
102 |
|
2020-12-02 |
| IFN-beta-1b and Remdesivir for COVID19 |
Coronavirus disease 19 infection |
interferon beta-1b plus remdesivir |
COVID19 non structural protein 8 modulator, COVID19 replicase polyprotein 1ab inhibitor, RNA polymerase modulator |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
The University of Hong Kong |
|
Hong Kong |
2020-11-20 |
2021-09-30 |
NCT04647695, UW 20-535 |
Phase 2 Clinical |
Recruiting |
1 |
10 Months |
100 |
Ivan FN Hung, MD FRCP, Kelvin KW To, MD FRCPath |
2020-12-04 |
| ASAP-C: Corticosteroids in Severe COVID-19 |
Coronavirus disease 19 infection, Respiratory distress syndrome |
|
|
Newborn Infants (up to 5 months), Infants (6-23 months), Preschool Children (2-5 yrs), Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University Hospital Brno |
|
Czech Republic |
2021-01-01 |
2021-04-01 |
ASAP-C, ASAP-C STUDY, NCT04648410 |
Phase Not Applicable |
Not yet recruiting |
1 |
3 Months |
2000 |
Jan Malaska, MD. Ph.D., Jan Malaska, MD., Ph.D, Jozef Klučka, assoc.Prof.MD, Ph.D, Jozef Klučka, assoc.prof.MD.Ph.D., Petr Štourač |
2020-12-03 |
| A retrospective study to evaluate the negative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patients |
Coronavirus disease 19 infection, Hyperglycemia |
tocilizumab alone |
|
|
University of Campania Luigi Vanvitelli |
|
Italy |
|
|
|
Phase Not Applicable |
Status not specified |
1 |
|
475 |
|
2020-12-02 |
| Starling Registry Study |
Coronavirus disease 19 infection |
Starling detector system alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Baxter Healthcare Corp |
|
US |
2020-12-07 |
2022-07-31 |
BXU553561, NCT04648293 |
Phase Not Applicable |
Not yet recruiting |
1 |
19 Months |
600 |
Baxter Clinical Trials Disclosure Call Center, Jennifer Sahatjian |
2020-12-02 |
| Covid outcomes among patients with comorbidities |
Asthma, Cancer, Cardiovascular disease, Cerebrovascular trauma, Chronic obstructive pulmonary disease, Connective tissue disease, Coronavirus disease 19 infection, Diabetes mellitus, Endocrine disease, HIV infection, Hematological disease, Hypertension, Immune deficiency, Interstitial lung disease, Mycobacterium tuberculosis infection, Obesity, Psychiatric disorder, Renal disease, Rheumatoid arthritis, Systemic lupus erythematosus, Vasculitis |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Sri Ramachandra University |
|
India |
2020-12-15 |
|
CTRI/2020/12/029452 |
Phase Not Applicable |
Not yet recruiting |
1 |
|
1000 |
Dr Swathy Moorthy, DrSPThiagarajan |
2020-12-03 |
| A phase IV clinical study to assess Carragelose in healthcare professionals, who are managing COVID-19 patients |
Coronavirus disease 19 infection |
iorta-carrageenan (intranasal, COVID-19), Marinomed Biotechnology alone |
|
|
Marinomed Biotechnologie GmbH |
|
Austria |
|
|
|
Phase 4 Clinical |
Planned |
1 |
|
334 |
Dr. Christoph Wenisch |
2020-12-02 |
| CLARITY: Controlled evaLuation of Angiotensin Receptor Blockers (DMX-200) for COVID-19 respiratory disease |
Coronavirus disease 19 infection |
irbesartan + propagermanium (oral extended release, chronic kidney disease/diabetic retinopathy/NASH/focal segmental glomerulosclerosis/diabetic nephropathy), Dimerix Bioscience alone |
Angiotensin II AT-1 receptor antagonist, CCR2 chemokine antagonist |
|
Dimerix Bioscience Pty Ltd |
|
|
|
|
CLARITY |
Phase Not Applicable |
Status not specified |
0 |
|
|
|
2020-12-08 |
| CLARITY 2.0: A prospective, multicenter, randomized, double-blind, placebo-controlled study to evaluate the assess the safety and effectiveness of DMX-200 in COVID-19 patients |
Coronavirus disease 19 infection |
irbesartan + propagermanium (oral extended release, chronic kidney disease/diabetic retinopathy/NASH/focal segmental glomerulosclerosis/diabetic nephropathy), Dimerix Bioscience alone |
Angiotensin II AT-1 receptor antagonist, CCR2 chemokine antagonist |
|
Dimerix Bioscience Pty Ltd |
|
Australia |
|
|
CLARITY 2.0 |
Phase 3 Clinical |
Recruiting |
1 |
|
600 |
Meg Jardine |
2020-12-08 |
| A clinical study to determine the effect of CL-20189 and CL-20193 in mild to moderate COVID-19 patients |
Coronavirus disease 19 infection |
CL-20189 alone, CL-20193 alone, standard therapy alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) |
CLS Pvt Ltd |
|
India |
2020-12-07 |
|
CLS/CV/CL20189/20 Version 1.0, CTRI/2020/12/029475 |
Phase 2 Clinical |
Not yet recruiting |
1 |
|
66 |
Dr K Sunil Naik, Mr Ajjarapu Srinivasu, Mr Kavangula Krishna Chaitanya |
2020-12-03 |
| A clinical trial to study the effect of herbal medicine on enhancing immune function in COVID recovery patients |
Coronavirus disease 19 infection |
aswagandha + amla + shilajeet extract alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) |
Natreon Inc, Kolkata |
|
India |
2020-12-15 |
|
CTRI/2020/12/029476, JBR/RU/CT-16/20 version 1.3 |
Phase 2 Clinical |
Not yet recruiting |
1 |
|
120 |
Dr Srikanta Pandit |
2020-12-04 |
| COVIMMUNITY: Evaluation and Longitudinal Follow-up of Biomarkers Predictive of Severe Forms of COVID-19 |
Coronavirus disease 19 infection |
ELISPOT assay alone, QuantiFERON assay alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Centre Hospitalier Universitaire de Saint Etienne |
|
France |
2020-12-01 |
2022-12-01 |
20CH207, COVIMMUNITY, NCT04648709 |
Phase Not Applicable |
Not yet recruiting |
1 |
24 Months |
100 |
Anne-Emmanuelle BERGER, MD, Florence Rancon, Stéphane PAUL, Stéphane Paul, PHD |
2020-12-04 |
| COVPROSHIELD: Effectiveness and Adherence to Closed Face Shields to Prevent COVID-19 Transmission |
Coronavirus disease 19 infection |
Closed face shield alone, Surgical face mask alone, educational video alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Universidad Los Andes |
Roche Pharma AG, United Nations |
Colombia |
2020-12-31 |
2021-03-31 |
1010166518, COVPROSHIELD, NCT04647305 |
Phase Not Applicable |
Not yet recruiting |
1 |
3 Months |
233 |
Alejandro Pacheco Gurruchaga, MSc, Andrea Ramirez Varela, PhD, Eduardo Behrentz, PhD, Giancarlo Buitrago Gutierrez, PhD, Jhon M. Gonzalez, PhD, José D. Pinzón, MSc, Juan D. Martin, MSc, Juan J. Yepes Nuñez, PhD, Luis J. Hernandez Florez, PhD, Rachid Laajaj, PhD, Silvia Restrepo Restrepo, PhD |
2020-12-02 |
| NOS: Nutritional Status in Locally Advanced or Metastatic Solid Cancer Patients in Spain: the NutriOncoSearch (NOS) Study |
Advanced solid tumor, Coronavirus disease 19 infection, Malnutrition |
chemotherapy alone, immunotherapy alone, radiotherapy alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Universidad Pontificia Comillas De Madrid |
Baxter Healthcare Corp, European Society for Medical Oncology, IQVIA RDS Pty Ltd |
Spain |
2020-06-10 |
2020-12-15 |
NCT04168814, NOS, SEEO-19-01-NOS |
Phase Not Applicable |
No longer recruiting |
11 |
6 Months |
586 |
Julio C de la Torre-Montero, Ph.D |
2020-12-03 |
| Responsible Gambling Telephone Intervention to High-risk Gamblers by a State-owned Gambling Operator in Sweden |
Coronavirus disease 19 infection |
Motivational telephone intervention alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Lunds University Bioscience |
Svenska Spel |
Sweden |
2020-11-30 |
2021-11-30 |
NCT04646421, OMSORGSSAMTAL |
Phase Not Applicable |
Recruiting |
1 |
12 Months |
3626 |
Anders Håkansson, PhD |
2020-12-03 |
| The effect of hemoperfusion on patients with severe symptoms of covid-19 which are resistant to conventional therapies |
Coronavirus disease 19 infection, Respiratory distress syndrome |
hemoperfusion alone |
|
|
Oroumia University of Medical Sciences |
|
Iran |
2020-11-10 |
|
IR.UMSU.REC.1399.259, IRCT20180625040232N7 |
Phase Not Applicable |
Recruiting |
1 |
|
20 |
Saman Farshid, ِDr Iraj Mohebi |
2020-12-02 |
| Effects of herbal drug Imfluna on patients with COVID-19 |
Coronavirus disease 19 infection, Viral pneumonia |
Imfluna, Zarsan Salamat Pharmaceutical Company alone, standard medications alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
Zarsan Salamat Company |
|
Iran |
2020-11-15 |
|
IR.MEDSAB.REC.1399.115, IRCT20080901001157N17 |
Phase 2 Clinical |
Recruiting |
1 |
|
60 |
Afsaneh Kafash, Fallah Huseini Hasan, Fereshtah Qorat, Mehdi Khairabadi, Mohammadreza Gholibeikian |
2020-12-02 |
| Epidemiology and clinical features in patients with COVID-19 in Mexican Southeast: A retrospective analysis |
Coronavirus disease 19 infection |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Hospital Regional de Alta Especialidad Juan Graham Tabasco |
|
Mexico |
2020-03-30 |
2020-12-31 |
ACTRN12620001265965, ANZCTR380303 |
Phase Not Applicable |
No longer recruiting |
1 |
9 Months |
1000 |
Guadalupe del Carmen Baeza Flores, Jesús Arturo Ruiz Quinones |
2020-12-02 |
| Evaluation of SARS-CoV-2 Serum Antibody Titer in Pediatric Health Workers |
Coronavirus disease 19 infection |
|
|
|
St Marianna University School of Medicine |
|
Japan |
2020-12-01 |
|
UMIN000042599 |
Phase Not Applicable |
Not yet recruiting |
1 |
|
30 |
Yukitsugu Nakamura |
2020-12-02 |
| A phase IV study of iorta-carrageenan (intranasal, COVID-19), Marinomed Biotechnology for the prevention of SARS-CoV-2 infection |
Coronavirus disease 19 infection |
iorta-carrageenan (intranasal, COVID-19), Marinomed Biotechnology alone |
|
|
Marinomed Biotechnologie GmbH |
|
|
|
|
|
Phase 4 Clinical |
Planned |
0 |
|
|
|
2020-12-02 |
| A Phase III Clinical Trial to Determine the Safety and Efficacy of ZF-2001 for Prevention of COVID-19 |
Coronavirus disease 19 infection |
ZF-2001 (Anhui Zhifei Longcom Biopharmaceutical Co Ltd) alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over), Asian Ancestry |
Anhui Zhifei Longcom Biopharmaceutical Co Ltd |
|
China |
2020-12-31 |
2022-04-30 |
LKM-2020-NCV-GJ01, NCT04646590 |
Phase 3 Clinical |
Not yet recruiting |
1 |
16 Months |
29000 |
Fan Di, Master, Fangjun Li, Bachelor |
2020-12-02 |
| MRG-001 as an Immunoregulatory and Regenerative Therapy for COVID-19 Patients |
Coronavirus disease 19 infection |
MRG-001, Medregen alone |
|
Young Adults (18-44 yrs) |
Medregen Llc |
Kendall Healthcare Group, Ltd |
US |
2021-01-05 |
2021-06-05 |
MRG2020, NCT04646603 |
Phase 1/Phase 2 Clinical |
Not yet recruiting |
1 |
5 Months |
12 |
Ali R Ahmadi, PhD, James F Burdick, MD, Michael E Nottidge, MD |
2020-12-08 |
| Psychological Health, Coping Strategies and Preferences of Military COVID-19 Deployers |
Acute stress disorder, Coronavirus disease 19 infection |
|
|
Healthy volunteers accepted |
David Grant USAF Medical Center |
|
US |
2020-12-31 |
2021-05-31 |
FWH20200203E, NCT04646642 |
Phase Not Applicable |
Not yet recruiting |
1 |
5 Months |
160 |
Amanda Fox |
2020-12-02 |
| The Relationship Between Covid-19 Infection in Pediatric Patients and Secondary Lymphoid Organs |
Coronavirus disease 19 infection |
|
|
Infants (6-23 months), Preschool Children (2-5 yrs), Children (6-12 yrs), Adolescents (13-17 yrs) |
Selcuk University |
|
Turkey |
2020-10-01 |
2021-02-01 |
2020/480, NCT04646525 |
Phase Not Applicable |
Recruiting |
1 |
4 Months |
300 |
Merih Onal, Assist. Prof., Merih Onal, M.D., Selcen Celik |
2020-12-02 |
| ARC: Establish and analyse a model of care for the management of people taking oral anti-cancer medications by an Advanced Nurse Practitioner: a pilot study |
Cancer, Coronavirus disease 19 infection |
anti-cancer medication alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Irish Cancer Society |
|
Ireland |
2020-04-08 |
2022-09-14 |
ARC, CNRA19RICH, ISRCTN10401455 |
Phase Not Applicable |
Recruiting |
2 |
29 Months |
40 |
Dr Janice Richmond, Prof Andrew Murphy |
2020-12-02 |
| EMOS-COVID: Enoxaparin at Prophylactic or Therapeutic Doses in COVID-19 |
Coronavirus disease 19 infection, Respiratory failure, Thrombosis, Viral pneumonia |
enoxaparin sodium alone |
Low molecular weight heparin |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
ASST Fatebenefratelli Sacco |
Universita degli Studi di Milano, Universita' Degli Studi Di Foggia, University of Milano-Bicocca |
Italy |
2020-07-27 |
2021-07-31 |
EMOS-COVID, HLS-02COVID19/2020, NCT04646655 |
Phase 3 Clinical |
Recruiting |
1 |
12 Months |
300 |
Maddalena A Wu, M.D., Massimo Arquati, M.D. |
2020-12-02 |
| Effect of internet-delivered psychoeducation program named 'Imacoco-care' on improving psychological distress among workers under COVID-19 infection |
Acute stress disorder, Coronavirus disease 19 infection, Panic disorder |
Imacoco-care alone, internet-delivered psychoeducational program alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University of Tokyo |
|
Japan |
2020-12-05 |
|
UMIN000042556 |
Phase Not Applicable |
Not yet recruiting |
1 |
|
1000 |
Kotaro Imamura, Norito Kawakami |
2020-12-02 |
| Covid-19 Risk Factors and Pattern Between Healthcare Workers |
Coronavirus disease 19 infection |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Assiut University |
|
Egypt |
2020-12-31 |
2022-01-31 |
COVID-19 PATTERRN, NCT04646551 |
Phase Not Applicable |
Not yet recruiting |
1 |
13 Months |
165 |
Duaa Bahgat Abdelhamed, Mohamed Mostafa Abdelhady, Sahar Ahmed, Sahar Ahmed Okily |
2020-12-02 |
| Remote Patient Monitoring (RPM) for patients with COVID-19 and other infection |
Coronavirus disease 19 infection, Infectious disease |
Medopad alone, Remote patient monitoring solutions alone, SaniQ Infekt alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Zentralinstitut für die kassenärztliche Versorgung in der Bundesrepublik Deutschland |
|
Germany |
2020-12-01 |
|
DRKS00023553, Eth-KB 19/20 |
Phase Not Applicable |
Not yet recruiting |
6 |
|
120 |
Sarah Eichler |
2020-12-03 |
| STOP CC: Effects of a low-threshold Substitution Therape of Opioid-dependent Patients during the Corona Crisis (COVID-19) |
Coronavirus disease 19 infection, Opiate dependence |
substitution therapy alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Drob Inn |
University of Hamburg |
Germany |
2020-10-14 |
|
2020-10058-BO, DRKS00023401, STOP CC |
Phase Not Applicable |
Recruiting |
1 |
|
80 |
Fabian Vorberg, Uwe Verthein |
2020-12-03 |
| CoV-Surv: Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population: study protocol for a cluster-randomized, two-factorial, controlled trial |
Coronavirus disease 19 infection |
Reverse Transcription Loop-mediated Isothermal Amplification (RT-LAMP) alone, pre-screening questionnaire alone, saliva sample alone |
|
Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University of Heidelberg |
Bundesministerium für Bildung und Forschung, Gesundheitsamt Rhein-Neckar |
Germany |
2020-11-18 |
|
CoV-Surv, DRKS00023271, S-790/2020, U1111-1259-3834 |
Phase Not Applicable |
Recruiting |
1 |
|
10000 |
Andreas Deckert |
2020-12-02 |
| CarECorona: Nursing care in times of corona (Covid-19). Scientific study on challenges and pressures from the perspective of leaders (continued) Is the threat of system collapse still present or are we normalizing the madness? |
Coronavirus disease 19 infection |
Lime-Survey alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University of Cologne |
|
Germany |
2020-12-03 |
|
20-1459, CarECorona, DRKS00023402 |
Phase Not Applicable |
Recruiting |
1 |
|
1000 |
Kira Hower |
2020-12-02 |
| A clinical trial to study effect of Madhav Rasayan tablets in COVID-19 patients |
Coronavirus disease 19 infection |
Madhav Rasayan alone, Standard treatment alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) |
Shri Vishwavati Ayurved Chikitsalaya and Research Centre |
|
India |
2020-12-03 |
|
CTRI/2020/11/029444, SVACRC/20/1 V 2.0 |
Phase 3 Clinical |
Not yet recruiting |
0 |
|
60 |
Dr Pankaj H Bansode, Dr Tushar Saundankar, Shailesh Balkrishna Malekar |
2020-12-09 |
| Effect of remote management on comprehensive management of diabetes mellitus during the COVID-19 epidemic |
Coronavirus disease 19 infection, Diabetes mellitus |
WeChat APP alone, remote management alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
Second Hospital of Jilin University |
|
China |
2020-12-01 |
2021-05-01 |
ChiCTR2000040366 |
Phase Not Applicable |
Recruiting |
1 |
5 Months |
90 |
Chuan Zhang, Jing Kang |
2020-12-02 |
| Special project to support elderly singleton or doubleton in the new wave of COVID-19 pandemic |
Coronavirus disease 19 infection |
Telecare alone |
|
Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
|
|
China |
2020-12-01 |
2022-11-30 |
ChiCTR2000040324 |
Phase 0 Clinical |
Recruiting |
1 |
24 Months |
11000 |
Daisy Dexing Zhang, Samuel YS Wong |
2020-12-04 |
| Reinfection with SARS-COV-2 and associated factors |
Coronavirus disease 19 infection |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
Christian Medical College, Vellore, India |
Bill & Melinda Gates Foundation |
India |
2021-01-04 |
|
CTRI/2020/11/029438 |
Phase Not Applicable |
Not yet recruiting |
0 |
|
600 |
Jacob John |
2020-12-09 |
| A phase I clinical trial to evaluate the safety and immunogenicity of BNT-162b2 in healthy Chinese subjects |
Coronavirus disease 19 infection |
BNT-162b2 alone |
COVID19 Spike glycoprotein modulator |
Healthy volunteers accepted, Asian Ancestry |
BioNTech SE, Shanghai Fosun Pharmaceutical (Group) Co Ltd |
|
China |
2020-08-01 |
|
|
Phase 1 Clinical |
Recruiting |
1 |
|
|
|
2020-12-01 |
| Effect of Favipiravir on Mortality in Patients With COVID-19 at a Tertiary Center Intensive Care Unit |
Coronavirus disease 19 infection |
favipiravir alone, lopinavir + ritonavir alone |
HIV protease inhibitor, RNA polymerase inhibitor |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Sisli Hamidiye Etfal Training and Research Hospital |
|
Turkey |
2020-03-15 |
2020-05-15 |
2854, NCT04645433 |
Phase Not Applicable |
Completed |
1 |
2 Months |
100 |
sultan acar sevinc |
2020-12-02 |
| A phase I/II, randomized, double-blind, placebo-controlled, two-stage, multicenter study of HFB-30132A in the treatment of patients with COVID-19 infection |
Coronavirus disease 19 infection |
HFB-30132A alone |
Angiotensin converting enzyme 2 inhibitor, COVID19 Spike glycoprotein inhibitor |
|
HiFiBio |
PJSC Pharmsynthez, Shemyakin Institute of Bioorganic Chemistry |
Russian Federation |
|
|
|
Phase 1/Phase 2 Clinical |
Planned |
1 |
|
|
|
2020-11-30 |
| The effect of wearing face masks on cognitive functioning |
Cognitive disorder, Coronavirus disease 19 infection |
PPE mask (Safe Plus) alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs) |
University of Otago |
|
New Zealand |
2020-07-29 |
2020-10-27 |
ACTRN12620001215910, ANZCTR380747 |
Phase Not Applicable |
Completed |
1 |
2 Months |
50 |
Liana Machado, Neda Nasrollahi |
2020-12-02 |
| Investigating the safety, satisfaction and efficacy of pulmonary tele rehabilitation for people with respiratory conditions, including patients recovering from COVID-19 |
Asthma, Bronchiectasis, Chronic obstructive pulmonary disease, Coronavirus disease 19 infection, Interstitial lung disease, Lung tumor |
Aerobic training alone, Strength training alone, Warm up stretches alone, education sessions alone, pulmonary telerehab exercise training alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Royal Prince Alfred Hospital |
|
Australia |
2021-02-01 |
|
ACTRN12620001279910p, ANZCTR380787, U1111-1259-9240 |
Phase Not Applicable |
Not yet recruiting |
1 |
|
100 |
Lissa Spencer |
2020-12-01 |
| Effects of Fuzheng Huayu Tablets on COVID-19 |
Coronavirus disease 19 infection |
Fuzheng Huayu capsule alone, conventional therapy alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
ShuGuang Hospital, China |
Hubei province hospital of Traditional Chinese Medicine, Jingmen No.1 People’s Hospital |
China |
2020-02-01 |
2020-04-15 |
FZHY-NCP-1, NCT04645407 |
Phase 4 Clinical |
Completed |
1 |
2 Months |
66 |
Liu Chenghai |
2020-12-02 |
| Using Whatsapp for the Consultation |
Coronavirus disease 19 infection |
Infectious disease specialist-led video consultation alone, whastapp application alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Kafkas University |
|
Turkey |
2020-03-11 |
2020-05-31 |
CLINICAL-3, NCT04645563 |
Phase Not Applicable |
Completed |
1 |
2 Months |
144 |
Ramazan Sbirli |
2020-12-02 |
| A novel PhIV precision medicine interventional clinical trial to assess potential link between COVID-19 and hypertension |
Coronavirus disease 19 infection, Hypertension |
drug therapy alone, smart phone app alone |
|
|
Closed Loop Medicine Ltd |
Queen Mary University of London, Technology Strategy Board, William Harvey Clinical Research Centre |
|
2020-11-18 |
|
|
Phase Not Applicable |
Recruiting |
0 |
|
1000 |
|
2020-11-30 |
| Impact of COVID-19 pandemic on hepatobiliary and pancreatic surgical services |
Coronavirus disease 19 infection, Surgical procedure |
|
|
Newborn Infants (up to 5 months), Infants (6-23 months), Preschool Children (2-5 yrs), Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Tan Tock Seng Hospital |
|
Singapore |
2019-01-01 |
2020-06-30 |
ChiCTR2000040265 |
Phase Not Applicable |
Completed |
1 |
18 Months |
547 |
Teo Zhe Hao Timothy |
2020-12-02 |
| A study to evaluate post COVID-19 lung damage |
Coronavirus disease 19 infection, Lung injury, Viral pneumonia |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Medanta The Medicity |
|
India |
2020-12-15 |
|
COVIP/2020/001 Version 01, CTRI/2020/11/029437 |
Phase Not Applicable |
Not yet recruiting |
1 |
|
300 |
Dr Bornali Datta |
2020-12-03 |
| A Placebo-Controlled Trial of Bempegaldesleukin (BEMPEG; NKTR-214) With Standard of Care in Patients With Mild COVID-19 |
Coronavirus disease 19 infection |
bempegaldesleukin alone, standard of care alone |
CD122 agonist, IL-2 receptor agonist |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Nektar Therapeutics |
|
US |
2020-11-13 |
2021-03-27 |
20-214-34, NCT04646044 |
Phase 1b Clinical |
Recruiting |
2 |
4 Months |
30 |
Nektar, Praveena Raman, Study Director |
2020-12-01 |
| Covid with AKI |
Coronavirus disease 19 infection, Renal injury |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Sardar Vallabhbhai Patel Institute of Medical Science and Research (SVPIMSR) |
|
India |
2020-12-14 |
|
CTRI/2020/11/029414 |
Phase Not Applicable |
Not yet recruiting |
1 |
|
100 |
DR ISHAN A DESAI, DR NEHAL M SHAH |
2020-12-01 |
| PEPCO: A Phase III, post exposure prophylaxis for COVID-19 study to evaluate avigan tablets (favipiravir) in the prevention of COVID-19 |
Coronavirus disease 19 infection |
Avigan alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Appili Therapeutics Inc |
Cato Research LLC |
Canada, US |
|
|
PEPCO |
Phase 3 Clinical |
Not yet recruiting |
2 |
|
1156 |
|
2020-12-04 |
| An observational study to evaluate the effect of hydroxychloroquine and azithromycin on arrhythmic profile and QT interval in patients with COVID-19 |
Coronavirus disease 19 infection |
azithromycin plus hydroxychloroquine |
|
Healthy volunteers accepted |
University of Padova |
|
|
|
|
|
Phase Not Applicable |
Status not specified |
0 |
|
22 |
|
2020-11-30 |
| Efficacy of Date Palm Leaf Extract (Phoenix dactylifera) in Patients with COVID-19 Hospitalized in Ganjavian Hospital in Dezful |
Coronavirus disease 19 infection |
palm leaf extract (Phoenix dactylifera) alone |
|
Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Dezful University of Medical Sciences |
|
Iran |
2020-09-12 |
2020-11-16 |
IR.DUMS.REC.1399.037, IRCT20201015049036N1 |
Phase 2 Clinical |
Completed |
1 |
2 Months |
100 |
Dr. Maysam Mard Soltani, Mohammad Dorchin |
2020-12-01 |
| Expanded-Access to T-89 for Treatment Use in Intermediate-size Patients Population With COVID-19 |
Coronavirus disease 19 infection |
T-89 alone |
|
|
Tasly Pharmaceuticals Inc |
Tasly Pharmaceutical Group Co Ltd |
US |
|
|
NCT04646031, T89-ROUSA-01 |
Phase Not Applicable |
Recruiting |
1 |
|
|
Anni Li, Danielle Wahinekapu, Henry H Sun, PhD, MD, Libby Bliss, Patrick Meehan, PhD, MD |
2020-12-01 |
| Biomarkers of Trained Immunity Following MMR Vaccination |
Coronavirus disease 19 infection |
MMR vaccine alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Washington University School of Medicine, US |
|
US |
2020-12-31 |
2021-04-30 |
202011081, NCT04646239 |
Phase Not Applicable |
Not yet recruiting |
1 |
4 Months |
80 |
Jonathan Jocum, MD, Leon du Toit, MD, Linda Yun, Michael S Avidan, MD, Shabaana Khader, PhD, Shail Mehta, MD |
2020-12-06 |
| Ivermectin for Severe COVID-19 Management |
Coronavirus disease 19 infection, Viral pneumonia |
Variable regimens including azithromycin , favipiravir , hydroxychloroquine , ivermectin (solution/enteral, COVID-19), NeuTec Pharma/Afyonkarahisar Health Sciences University |
RNA polymerase inhibitor |
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Afyon karahisar University of Health Sciences |
NeuTec Pharma plc |
Turkey |
2020-05-11 |
2020-09-02 |
IVMC_03, NCT04646109 |
Phase 3 Clinical |
Completed |
4 |
3 Months |
60 |
Neşe Demirtürk, A. Prof. Dr., Nurullah Okumuş, Nurullah Okumuş, Prof. Dr., Rahmet Güner, Prof. Dr., Rıza A. Çetinkaya, Prof. Dr., İsmail Y. Avcı |
2020-12-09 |
| COVID19-MHM: COVID-19 and Hereditary Metabolic Diseases |
Coronavirus disease 19 infection, Gaucher disease, Urea cycle disorder |
|
|
|
Centre Hospitalier Regional Universitaire de Lille |
|
France |
2021-01-31 |
2023-01-31 |
2020-A02886-33, 2020_52, COVID19-MHM, NCT04645498 |
Phase Not Applicable |
Not yet recruiting |
1 |
24 Months |
77 |
Claire Douillard, MD |
2020-12-01 |
| Comparing two medications (dexamethasone and methylprednisolone high dose) for the treatment of pneumonia in patients with COVID-19 |
Coronavirus disease 19 infection, Viral pneumonia |
Dexamethasone alone, methylprednisolone alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Clínica Medellín - Comprometidos con tu Salud |
|
Colombia |
2020-04-01 |
2020-11-15 |
20-33686, ISRCTN33037282 |
Phase Not Applicable |
Completed |
1 |
7 Months |
213 |
Dr Pinzón |
2020-12-03 |
| Study of Longidaze in the Prevention and Treatment of Pulmonary Fibrosis, Interstitial Lung Diseases Caused by COVID-19 |
Coronavirus disease 19 infection, Interstitial lung disease, Pulmonary fibrosis |
Botkin.AI alone, bovhyaluronidase azoximer alone |
Hyaluronidase stimulator |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
NPO Petrovax Pharm LLC |
|
Russian Federation, Kazakhstan |
2020-07-01 |
2021-07-31 |
DISSOLVE, NCT04645368 |
Phase Not Applicable |
Recruiting |
16 |
13 Months |
160 |
A. A. Zaycev, A. G. Borisov, A. U. Petuhova, G. L. Ignatova, L. I. Korneva, L. M. Kudelya, N. V. Kotova, Nikolay S. Dodonov, O. A. Chernyavskaya, O. A. Shagabutdinova, O. V. Masalkina, T. R. Kasyanova, T. V. Rubanik, U. V. Argamakova, V. V. Naumov |
2020-12-01 |
| SSC: SARS-CoV-2 Surveillance in childcare facilities |
Coronavirus disease 19 infection |
SARS-CoV-2 surveillance alone, saliva samples alone |
|
|
Uniklinik Köln - Zentrum Innere Medizin |
|
Germany |
2020-11-29 |
|
20-1466, DRKS00023507, SSC |
Phase Not Applicable |
Recruiting |
1 |
|
120 |
Felix Dewald |
2020-12-01 |
| A multicenter, single-blind, randomized controlled trial on ruxolitinb in treatment of severe coronavirus disease 2019 |
Coronavirus disease 19 infection |
ruxolitinib alone, standard-of-care alone |
Jak1 tyrosine kinase inhibitor, Jak2 tyrosine kinase inhibitor |
|
Cincinnati Children's Hospital Medical Center, Huazhong University of Science and Technology |
|
|
|
|
|
Phase 2 Clinical |
Status not specified |
0 |
|
43 |
|
2020-12-08 |
| Self-perceived depression, anxiety, stress in caregivers of patients in IKN during COVID-19 pandemic |
Acute stress disorder, Anxiety disorder, Coronavirus disease 19 infection, Depression |
|
|
|
Universiti Sains Malaysia |
|
Malaysia |
2021-01-17 |
2021-10-17 |
57267, NMRR-20-2534-57267 |
Phase Not Applicable |
Status not specified |
2 |
9 Months |
|
Sarah Aqilah Binti Ghazali |
2020-11-30 |
| The outcome of Pohon Sihat among healthcare workers during COVID-19 |
Coronavirus disease 19 infection |
|
|
|
Hospital Kuala Lumpur |
|
Malaysia |
2021-01-01 |
2021-04-30 |
55907, NMRR-20-2568-55907 |
Phase Not Applicable |
Recruiting |
1 |
4 Months |
60 |
Hariani binti ishak |
2020-11-30 |
| DOSHHCW: COVID-19 Pandemic: determinants of occupational safety and health compliance among healthcare workers in Penampang and Putatan districts of Sabah |
Coronavirus disease 19 infection |
|
|
|
PEJABAT KESIHATAN KAWASAN PENAMPANG |
|
Malaysia |
2020-12-01 |
2021-12-01 |
57340, DOSHHCW, NMRR-20-2554-57340 |
Phase Not Applicable |
Not yet recruiting |
1 |
12 Months |
|
Dr Ahmad Firdaus bin Mohamed, Dr SAM FROZE ANAK JIEE |
2020-12-06 |
| New norms and PPE usage compliancy |
Coronavirus disease 19 infection |
|
|
|
Slim River Hospital |
|
Malaysia |
2020-11-27 |
2021-01-26 |
57427, NMRR-20-2547-57427 |
Phase Not Applicable |
Status not specified |
1 |
2 Months |
|
Dr Nur Hidayah Binti P.Azhar |
2020-11-30 |
| An observational, retrospective study to compare the outcome of metformin users and nonusers in hospitalized COVID-19 patients with diabetes |
Coronavirus disease 19 infection, Diabetes mellitus |
metformin hydrochloride alone |
AMP activated protein kinase stimulator |
|
Tongji Hospital, Huazhong University of Science and Technology |
|
China |
|
|
|
Phase Not Applicable |
Status not specified |
1 |
|
283 |
|
2020-11-30 |
| A Phase II, Randomized, Double-blinded, Placebo-controlled, Dose-finding Clinical Study to Evaluate the Safety and Immunogenicity of Different Doses of INO-4800 Administered Intradermally Followed by Electroporation in Healthy Adult and Elderly Volunteers |
Coronavirus disease 19 infection |
INO-4800 alone |
COVID19 Spike glycoprotein modulator |
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Advaccine (Suzhou) Biopharmaceuticals Co Ltd, Jiangsu Province Centers for Disease Control and Prevention |
|
China |
2020-11-27 |
2020-12-15 |
ChiCTR2000040146 |
Phase 2 Clinical |
Not yet recruiting |
1 |
|
640 |
Fengcai Zhu, Xuefen Huai |
2020-12-01 |
| Eye Diseases associated with COVID-19 |
Choroid disease, Coronavirus disease 19 infection, Retinopathy |
bedside fundus examination alone, ophthalmoscopy alone, optical coherence tomography alone, optical coherence tomography angiography alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Lilavati Hospital and Research Center |
|
India |
2020-11-30 |
|
CTRI/2020/11/029393 |
Phase Not Applicable |
Not yet recruiting |
1 |
|
30 |
Dr Salil Mehta |
2020-12-02 |
| A study of clinical profile of children with COVID-19 Infection admitted at tertiary care hospital |
Coronavirus disease 19 infection |
|
|
Newborn Infants (up to 5 months), Infants (6-23 months), Preschool Children (2-5 yrs), Children (6-12 yrs) |
Smt. NHL Municipal Medical College |
|
India |
2020-11-28 |
|
CTRI/2020/11/029390 |
Phase Not Applicable |
Not yet recruiting |
1 |
|
200 |
DR Sweety Patel |
2020-11-30 |
| Virtual Enhanced Lifestyle for Metabolic Syndrome (ELM) Proof-of-Concept Study |
Coronavirus disease 19 infection, Metabolic syndrome X |
virtual enhanced lifestyle for metabolic syndrome program alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Rush University Medical Center |
Geisinger Clinic, Rochester Institute Of Technology, University of Colorado, University of Missouri |
US |
2020-08-01 |
2021-03-30 |
20061108, NCT04637477 |
Phase Not Applicable |
No longer recruiting |
2 |
7 Months |
10 |
Lynda Powell, PhD |
2020-12-01 |
| Phase II, Multi-Site, Randomized, Placebo-Controlled, Double-Blind, Single-Dose Study of TY-027 for Early Treatment of COVID-19 |
Coronavirus disease 19 infection |
TY-027, Tychan alone |
|
|
Tychan Pte Ltd |
|
Singapore |
|
|
SCT-201 |
Phase 2 Clinical |
Status not specified |
1 |
|
|
Dr Jenny Low |
2020-11-30 |
| XACT: Factor Xa Inhibitor Versus Standard of Care Heparin in Hospitalized Patients With COVID-19 |
Coronavirus disease 19 infection |
rivaroxaban alone |
Factor Xa antagonist |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
|
|
US |
2020-12-01 |
2021-07-31 |
2020-001708-41, NCT04640181, XACT |
Phase 2 Clinical |
Not yet recruiting |
1 |
8 Months |
150 |
Edward Chafizadeh, MD, Matt Cowperthwaite, PhD, Theresa Pham, MD |
2020-11-30 |
| Pirdal Nasal Spray in preventing symptomatic manifestation of disease in COVID-19 proven cases |
Coronavirus disease 19 infection, Respiratory distress syndrome |
Covispray (Vitro-Bio Sarl) alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
Mudra Clincare, Vitro-Bio Sarl |
|
India |
2020-11-27 |
|
CTRI/2020/11/029388, PIR/OBS/2020, Version No.: 4.0 |
Phase 2 Clinical |
Not yet recruiting |
1 |
|
200 |
Dr S Sadgune, Dr Uma Mulay |
2020-12-02 |
| Evaluation of the efficacy and safety of bromhexine administration in COVID-19 |
Coronavirus disease 19 infection |
Variable regimens including bromhexine (Tolid Daru Company) , interferon beta-1a follow-on biologic (subcutaneous), CinnaGen , lopinavir + ritonavir (Hetero Labs Limited) |
Interferon beta ligand |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Shaheed Beheshti Medical University |
|
Iran |
2020-07-10 |
|
IR.SBMU.NRITLD.REC.1399.142, IRCT20151227025726N24 |
Phase 2 Clinical |
No longer recruiting |
1 |
|
100 |
Afshin Zarghi, Farzaneh Dastan, Payam Tabarsi |
2020-11-30 |
| A phase II clinical study to assess Persavita's experimental natural health product in the treatment of patients with COVID-19 |
Coronavirus disease 19 infection |
natural health product alone |
|
|
Persavita Ltd |
|
Canada |
|
|
|
Phase Not Applicable |
Planned |
1 |
|
|
Dr Piraee |
2020-11-27 |
| Effect of cupping on respiratory symptoms of COVID-19 |
Coronavirus disease 19 infection, Respiratory disease |
cupping therapy alone, disposable plastic cup alone, standard medication therapy alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) |
Shaheed Beheshti Medical University |
|
Iran |
2020-09-08 |
|
IR.SBMU.RETECH.REC.1399.563, IRCT20200428047229N3 |
Phase 3 Clinical |
Recruiting |
1 |
|
72 |
Dr. Rasool Choopani, Hanieh Tahermohammadi, Mojgan Tansaz, Zahra Aqanouri |
2020-11-30 |
| Formative research for management of serious infections in infants < 2 months of age during COVID pandemic |
Bacterial infection, Coronavirus disease 19 infection |
|
|
Healthy volunteers accepted |
Society for Applied Studies |
World Health Organization |
India |
2020-12-15 |
|
CTRI/2020/11/029377 |
Phase Not Applicable |
Not yet recruiting |
1 |
|
70 |
Nita Bhandari, Sarmila Mazumder |
2020-11-30 |
| An online study to assess the disposal of Personal protective equipments at home amid COVID-19 Pandemic in India |
Coronavirus disease 19 infection |
|
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Lady Hardinge Medical College |
|
India |
2020-05-06 |
|
CTRI/2020/11/029376 |
Phase Not Applicable |
Completed |
1 |
|
500 |
ARCHANA THAKUR |
2020-11-30 |
| Pentoxifyliine in COVID-19 |
Coronavirus disease 19 infection, Viral pneumonia |
Variable regimens including hydroxychloroquine , interferon beta-1b , lopinavir + ritonavir , pentoxyfylline, Arya company |
HIV protease inhibitor |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Mazandaran University of Medical Sciences |
|
Iran |
2020-11-10 |
|
IR.MAZUMS.REC.1399.744, IRCT20190804044429N4 |
Phase 2/Phase 3 Clinical |
Recruiting |
1 |
|
60 |
Majid Saeedi, Monireh Ghazaeian |
2020-12-02 |
| A clinical study to compare high-flow nasal oxygen and non-invasive ventilation in patients with COVID-19 |
Coronavirus disease 19 infection, Respiratory distress syndrome, Respiratory failure |
high-flow nasal cannula therapy alone, non-invasive ventilation alone, oxygen alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) |
BLDE University |
Sri B. M. Patil Medical College |
India |
2020-11-25 |
|
CTRI/2020/11/029356 |
Phase 2 Clinical |
Not yet recruiting |
1 |
|
82 |
Dr Pratibha S D |
2020-11-30 |
| Assessing the knowledge and precautions taken by dentists and dental auxiliaries (operating, non-operating) in dental office during the pandemic of Corona virus (COVID-19) |
Coronavirus disease 19 infection |
|
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) |
Manipal College of Dental Sciences |
|
India |
2020-12-01 |
|
CTRI/2020/11/029350 |
Phase 2/Phase 3 Clinical |
Not yet recruiting |
1 |
|
108 |
Dr Deepak Kumar Singhal, Dr Saloni Gupta |
2020-11-30 |
| Spectrum of eye infections in COVID-19 affected individuals |
Coronavirus disease 19 infection, Endophthalmitis, Panophthalmitis, Uveitis |
abscess drainage treatment alone, cycloplegic treatment alone, empirical intra-vitreal antibiotic therapy alone, exudation clearance treatment alone, intraocular antibiotic injection therapy alone, non steroidal anti inflammatory drug therapy alone, pars plana vitrectomy alone, silicone oil based retina attachment alone, steroid therapy alone, systemic broad spectrum antibiotic therapy alone, topical broad spectrum antibiotic therapy alone, vitreous biopsy alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
L V Prasad Eye Institute |
|
India |
2020-11-26 |
|
CTRI/2020/11/029346 |
Phase Not Applicable |
Not yet recruiting |
1 |
|
20 |
Dr Sameera Nayak |
2020-11-30 |
| PCOVID: Clarithromycin in post Covid-19 parenchymal organizing pneumonia |
Coronavirus disease 19 infection, Respiratory disease, Viral pneumonia |
anti-tussive medication therapy alone, bronchodilator therapy alone, clarithromycin alone, mucolytics therapy alone, oral anti-fibrotic therapy alone, oral corticosteroid therapy alone, supplementary micronutrient therapy alone, clarithromycin plus oxygen |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
Sri Ramachandra Hospital, Chennai |
|
India |
2020-11-25 |
|
CTRI/2020/11/029305, PCOVID |
Phase 2 Clinical |
Not yet recruiting |
1 |
|
120 |
Irfan Ismail Ayub |
2020-12-01 |
| The Efficacy and Safety of SCTA-01 in Hospitalized Patients With Severe COVID-19 |
Coronavirus disease 19 infection |
Best supportive care alone, SCTA-01 alone |
COVID19 Spike glycoprotein inhibitor |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Sinocelltech Ltd |
|
|
2021-02-10 |
2021-10-10 |
NCT04644185, SCTA01-B301 |
Phase 2/Phase 3 Clinical |
Not yet recruiting |
0 |
8 Months |
795 |
Ji Qi, PhD, Zhanghua Lan, PhD |
2020-11-30 |
| Effectiveness of Pulmonary Rehabilitation Program in Patients With SARS-CoV-2 Pneumonia |
Anxiety disorder, Coronavirus disease 19 infection, Respiratory distress syndrome, Respiratory tract infection, Viral pneumonia |
alternate breathing alone, diaphragmatic breathing alone, early-mobilization and progressive ambulation alone, instructional exercise videos alone, joint ROM exercise alone, peripheral muscle strengthening exercises alone, pulmonary Rehabilitation program alone, pursed-lip breathing alone, respiratory muscle exercises alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Sisli Etfal Hospital |
|
Turkey |
2020-06-30 |
2021-01-31 |
2857, NCT04642040 |
Phase Not Applicable |
Recruiting |
1 |
7 Months |
100 |
Ali Sahillioglu, MD, Enes Efe Is, MD |
2020-11-30 |
| Comparative Effectiveness of IIMR Versus CDSMP |
Bipolar disorder, Cardiac failure, Cardiovascular disease, Chronic obstructive pulmonary disease, Coronavirus disease 19 infection, Depression, Diabetes mellitus, Drug dependence, Hyperlipidemia, Hypertension, Obesity, Respiratory disease, Schizoaffective disorder, Schizophrenia |
Integrated Illness Management and Recovery alone, Stanford Chronic Disease Self-Management Program alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Dartmouth-Hitchcock Medical Center |
Patient Centered Outcome Research Institute |
US |
2019-09-02 |
2024-03-31 |
D19103 31245, NCT03966872 |
Phase Not Applicable |
No longer recruiting |
2 |
54 Months |
600 |
Sarah Pratt |
2020-12-01 |
| Preoperative Covid-19 Screening In Otorhinolaryngolagy, Head And Neck Elective Surgery |
Coronavirus disease 19 infection, Surgical procedure |
Otorhinolaryngolagy alone |
|
|
Hospital Ampang |
|
Malaysia |
2020-11-26 |
2020-12-31 |
57395, NMRR-20-2530-57395 |
Phase Not Applicable |
Status not specified |
1 |
1 Month |
|
Dr NOR AZIRAH BINTI SALAHUDDIN |
2020-11-30 |
| The Role of Hemoperfusion as a Countermeasure for Cytokine Storm in COVID-19 Patients Admitted in a Public Tertiary Hospital in Davao City |
Coronavirus disease 19 infection |
|
|
|
Southern Philippines Medical Center |
|
Philippines |
2020-03-01 |
|
PHRR201120-003164 |
Phase Not Applicable |
Not yet recruiting |
1 |
|
|
Nian Joy T. Ibot, MD |
2020-11-30 |
| Development and Validation of Clinical Scoring for Predicting In-Hospital 30-day Mortality Among COVID-19 Patients in University of the Philippines – Philippine General Hospital: A Retrospective, Cohort Study |
Coronavirus disease 19 infection |
|
|
|
Philippine General Hospital |
|
Philippines |
2020-08-10 |
2020-11-10 |
PHRR201120-003161 |
Phase Not Applicable |
No longer recruiting |
1 |
3 Months |
|
Anna Flor Malundo, MD, Dr. Regina P. Berba MD, Karla Kristel A. Banares, MD, Karla Kristel Banares, Maria Sonia Salamat, MD, Marissa M. Alejandria, MD |
2020-11-30 |
| Tele-monitoring of COVID-19 Survivors for Long-Term Impacts |
Coronavirus disease 19 infection |
Custom-designed miniaturized monitoring system alone, Tele-monitoring alone, video-conferencing sessions alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University of Manitoba |
Function Four Ltd |
|
2020-12-01 |
2021-11-01 |
B2020:114 (HS24395), NCT04644341 |
Phase Not Applicable |
Not yet recruiting |
0 |
11 Months |
20 |
Zahra Moussavi, Ph.D. |
2020-11-30 |
| Characteristics of novel coronavirus pneumonia (COVID-19) patients with mild nucleic acid in hospital for over 30 days |
Coronavirus disease 19 infection, Viral pneumonia |
|
|
Infants (6-23 months), Preschool Children (2-5 yrs), Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
People's Hospital of Shapingba District, Chongqing City |
Chongqing Science and Technology Commission |
China |
2020-09-30 |
2021-08-31 |
ChiCTR2000040179 |
Phase Not Applicable |
Not yet recruiting |
1 |
11 Months |
170 |
Huang Zi-Yang |
2020-11-30 |
| Safety and Pharmacokinetics of a Novel Niclosamide Solution in Combination With Camostat |
Coronavirus disease 19 infection |
niclosamide alone, camostat mesylate plus niclosamide |
Serine protease inhibitor, Transmembrane serine protease 2 inhibitor, Trypsin inhibitor |
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) |
Charite Research Organisation |
Bayer AG |
Germany |
2020-11-02 |
2021-05-31 |
201767, NCT04644705, NIC-002 |
Phase 1 Clinical |
Recruiting |
1 |
6 Months |
28 |
Frank D Wagner, Prof. Dr. med., Maximilian Posch, Dr. med. |
2020-11-30 |
| NeuroCovid: WHO Covid19- Neurological Abnormalities in SARS-CoV-2 ICU Patients |
Coronavirus disease 19 infection |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University Hospital Clermont-Ferrand |
|
France |
2020-10-13 |
2021-08-13 |
NCT04643548, NEUROCOVID-RNI 2020 GODET, NeuroCovid |
Phase Not Applicable |
Recruiting |
1 |
10 Months |
20 |
Benjamin Rieu, Lise Laclautre, Thomas Godet |
2020-12-02 |
| A phase II study to evaluate safety and effectiveness of IND-02 capsules in patients who are hospitalized SARS-CoV2 positive patients with mild to moderate COVID-19 at COVID management centers offering ayurvedic care |
Coronavirus disease 19 infection |
IND-02 alone, standard of care treatment alone |
ApoB editing catalytic polypeptide 3G modulator, HIV gp120 protein modulator |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) |
IQVIA RDS (India) Pvt Ltd, Indus Biotech Pvt Ltd |
|
India |
2020-11-30 |
|
CTRI/2020/11/029328, IND02-ORAL-COVID-19 Version 1.0 |
Phase 2 Clinical |
Not yet recruiting |
5 |
|
118 |
Dr Ajay Javeri, Dr Amlendu Yadav, Dr Amol Laxmanrao Dange, Dr Jaya Prakash Appajigol, Dr Shrikant Deshpande, Suneela Thatte |
2020-11-30 |
| Differential Leukocyte Count and Covid-19 Diagnosis |
Coronavirus disease 19 infection |
CLDC algorithm alone, Differential leukocyte count (CLDC) device alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Istituto Neurologico Mediterraneo NEUROMED |
|
Italy |
2020-12-31 |
2021-05-31 |
DEP_042020, NCT04643860 |
Phase Not Applicable |
Not yet recruiting |
2 |
5 Months |
1000 |
Licia Iacoviello |
2020-12-01 |
| Mask Adhesive Institutional Study |
Coronavirus disease 19 infection, Respiratory failure |
AF531 non-invasive ventilation mask (Philips) alone, PerformaTrak non-invasive ventilation mask (Philips) alone, mask adhesive (Philips) alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Royal Philips Electronics |
|
US |
2020-11-17 |
2020-12-17 |
NCT04644276, SRCHRCMASK ADHESIVE 2020_11130 |
Phase Not Applicable |
Not yet recruiting |
1 |
1 Month |
30 |
Robert Doekel, Wes Booth |
2020-11-30 |
| Telerehabilitation Following Meniscectomy |
Coronavirus disease 19 infection, Knee injury |
knee exercises alone, meniscectomy alone, proprioception and balance training alone, telerehabilitation therapy alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
NYU Langone Health |
|
US |
2020-12-01 |
2022-12-01 |
20-01584, NCT04644640 |
Phase Not Applicable |
Not yet recruiting |
1 |
24 Months |
60 |
Eoghan Hurley, MB, BCh, MCh, Eric Strauss, MD, Guillem Gonzalez-Lomas, MD, Kirk Campbell, MD, Laith Jazrawi, MD, Michael Alaia, MD |
2020-11-26 |
| Apprehensions and challenges faced by dentists during Covid-19 pandemic |
Coronavirus disease 19 infection |
|
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Manipal College of Dental Sciences |
|
India |
2020-12-02 |
|
CTRI/2020/11/029335 |
Phase Not Applicable |
Not yet recruiting |
1 |
|
189 |
Dr Sunitha Carnelio, Muskaan Chichra |
2020-11-30 |
| Improving Thinking in Everyday Life After Covid-19 |
Cognitive disorder, Coronavirus disease 19 infection |
instrumental activities of daily living shaping alone, speed of processing training alone, transfer package alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University of Alabama at Birmingham |
|
US |
2020-11-01 |
2024-11-30 |
IRB-300002814C, NCT04644172 |
Phase 1/Phase 2 Clinical |
Recruiting |
1 |
49 Months |
40 |
Edward Taub, Edward Taub, Ph.D., Staci McKay |
2020-12-01 |
| Brief Video Interventions for Depression |
Coronavirus disease 19 infection, Depression |
video-based intervention on behavioral emotion regulation skill alone, video-based intervention on cognitive emotion regulation skill alone, video-based intervention on interpersonal emotion regulation skill alone, video-based intervention on three emotion regulation skill alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Ohio State University |
|
US |
2020-11-30 |
2020-11-30 |
2020B0326, NCT04643964 |
Phase Not Applicable |
Recruiting |
1 |
|
501 |
Daniel R Strunk, Ph.D., Graham C Bartels, B.S., Jennifer S Cheavens, PhD, Robert J Zhou, B.A. |
2020-11-30 |
| Effects of a Biomechanical-based Tai Chi Program on Gait and Posture in People With Parkinson's Disease |
Coronavirus disease 19 infection, Parkinsons disease |
Tai Chi training alone |
|
Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
University of Ottawa |
|
Canada |
2021-01-31 |
2021-12-31 |
H-01-19-2284, NCT04644367 |
Phase Not Applicable |
Not yet recruiting |
1 |
11 Months |
40 |
Jing Xian Li, PhD., Nok-Yeung Law, Nok-Yeung Law, M.Sc. |
2020-12-01 |
| Using Travelan to Boost Immune Response in Vitro to COVID-19 |
Coronavirus disease 19 infection |
Travelan alone |
|
Healthy volunteers accepted, Male, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Hadassah Medical Organization |
|
Israel |
2020-11-01 |
2020-12-31 |
HEALTHYTRAVELANCOV19- HMO-CTIL, NCT04643561 |
Phase 1/Phase 2 Clinical |
No longer recruiting |
1 |
2 Months |
5 |
Assaf Potruch, MD |
2020-11-30 |
| The Doctors for Coronavirus Prevention Project Thanksgiving Messaging Campaign |
Coronavirus disease 19 infection |
Facebook Ads alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
National Bureau of Economic Research Inc |
Harvard University, Massachusetts General Hospital, Massachusetts Institute of Technology, Stanford University, Yale University |
US |
2020-11-14 |
2021-11-26 |
2003000118A010, NCT04644328 |
Phase Not Applicable |
Not yet recruiting |
1 |
12 Months |
20000000 |
Esther Duflo |
2020-11-26 |
| Management of Type 1 Supracondylar Humeral Fractures |
Coronavirus disease 19 infection, Upper limb fracture |
long arm soft casting alone |
|
Healthy volunteers accepted, Preschool Children (2-5 yrs), Children (6-12 yrs) |
University of British Columbia |
Lady Cilento Children's Hospital |
Canada |
2021-01-31 |
2023-01-31 |
H20-02942, NCT04642807 |
Phase Not Applicable |
Not yet recruiting |
1 |
24 Months |
52 |
Anthony Cooper, Anthony Cooper, FRCSC, Harpreet Chhina, MSc |
2020-12-01 |
| Convalescent Plasma Transfusion in Severe COVID-19 Patients in Jamaica |
Coronavirus disease 19 infection |
convalescent plasma alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
University of the West Indies |
|
Jamaica |
2020-12-01 |
2021-12-01 |
ECP/195,19/20, NCT04644198 |
Phase 2 Clinical |
Not yet recruiting |
1 |
12 Months |
30 |
Gilian G Wharfe, Giliian G Wharfe, MB, BS, DM, Tomlin Paul |
2020-11-30 |
| COVID-OISE: Longitudinal Follow-up of a Population Cohort in a French City With High SARS-CoV-2 Circulation in Early 2020 (COVID 19) |
Coronavirus disease 19 infection |
|
|
Healthy volunteers accepted, Preschool Children (2-5 yrs), Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Institut Pasteur |
|
France |
2020-11-13 |
2023-11-01 |
2020-060, COVID-OISE, NCT04644159 |
Phase Not Applicable |
Recruiting |
2 |
35 Months |
2000 |
Aymar KOFFI, Dr, Bruno HOEN, Pr, Cécile DURU, Dr, Laurie Pinaud, Marie-Noëlle UNGEHEUER,, Sandrine Fernandes Pellerin |
2020-12-01 |
| Develop homeopathic Nosodes for Immunity Against COVID 19 |
Coronavirus disease 19 infection |
nosode alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Central Council for Research in Homeopathy |
Ministry of Ayush, National Cancer Institute, Jhajjar, AIIMS |
India |
2020-12-10 |
|
CTRI/2020/11/029399 |
Phase 1 Clinical |
Not yet recruiting |
1 |
|
20 |
Dr Naval Kumar Verma, Dr Sushma Bhtanagar |
2020-11-28 |
| Palliative Care in COVID-19 |
Coronavirus disease 19 infection |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Kasturba Medical College and Hospital |
|
India |
2020-12-07 |
|
CTRI/2020/11/029398 |
Phase Not Applicable |
Not yet recruiting |
1 |
|
50 |
Seema Rajesh Rao |
2020-11-28 |
| Changing Trends in Presentation of Trauma Patients during Nationwide lockdown for COVID-19 |
Coronavirus disease 19 infection, Injury |
|
|
Newborn Infants (up to 5 months), Infants (6-23 months), Preschool Children (2-5 yrs), Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
HBTMC and Dr RN Cooper Municipal General Hospital |
|
India |
2020-12-01 |
|
CTRI/2020/11/029297 |
Phase Not Applicable |
Not yet recruiting |
1 |
|
100 |
Vipul Versi Nandu |
2020-12-01 |
| Study to Assess Adverse Events and How Intravenous ABBV-47D11 Moves Through the Body of Adult Participants Hospitalized With Coronavirus Disease 2019 (COVID-19) |
Coronavirus disease 19 infection, Lower respiratory tract infection |
ABBV-47D11 alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
AbbVie Inc |
|
US |
2020-11-27 |
2021-05-01 |
2020-005203-39, M20-404, NCT04644120 |
Phase 1 Clinical |
Not yet recruiting |
11 |
5 Months |
24 |
ABBVIE CALL CENTER, AbbVie Inc. |
2020-11-27 |
| Safety of an aerosol having as its active ingredient 8.4% sodium bicarbonate and xylitol 5% when administered to the nasopharynx and oropharynx |
Coronavirus disease 19 infection, Influenza virus infection |
Variable regimens including benzalkonium chloride , glycerine , propylene glycol , sodium bicarbonate , xylitol |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
DR BHARAT MODY, Myself Health Check Ltd |
Welcare Hospital |
India |
2020-12-01 |
|
CTRI/2020/11/029396 |
Phase 2 Clinical |
Not yet recruiting |
1 |
|
325 |
Dr Kshitij Mody, Dr Manoj Parmar, Dr Vidhi Hingu |
2020-12-02 |
| Semen Parameters and COVID-19 in Infertile Men |
Coronavirus disease 19 infection, Male infertility |
reverse transcriptase polymerase chain reaction test alone, spermiogram analysis alone |
|
Male, Young Adults (18-44 yrs) |
Ankara City Hospital Bilkent |
|
Turkey |
2020-01-07 |
2020-10-10 |
E1-20-1237, NCT04643522 |
Phase Not Applicable |
Completed |
1 |
9 Months |
21 |
Erdem Koc |
2020-12-01 |
| Precautionary measure during surgical process during COVID-19 pandemic around the globe |
Coronavirus disease 19 infection |
FFP-2 mask alone, N-95 mask alone, nasal prongs alone, oxygen therapy alone, suction cannula alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
Harsiddhi Cosmetic and Plastic Surgery Hospital |
|
India |
2020-12-01 |
|
CTRI/2020/11/029394 |
Phase Not Applicable |
Not yet recruiting |
1 |
|
30 |
Dr Pradipkumar Raghuvirsinh Atodaria |
2020-12-02 |
| Circulatory Coherence in COVID-19 and Non-COVID-19 Patients With Sepsis |
Coronavirus disease 19 infection, Sepsis |
microcirculation recording alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University Hospital Hradec Kralove |
|
Czech Republic |
2020-02-01 |
2021-12-31 |
FNHK_IGS_8144, NCT04644302 |
Phase Not Applicable |
Recruiting |
1 |
23 Months |
25 |
David Astapenko, M.D., Pavel Dostal, M.D., Ph.D., MBA, Vladimir Cerny, Vladimir Cerny, prof. |
2020-12-01 |
| Anakinra in the Management of COVID-19 Infection |
Coronavirus disease 19 infection, Respiratory distress syndrome, Viral pneumonia |
Standard of care alone, anakinra alone |
Type I IL-1 receptor antagonist |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Hamad Medical Corp |
|
Qatar |
2020-10-30 |
2021-10-30 |
MRC-05-140, NCT04643678 |
Phase 2/Phase 3 Clinical |
Recruiting |
1 |
12 Months |
80 |
Dr. Eman Elmekaty, PharmD |
2020-12-09 |
| Iodine treatment Coronavirus infection |
Coronavirus disease 19 infection |
iodine alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Maxima Medisch Centrum Veldhoven |
|
Netherlands |
2020-07-14 |
|
01-04-2020, 2020-001852-16 |
Phase 2 Clinical |
Recruiting |
1 |
|
224 |
reumatology department |
2020-11-27 |
| PoliCOV: Police COVID-19 Serosurvey |
Coronavirus disease 19 infection |
|
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
University of Bern |
Blutspendedienst SRK Bern AG |
Switzerland |
2021-01-31 |
2022-06-30 |
2020-02650, NCT04643444, PoliCOV |
Phase Not Applicable |
Not yet recruiting |
2 |
17 Months |
1000 |
Parham Sendi, MD |
2020-12-01 |
| COVIDGEN: Genetic Predisposition to Severe Forms of COVID-19 (SARS-CoV2 Infection) |
Coronavirus disease 19 infection |
|
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
Hospices Civils De Lyon |
|
France |
2020-12-01 |
2021-12-01 |
69HCL20_1072, COVIDGEN, NCT04644146 |
Phase Not Applicable |
Recruiting |
1 |
12 Months |
40 |
Alain CALENDER, MD |
2020-11-27 |
| Inflammatory Markers and Hematological Indices in the Prediction of Severity of COVID-19: A Single Center Study in Southern Philippines |
Coronavirus disease 19 infection |
|
|
|
Southern Philippines Medical Center |
|
Philippines |
2020-11-30 |
2021-04-30 |
PHRR201117-003152 |
Phase Not Applicable |
Not yet recruiting |
1 |
5 Months |
|
Meccar Moniem Haradji Elino |
2020-11-27 |
| The effect of selenium in patients with COVID-19 |
Coronavirus disease 19 infection |
selenium alone |
|
|
Ghoum University of Medical Sciences |
Qom University of Medical Science |
Iran |
2020-03-20 |
2020-06-20 |
IR.MUQ.REC.1398.161, IRCT20160919029870N3 |
Phase 3 Clinical |
Completed |
1 |
3 Months |
80 |
Hamed Shafiee |
2020-11-27 |
| An interventional study on the assessment of QT interval prolongation under hydroxychloroquine/azithromycin association among inpatients with SARS-CoV-2 lower respiratory tract infection |
Coronavirus disease 19 infection, Lower respiratory tract infection |
azithromycin plus hydroxychloroquine |
|
|
Centre Hospitalier Universitaire De Nice |
|
|
|
|
|
Phase 2 Clinical |
Status not specified |
0 |
|
73 |
|
2020-11-26 |
| Health-related Quality of Life among Filipino Breast Cancer Patients referred for Radiotherapy using a Validated, Culture-Specific tool in a State Referral Center during the COVID-19 Pandemic |
Breast tumor, Coronavirus disease 19 infection |
Radiotherapy alone |
|
|
Philippine General Hospital |
|
Philippines |
2020-06-18 |
2020-12-18 |
PHRR201117-003126 |
Phase Not Applicable |
Recruiting |
1 |
6 Months |
|
Benedict Mihangel P. Crisostomo |
2020-12-02 |
| Repeat Computed Tomography Simulation among Head and Neck Cancer Patients experiencing Delayed Radiation Therapy in a State Referral Center during the COVID-19 Pandemic |
Coronavirus disease 19 infection, Head and neck tumor |
Computed Tomography (CT) simulation alone, external beam radiotherapy alone |
|
|
Philippine General Hospital |
|
Philippines |
2020-06-18 |
2020-12-18 |
PHRR201117-003125 |
Phase Not Applicable |
Recruiting |
1 |
6 Months |
|
Benedict Crisostomo |
2020-11-27 |
| A Phase II/III Study of Sargramostim |
Coronavirus disease 19 infection, Viral pneumonia |
sargramostim (inhalant, COVID-19), Nobelpharma alone, standard treatment alone |
CSF-1 agonist, GM-CSF receptor agonist |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over), Japanese Ancestry |
Nobelpharma Co Ltd |
|
Japan |
2020-11-24 |
2021-04-30 |
NCT04642950, NPC-26-1 |
Phase 2/Phase 3 Clinical |
Not yet recruiting |
4 |
5 Months |
60 |
Masaki Taniguchi |
2020-11-30 |
| EPIC-19: Application of Convalescent Plasma in the Treatment of SARS CoV-2 Disease (COVID-19) With Evaluation of Therapy Effectiveness |
Coronavirus disease 19 infection, Respiratory distress syndrome |
anti SARS-CoV-2 convalescent plasma alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
Wroclaw Medical University |
Medical Research Agency (Agencja Badań Medycznych) |
Poland |
2020-12-01 |
2022-05-01 |
2020.ABM.COVID19.0005, EPIC-19, NCT04642014 |
Phase 2 Clinical |
Not yet recruiting |
1 |
17 Months |
500 |
Jarocław Dybko, PhD, Siddarth Agrawal, PhD |
2020-11-27 |
| PEER MHEALTH: The impact of WASH text messages and environmental cues intervention on hand hygiene practice among healthcare workers in the greater Kampala metropolitan area, Uganda |
Coronavirus disease 19 infection, Sepsis |
Glo Germ gel alone, environmental cues intervention alone, mhealth water, sanitation and hygiene text message intervention alone, simple hand washing facility usage alone |
|
|
National Academy of Sciences |
|
Uganda |
2020-01-01 |
2021-09-30 |
8-187, ISRCTN98148144, PEER MHEALTH |
Phase 2 Clinical |
Not yet recruiting |
1 |
21 Months |
450 |
Dr Richard Mugambe |
2020-11-27 |
| Mortality in Patients With Severe COVID-19 Pneumonia Who Underwent Tracheostomy |
Coronavirus disease 19 infection, Respiratory failure, Viral pneumonia |
mechanical ventilation alone, percutaneous tracheostomy alone, surgical tracheostomy alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University of Chile |
|
Chile |
2020-03-03 |
2021-11-30 |
65/20, NCT04642703 |
Phase Not Applicable |
Recruiting |
1 |
20 Months |
100 |
Abraham Gajardo, MD, Carlos Romero, MD |
2020-11-28 |
| UK-REACH: United Kingdom research study into ethnicity and COVID-19 outcomes in healthcare workers |
Coronavirus disease 19 infection |
|
|
Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University of Leicester |
National Institute for Health Research (NIHR), United Kingdom Research & Innovation |
UK |
2020-08-01 |
2045-08-01 |
IRAS 288316, ISRCTN11811602, SPONSOR REFERENCE 0801, UK-REACH |
Phase Not Applicable |
Recruiting |
1 |
300 Months |
1530180 |
Dr Claire Garwood, Dr Pareek |
2020-11-27 |
| Clinical Trial of the Immunogenicity, Safety, and Efficacy of the Gam-COVID-Vac Vaccine Against COVID-19 in Venezuela |
Coronavirus disease 19 infection |
Sputnik V alone |
COVID19 Spike glycoprotein modulator |
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Gamalei Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation Collaborator |
Ministerio del Poder Popular para la Salud de la República Bolivariana de Venezuela |
Venezuela |
2020-11-30 |
2021-12-31 |
01V-GAM-COVID-VAC-2020, NCT04642339 |
Phase 3 Clinical |
Not yet recruiting |
1 |
13 Months |
2000 |
Alexis H García Piñero, MD |
2020-11-30 |
| A pilot, randomized, controlled trial examining the feasibility, acceptability and preliminary efficacy of an internet-delivered cognitive bias modification to reduce co-occurring social anxiety and alcohol use in young Australians |
Alcoholism, Anxiety disorder, Coronavirus disease 19 infection, Social phobia |
Approach Bias Modification alone, Interpretation Bias Modification (IBM) alone, treatment as usual alone |
|
Young Adults (18-44 yrs), Oceanic Ancestry |
University of Sydney |
Australian Rotary Health, National Health and Medical Research Council |
Australia |
2021-01-04 |
|
ACTRN12620001273976, U1111-1252-8422 |
Phase Not Applicable |
Not yet recruiting |
1 |
|
90 |
Dr Katrina Prior |
2020-11-29 |
| AIR: Air for Infant Resuscitation |
Birth complication, Coronavirus disease 19 infection, Respiratory disease |
|
|
Infants (6-23 months) |
Royal Hospital for Women, University of New South Wales |
|
Vietnam, Guatemala, Australia, Malaysia, China, India, US, Singapore, Indonesia, Canada, Spain |
2020-12-01 |
2021-09-01 |
ACTRN12620001252909, AIR |
Phase Not Applicable |
Not yet recruiting |
17 |
9 Months |
200 |
A/Prof Ju-Lee Oei, Mr James Sotiropoulos |
2020-11-29 |
| A trial to evaluate aprotinin (inhalation therapy), ChemRar High Tech Center for the treatment of patients with severe COVID-19 |
Coronavirus disease 19 infection |
aprotinin (inhalation therapy), ChemRar High Tech Center alone |
|
|
ChemRar High Tech Center |
|
|
|
|
|
Phase Not Applicable |
Status not specified |
0 |
|
|
|
2020-11-25 |
| A trial to evaluate aprotinin (intravenous), ChemRar High Tech Center for the treatment of patients with moderate COVID-19 |
Coronavirus disease 19 infection |
aprotinin (intravenous), ChemRar High Tech Center alone |
|
|
ChemRar High Tech Center |
|
|
|
|
|
Phase Not Applicable |
Status not specified |
0 |
|
|
|
2020-11-25 |
| A trial to evaluate aprotinin (nasal spray) for the prevention of coronavirus infection |
Coronavirus disease 19 infection |
aprotinin (nasal spray) alone |
|
|
ChemRar High Tech Center |
|
|
|
|
|
Phase Not Applicable |
Status not specified |
0 |
|
|
|
2020-11-25 |
| The Loddon Mallee Healthcare Worker COVID-19 Study |
Anxiety disorder, Coronavirus disease 19 infection |
|
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Bendigo Health Care Group, La Trobe University |
Victorian State Government |
Australia |
2020-11-27 |
2023-08-31 |
ACTRN12620001269921 |
Phase Not Applicable |
Not yet recruiting |
1 |
33 Months |
4000 |
A/Prof Mark McEvoy, Dr Carol Parker |
2020-11-29 |
| Contrast Enhanced Ultrasound in COVID-19 |
Coronavirus disease 19 infection, Vascular disease |
contrast-enhanced ultrasound alone, sodium chloride plus sulphur hexafluoride microbubble ultrasound agent, Bracco |
|
Newborn Infants (up to 5 months), Infants (6-23 months), Preschool Children (2-5 yrs), Children (6-12 yrs), Adolescents (13-17 yrs) |
Childrens Hospital of Philadelphia |
|
US |
2020-12-31 |
2022-12-31 |
20-017501, NCT04640038 |
Phase 3 Clinical |
Recruiting |
1 |
24 Months |
30 |
Luis Tierradentro, MD, Misun Hwang, Misun Hwang, MD |
2020-12-08 |
| CHAT: Intravenous immunoglobulin rich in neutralising antibodies to SARS-CoV-2 as a passive immunity modality in healthy individuals at risk of infection with COVID-19: an open-label, active control, Phase I/II Study |
Coronavirus disease 19 infection |
hyperimmune IG (HIVIG) alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Aegros Ltd |
|
Australia |
2020-12-01 |
2021-10-01 |
ACTRN12620001249943p, AEG-CTP-01, CHAT, U1111-1261-2497 |
Phase 1/Phase 2 Clinical |
Not yet recruiting |
2 |
10 Months |
30 |
A/Prof Roderick Clifton-Bligh, Dr Guy Gavagna |
2020-12-08 |
| A study to assess safety and efficacy of COR-101 for the potential use of COVID-19 |
Coronavirus disease 19 infection |
COR-101 alone |
|
|
Corat Therapeutics GmbH |
|
|
2021-01-01 |
|
|
Phase Not Applicable |
Status not specified |
0 |
|
|
|
2020-12-07 |
| Efficacy and Safety of Ovotransferrin in COVID-19 Patients |
Coronavirus disease 19 infection, Viral pneumonia |
ovotransferrin alone, standard of care alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo |
|
Italy |
2020-12-01 |
2021-03-30 |
20201116, NCT04643054 |
Phase Not Applicable |
Not yet recruiting |
1 |
3 Months |
100 |
Antonio Cascio, Antonio Cascio, MD, Antonio Cascio, MD, PhD |
2020-11-26 |
| Virtual models for delivery of exercise training in Cystic Fibrosis (CF): an evaluation of patient engagement and feasibility |
Coronavirus disease 19 infection, Cystic fibrosis |
online exercise classes alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
The Prince Charles Hospital |
|
Australia |
2020-12-31 |
2021-04-30 |
ACTRN12620001237976p |
Phase Not Applicable |
Not yet recruiting |
1 |
4 Months |
24 |
Miss Kelly Burgess |
2020-11-29 |
| COROBIOCHIC: Cardiac Biomarkers and Mortality in Critically Ill Patients With SARS-CoV-2 (COVID-19) |
Coronavirus disease 19 infection |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University Hospital, Montpellier |
|
France |
2020-02-01 |
2020-06-30 |
COROBIOCHIC, NCT04641988, RECHMPL20-0625 |
Phase Not Applicable |
Completed |
1 |
5 Months |
111 |
Romaric Larcher, MD, PharmD, MSc |
2020-11-26 |
| TBA: Evolution of diaphragm and abdominal muscle thickness in ventilated COVID-19 patients |
Coronavirus disease 19 infection, Muscle weakness |
Ultrasound alone, mechanical ventilation alone |
|
|
Amsterdam UMC |
|
Netherlands |
2020-11-09 |
2021-01-15 |
2017.056, NL9053, TBA |
Phase Not Applicable |
Recruiting |
1 |
2 Months |
40 |
Mark Haaksma |
2020-11-26 |
| Light on COVID-19 |
Coronavirus disease 19 infection |
Respiratory physiotherapy alone, conventional treatment alone, infrared LED alone |
|
Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Anhembi Morumbi |
|
Brazil |
2020-10-04 |
|
36988320.5.0000.5492, 4.269.568, 4.317.859, CAAE 37010820.0.0000.5492, RBR-2z5t7z, U1111-1261-1981 |
Phase 1 Clinical |
Recruiting |
1 |
|
40 |
Pâmela Camila Pereira |
2020-12-08 |
| A phase Ib, open-label, single-arm, investigator-initiated trial to evaluate the safety and efficacy of motixafortide in the treatment of patients suffering from acute respiratory distress syndrome (ARDS) secondary to COVID-19 and other respiratory viral infections |
Coronavirus disease 19 infection, Respiratory distress syndrome, Viral respiratory tract infection |
motixafortide alone |
CXCR4 chemokine antagonist |
|
BioLineRx Ltd |
|
Israel |
2020-11-18 |
|
|
Phase 1b Clinical |
Recruiting |
1 |
|
25 |
Dr Yasmin Maor |
2020-11-25 |
| Analysis of motor response time, electromyography and muscle strength in volunteers from the group at risk for covid-19 submitted to a home exercise protocol: randomized, controlled, clinical trial, cross over |
Coronavirus disease 19 infection |
PhysioPlay alone, electromyography alone, home exercise alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
Federal University of Alfenas |
|
Brazil |
2021-04-05 |
|
36899320.7.0000.5142, 4.355.736, RBR-2fvw6v, U1111-1257-6957 |
Phase Not Applicable |
Not yet recruiting |
1 |
|
20 |
Leonardo Cesar Carvalho |
2020-11-30 |
| LYMPHO-Cov-2: Clinical and Immunological Evolution of COVID-19 Occurring in a Context of Non-Hodgkin Lymphoma |
B-cell lymphoma, Coronavirus disease 19 infection, Non-Hodgkin lymphoma |
monoclonal anti-CD20 antibodies therapy alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Versailles University Hospital |
|
France |
2020-12-15 |
2021-09-16 |
LYMPHO-Cov-2, NCT04641806, P20/21-LYMPHO-COV-2 |
Phase Not Applicable |
Not yet recruiting |
1 |
9 Months |
120 |
Caroline BESSONHospital |
2020-11-26 |
| BCG-COVID-RCT: BCG to Reduce Absenteeism Among Health Care Workers During the COVID-19 Pandemic (EDCTP) |
Coronavirus disease 19 infection |
BCG-Denmark alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University of Southern Denmark |
Bandim Health Project, Centro de Investigacao em Saude de Manhica, European and Developing Countries Clinical Trials Partnership, Instituto De Higiene E Medicina Tropical, The University of Cape Verde |
Guinea-Bissau, Cape Verde, Mozambique |
2020-12-03 |
2022-03-31 |
BCG-COVID-RCT, BCG-COVID-RCT, NCT04641858 |
Phase 4 Clinical |
Recruiting |
3 |
15 Months |
1050 |
Amabélia Rodrigues, MD, PhD, Christine Stabell Benn, Professor, Helio Mucavele, MD, Inês Fronteira, PhD, Isabel Inês Araújo, Professor, Maria da Luz Lima, Pedro Aide, MD, MSc, PhD, Peter Aaby, DMSc |
2020-12-07 |
| INNOVATE: Safety, Immunogenicity and Efficacy of INO-4800 for COVID-19 in Healthy Seronegative Adults at High Risk of SARS-CoV-2 Exposure |
Coronavirus disease 19 infection |
CELLECTRA 2000 device alone, INO-4800 alone, electroporation alone |
COVID19 Spike glycoprotein modulator |
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Inovio Pharmaceuticals Inc |
US Department of Defense, US Government |
US |
2020-11-30 |
2022-09-30 |
COVID19-311, INNOVATE, INNOVATE, NCT04642638 |
Phase 2/Phase 3 Clinical |
Recruiting |
16 |
22 Months |
6578 |
Barbara Rizzardi, Christopher Chambers, Corey Anderson, Donna DeSantis, Ernie Riffer, Inovio Call Center, Jeffrey Rosen, John Ervin, Louis Saravolatz, Mammen P. Mammen Jr, M.D., FACP, FIDSA, Mark Adams, Melinda Hamer, Michael Jacobs, Olutola Adetona, Pablo Tebas, Patrick Yassini, Principal Investigator Christopher Chambers, Principal Investigator Melinda Hamer, Prinicipal Investigator Barbara Rizzardi, Prinicipal Investigator Corey Anderson, Prinicipal Investigator Donna DeSantis, Prinicipal Investigator Ernie Riffer, Prinicipal Investigator Jeffrey Rosen, Prinicipal Investigator Louis Saravolatz, Prinicipal Investigator Michael Jacobs, Prinicipal Investigator Olutola Adetona, Prinicipal Investigator Patrick Yassini, Prinicipal Investigator Sady A. Alpizar, Prinicipal Investigator Vickie Miller, Program Manager Amanda Bear, Program Manager Barbara Bradshaw, Program Manager Ginger Switzer, Sady A. Alpizar, Vickie Miller |
2020-12-09 |
| COVID-19 in Home Healthcare |
Coronavirus disease 19 infection |
home health care alone |
|
Newborn Infants (up to 5 months), Infants (6-23 months), Preschool Children (2-5 yrs), Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs) |
University Hospital, Linkoeping |
|
Sweden |
2020-05-02 |
2020-10-10 |
HOME HEALTHCARE 2020, NCT04642196 |
Phase Not Applicable |
Completed |
1 |
5 Months |
155 |
Lena Nilsson |
2020-11-27 |
| Study Investigating the Effects of UVC Beam and Laser Beam Therapy According to Standard Therapy in Patients With Covid-19 Diagnosis |
Coronavirus disease 19 infection, Dyspnea, Respiratory disease, Viral pneumonia |
Turkish Beam-Selective UV device (Rd Global Arastirma Gelistirme Saglik Ilac Insaat Yatirimlari AS) alone, anitibiotic therapy alone, antimalarial therapy alone, antiviral therapy alone, ultraviolet C application alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
Rd Global Arastirma Gelistirme Saglik Ilac Insaat Yatirimlari Sanayi Ve Ticaret Anonim Sirketi |
Gazi University |
Turkey |
2020-06-26 |
2021-05-04 |
MD2020/001, NCT04642326 |
Phase Not Applicable |
No longer recruiting |
1 |
10 Months |
50 |
Hikmet Selcuk Gedik |
2020-11-27 |
| Investigation of the Safety and Efficacy of Oxygen Administration over a Surgical Facemask |
Coronavirus disease 19 infection |
Surgical Facemask alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Fukuoka Children's Hospital |
|
Japan |
2020-11-24 |
|
UMIN000042524 |
Phase Not Applicable |
Recruiting |
1 |
|
20 |
Keiichiro Mizuno |
2020-12-02 |
| Response of patients and chest X-ray improvement after Remdesivir |
Coronavirus disease 19 infection |
remdesivir alone |
COVID19 non structural protein 8 modulator, COVID19 replicase polyprotein 1ab inhibitor, RNA polymerase modulator |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Kasturba Medical College, Kasturba hospital |
|
India |
2020-12-04 |
|
CTRI/2020/11/029266 |
Phase Not Applicable |
Not yet recruiting |
1 |
|
126 |
Vishal Shanbhag |
2020-11-26 |
| A trial to evaluate saliva-based test detect the presence of antibodies to SARS-CoV-2 |
Coronavirus disease 19 infection |
saliva-based test alone |
|
|
Johns Hopkins Bloomberg School of Public Health |
|
|
|
|
|
Phase Not Applicable |
Status not specified |
0 |
|
|
|
2020-11-25 |
| To study the long-term ill effects of COVID-19 infection in old age people |
Coronavirus disease 19 infection |
|
|
Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Sri Ramachandra Institute of Higher Education and Research |
|
India |
2020-12-01 |
|
CTRI/2020/11/029264 |
Phase Not Applicable |
Not yet recruiting |
1 |
|
400 |
Dr Sathyamurthy |
2020-11-26 |
| A Phase III Clinical Trial for SARS-CoV-2 Vaccine, Inactivated (Vero Cell) in Malaysia |
Coronavirus disease 19 infection |
SARS-CoV-2 Vaccine, Inactivated (Vero Cell) alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Institute of Medical Biology Chinese Academy of Medical Sciences |
|
Malaysia |
2020-12-01 |
2022-01-31 |
20200404, 57143, NMRR-20-2514-57143 |
Phase 3 Clinical |
Not yet recruiting |
5 |
14 Months |
3000 |
Cheung Tian Pei, Datuk Dr. Muhammad Radzi Abu Hassan, Doctor DR Yasmin Mohamed Gani, Dr Cheah Wee Kooi, Dr Chua Hock Hin, Dr DAMENTHI NAIR A/P NARAYANAN, Dr Liew Boon Seng, Dr Looi Irene, Dr Yoon Chee Kin, Dr philip rajan |
2020-11-26 |
| Vitamin D and Zinc Supplementation for Improving Treatment Outcomes Among COVID-19 Patients in India |
Coronavirus disease 19 infection |
Vitamin D3 (cholecalciferol) alone, Zinc (zinc gluconate) alone, Vitamin D3 (cholecalciferol) plus Zinc (zinc gluconate) |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Harvard TH Chan School of Public Health |
Foundation for Medical Research, The University Health Network |
India |
2020-12-07 |
2021-12-31 |
NCT04641195, VR3- 172649 |
Phase 3 Clinical |
Not yet recruiting |
2 |
12 Months |
700 |
Guaray Gupta, MD, Kevin Kain, MD, Wafaie W Fawzi, MBBS, MPH, MS, DrPH, Wafaie W Wafaie, MBBS, MPH, MS, DrPH |
2020-11-30 |
| A reasearch study to utilize the AIRx Health platform to monitor COVID-19 outpatients to better understand which patients deteriorate faster and require hospitalization |
Coronavirus disease 19 infection |
AIRx Health alone |
|
|
Stanford Medicine |
|
US |
|
|
|
Phase Not Applicable |
Status not specified |
1 |
|
2000 |
|
2020-11-25 |
| Associated factors for COVID-19 infection in Terengganu |
Coronavirus disease 19 infection |
|
|
|
|
|
Malaysia |
2020-11-20 |
2020-12-20 |
57220, NMRR-20-2468-57220, PKDD2020/1 |
Phase Not Applicable |
Not yet recruiting |
1 |
1 Month |
|
Dr Hafizuddin Bin Awang, Dr. Effah Leiylena Binti Yaacob |
2020-11-26 |
| Accuracy of POCUS ultrasound in detecting severity of confirmed symptomatic COVID-19 patients in MTC |
Coronavirus disease 19 infection |
point-of-care lung ultrasound alone |
|
|
Sultanah Bahiyah Hospital |
|
Malaysia |
2020-11-17 |
2020-12-31 |
56961, NMRR-20-2480-56961 |
Phase Not Applicable |
Status not specified |
1 |
1 Month |
|
Dr Fatahul Laham Mohamed, Ong Sheue Fen |
2020-11-26 |
| A clinical study on favipiravir in mild to moderate COVID-19 patients |
Coronavirus disease 19 infection |
favipiravir alone |
RNA polymerase inhibitor |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Glenmark Pharmaceuticals Ltd |
|
India |
2020-11-30 |
|
CTRI/2020/11/029263, GPL/CT/2020/007/IV Version 2.0 |
Phase 4 Clinical |
Not yet recruiting |
3 |
|
1200 |
Dr Saiprasad Patil, Rajesh Gaikwad |
2020-11-26 |
| Role of vitamin C in management of COVID 19 |
Coronavirus disease 19 infection |
vitamin C alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
All India Institute of Medical Sciences Patna |
|
India |
2020-11-20 |
|
CTRI/2020/11/029230 |
Phase 3 Clinical |
Not yet recruiting |
1 |
|
80 |
DR VIJAY KUMAR |
2020-11-26 |
| Characterization of COVID-19 long-term immunity |
Coronavirus disease 19 infection |
6 min walking respiratory function testing alone, serological testing alone, sit-to-stand respiratory function testing alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University of Bristol |
Medical Research Council |
UK |
2020-08-01 |
2021-11-30 |
CPMS 47414, IRAS 289646, ISRCTN11946807 |
Phase Not Applicable |
Recruiting |
1 |
16 Months |
250 |
Dr Lewcock, Prof Timpson |
2020-11-26 |
| REGAIN: A randomized trial to assess the effects of physical and mental health rehabilitation for people recovering from COVID-19 |
Coronavirus disease 19 infection |
home-based rehabilitation program alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University Hospitals Coventry & Warwickshire NHS Trust |
NIHR Evaluation, Trials and Studies Coordinating Centre (NETSCC) |
UK |
2020-09-01 |
2022-08-31 |
CPMS 46819, IRAS 288362, ISRCTN11466448, REGAIN |
Phase Not Applicable |
Not yet recruiting |
1 |
24 Months |
535 |
Ms Sharisse Alleyne |
2020-11-25 |
| Evaluation of stem cells treatment in Covid-19 patients |
Coronavirus disease 19 infection |
Mensenchymal Stem Cells alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Stemcorp |
|
Brazil |
2020-11-19 |
|
4.167.621, A01224210603, CAAE: 32650720.1.0000.0068, RBR-4jh63b |
Phase 1/Phase 2 Clinical |
Recruiting |
1 |
|
30 |
Eder Zucconi, Mariane Secco, Natassia Vieira Serafini |
2020-11-25 |
| TRISTARDS: A Study to Test Whether Different Doses of Alteplase Help People With Severe Breathing Problems Because of COVID-19 |
Coronavirus disease 19 infection, Respiratory distress syndrome |
alteplase alone, standard of care alone |
Tissue plasminogen activator stimulator |
Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Boehringer Ingelheim International GmbH |
|
Netherlands, Austria |
2020-12-07 |
2022-09-01 |
0135-0347, 2020-002913-16, NCT04640194, TRISTARDS |
Phase 2/Phase 3 Clinical |
Not yet recruiting |
2 |
20 Months |
270 |
Boehringer Ingelheim, CT Disclosure & Data Transparency |
2020-12-08 |
| Dulce: HbA1c Pre and Post-Confinement in Latin American Children With Type 1 Diabetes |
Coronavirus disease 19 infection, Insulin dependent diabetes |
|
|
Preschool Children (2-5 yrs), Children (6-12 yrs), Adolescents (13-17 yrs) |
Hospital General Puyo |
|
Argentina |
2020-11-22 |
2021-04-22 |
0019, Dulce, NCT04640064 |
Phase Not Applicable |
Not yet recruiting |
1 |
5 Months |
500 |
Angela Figueroa Sobrero, MD, Carlos Del Aguila Villar, MD, Diana Gonzalez, MD, Edgar Mora, MD, Edit Scaiola, MD, Fabio Palacios Porta, MD, Franco Giraudo Abarca, MD, Julie Pelicand, MD, Kesia Granela, MD, Nicole Monteverde, MD, Valeria Hirschler |
2020-11-26 |
| Effect of the drug indomethacin in the treatment of COVID-19 patients |
Coronavirus disease 19 infection |
Standard care alone, indomethacin alone, proton pump inhibitor therapy alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Indian Institute Of Technology Madras |
|
India |
2020-07-27 |
2021-01-01 |
CR/20-21/ED/208/ALUM/002553, ISRCTN11970082 |
Phase 2 Clinical |
Recruiting |
2 |
5 Months |
250 |
Dr Rajan Ravichandran, Prof KrishnaKumar |
2020-11-25 |
| Prognostic value of simple computer-aided quantitative chest CT analysis among known cases of COVID-19 pneumonia in Philippine General Hospital |
Coronavirus disease 19 infection, Viral pneumonia |
chest CT analysis alone |
|
|
Philippine General Hospital, University of the Philippines |
|
Philippines |
2020-12-01 |
2021-03-01 |
PHRR201120-003166 |
Phase Not Applicable |
Completed |
1 |
3 Months |
|
Mark Jerome G Mauricio |
2020-11-25 |
| Patient satisfaction with psychiatry services during the pandemic |
Coronavirus disease 19 infection, Psychiatric disorder |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Bhabha Atomic Research Centre Hospital |
|
India |
2020-12-01 |
|
CTRI/2020/11/029236 |
Phase 4 Clinical |
Recruiting |
1 |
|
347 |
Dr Saumitra Nemlekar |
2020-11-24 |
| MATCH: MAnaging The COVID-19 in Hemodialysis |
Coronavirus disease 19 infection, End stage renal disease |
Dialysis alone |
|
Healthy volunteers accepted |
Hospital Kuala Lumpur |
|
Malaysia |
2020-12-01 |
2020-12-31 |
54601, MATCH, NMRR-20-2484-54601 |
Phase Not Applicable |
No longer recruiting |
1 |
1 Month |
|
Dr NG YONG MUH |
2020-11-25 |
| Clinical Trial to Assess Safety and Immunogenicity of Gam-COVID-Vac Combined Vector Vaccine for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Сov-2) Infection |
Coronavirus disease 19 infection |
Sputnik V alone |
COVID19 Spike glycoprotein modulator |
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over), Asian Ancestry |
Dr Reddy's Laboratories Ltd, Sputnik LLC |
Gamalei Institute of Epidemiology and Microbiology, Max Neeman International, Russian Direct Investment Fund |
India |
2020-12-31 |
2021-09-30 |
CTRI/2020/11/029234, NCT04640233, RDI-GCV-001, RDI-GCV-001 V3.0 |
Phase 2/Phase 3 Clinical |
Not yet recruiting |
12 |
9 Months |
1600 |
Akash Khobragade, MD, Asim Das, MD, Dr Anand Kawade, Dr Anil Purty, Dr Jayaprakash Appajigol, Dr Lalit Lakhwani, Dr Manish Kumar Jain, Dr Sandeep Kumar Gupta, Dr Saurabh Agarwal, Dr Shariq Anwar, Dr Shilpa Avarebeel, Dr Sidram Raut, Dr Sonika Newar, Dr Winsley Rose, Dr. Agam Shah, MD, Dr. Lalit Lakhwani, MD, Manish K Jain, MD, N K Arora, MD, S K Raut, MBBS, DIH, Saurabh Agarwal, MD |
2020-11-25 |
| A clinical study to assess safety and efficacy of baricitinib in addition to standard care in the treatment of patients hospitalized with COVID-19 pneumonia |
Coronavirus disease 19 infection, Viral pneumonia |
baricitinib alone, standard care alone |
Jak1 tyrosine kinase inhibitor, Jak2 tyrosine kinase inhibitor |
|
BenevolentAI Ltd |
Biomedical Research Networking Center on Frailty and Healthy Aging (CIBERFES), Diamond Innovative Medicines Initiative, Experimental Cancer Medicine Centre Network, Instituto de Salud Carlos III, National Institute for Health Research (NIHR), National Institutes of Health, National Science Foundation, Swedish Research Council, The European Union |
UK, Spain, Italy |
|
|
|
Phase Not Applicable |
Status not specified |
3 |
|
166 |
Professor Justin Stebbing |
2020-11-24 |
| Measurement of Quality of food intake, mental health status, and safety measures followed by the hospital support staff during COVID-19 |
Acute stress disorder, Coronavirus disease 19 infection |
|
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) |
Manipal Academy of Higher Education, Welcomgroup Graduate School of Hotel Administration |
|
India |
2020-11-24 |
|
CTRI/2020/11/029221 |
Phase Not Applicable |
Not yet recruiting |
1 |
|
354 |
Apoorva Jain, Mrs Pallavi Mahesh Shettigar, P Vaishnavi Yadav |
2020-11-25 |
| Assessing knowledge, attitudes, perceptions, and practices surrounding COVID-19 and tuberculosis (TB) in Kajang prison staff: a survey study in Kuala Lumpur |
Coronavirus disease 19 infection |
|
|
Healthy volunteers accepted |
University of Malaya |
|
Malaysia |
2021-01-01 |
2021-08-15 |
57106, NMRR-20-2483-57106 |
Phase Not Applicable |
Status not specified |
1 |
7 Months |
|
Dr. NUR AFIQAH BINTI MOHD SALLEH |
2020-11-30 |
| COVID-KEDAH: COVID-19 Infection among Healthcare Worker in Kedah |
Coronavirus disease 19 infection |
|
|
Healthy volunteers accepted |
Ministry of Health, Malaysia |
|
Malaysia |
2020-11-17 |
2021-04-30 |
57138, COVID-KEDAH, NMRR-20-2478-57138 |
Phase Not Applicable |
Status not specified |
1 |
5 Months |
|
Dr. ROSIDAH BINTI OMAR |
2020-11-30 |
| ACTT-4: Adaptive COVID-19 Treatment Trial 4 |
Coronavirus disease 19 infection |
baricitinib plus remdesivir |
COVID19 non structural protein 8 modulator, COVID19 replicase polyprotein 1ab inhibitor, Jak1 tyrosine kinase inhibitor, Jak2 tyrosine kinase inhibitor, RNA polymerase modulator |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
National Institute of Allergy and Infectious Diseases |
|
US |
2020-11-24 |
2021-06-30 |
20-0006 ACTT-4, ACTT-4, NCT04640168 |
Phase 3 Clinical |
Recruiting |
12 |
7 Months |
1500 |
20-0006 Central Contact |
2020-12-09 |
| Prone Position for Nonintubated Patients With COVID-19 and Hypoxemic Respiratory Failure |
Coronavirus disease 19 infection, Respiratory failure, Viral pneumonia |
Prone position alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Pontificia Universidad Catolica De Chile |
|
Chile |
2020-07-06 |
2020-09-16 |
0001, NCT04641182 |
Phase Not Applicable |
Completed |
1 |
2 Months |
66 |
|
2020-11-25 |
| An observational, retrospective study to evaluate the role of thromboprophylaxis regimens on the occurrence of pulmonary embolism in COVID-19 patients |
Coronavirus disease 19 infection |
CT pulmonary angiography alone, enoxaparin sodium alone, heparin alone, thromboprophylaxis alone |
Low molecular weight heparin |
|
Universite Libre de Bruxelles |
|
|
|
|
|
Phase Not Applicable |
Status not specified |
0 |
|
|
|
2020-11-24 |
| Coping during COVID-19: peer-delivered training to improve adolescent wellbeing |
Coronavirus disease 19 infection, Psychiatric disorder |
coping based COVID-19 online training alone |
|
Healthy volunteers accepted, Adolescents (13-17 yrs), Young Adults (18-44 yrs) |
University of Oxford |
Westminster Foundation |
UK |
2020-10-01 |
2021-03-30 |
ISRCTN77941736 |
Phase Not Applicable |
No longer recruiting |
1 |
5 Months |
120 |
Dr Gabriela Pavarini |
2020-12-07 |
| Preventive trial of Homoeopathic medicines in COVID-19 |
Coronavirus disease 19 infection |
general hygienic measure teaching alone, healthy dietary advice alone, Variable regimens including Bryonia alba (Hahnemann Publishing Company) , Gelsemium sempervirens (Hahnemann Publishing Company) , ascorbic acid (Dusap Pharmaceuticals) , phosphorus (Hahnemann Publishing Company) |
|
Healthy volunteers accepted, Infants (6-23 months), Preschool Children (2-5 yrs), Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
D.N. De Homoeopathic Medical College & Hospital, Ministry of Ayush |
|
India |
2020-11-30 |
|
CTRI/2020/11/029265, U1111-1259-4250 |
Phase 3 Clinical |
Recruiting |
1 |
|
20000 |
Prof Dr Satadal Das, Prof Dr Shyamal Kumar Mukherjee, Prof Dr Subhasish Ganguly |
2020-11-25 |
| ACE2-AVG: Angiotensin-converting Enzyme 2 (ACE2) Expression in Tonsils and Adenoids |
Coronavirus disease 19 infection, Tonsillitis |
adenoidectomy alone, tonsillectomy alone |
|
|
Assistance Publique Hopitaux de Paris |
|
France |
2020-12-31 |
2021-09-30 |
ACE2-AVG, APHP201032, NCT04640610 |
Phase Not Applicable |
Not yet recruiting |
9 |
9 Months |
40 |
André Coste, MD, PhD, Benjamin Verillaud, MD, Bertrand Baujat, MD, PhD, Béatrix Barry, MD, PhD, Diane Evrard, MD, Emilie Bequignon, MD, Fiona Alvin, MD, Frédéric Tankere, MD, PhD, Hélène Morel, Jean-François Papon, MD, PhD, Philippe Herman, MD, PhD, Pierre Bonfils, MD, PhD, Pierre-Louis Tharaux, MD, PhD, Romain Luscan, MD, Sarah Atallah, MD, Vincent Couloigner, MD, PhD |
2020-11-25 |
| A phase II study of REVTx-99 for the treatment of early stage COVID‑19 patients at risk for hospitalization |
Coronavirus disease 19 infection |
REVTx-99 alone |
TLR-4 agonist |
|
Revelation Biosciences |
|
|
|
|
|
Phase 2 Clinical |
Planned |
0 |
|
|
|
2020-11-24 |
| An observation and comparison of the efficacy and relative satisfaction of health care workers while being monitored by the standard buddy technique versus the remote audio visual doffing surveillance (RADS) of the doffing process during the COVID-19 pandemic |
Coronavirus disease 19 infection |
remote audio visual surveillance technique alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) |
Nehru HOSPITAL, Postgraduate Institute of Medical Education and Research |
|
India |
2020-12-15 |
|
CTRI/2020/11/029233 |
Phase Not Applicable |
Not yet recruiting |
1 |
|
200 |
Naveen Naik B |
2020-11-24 |
| An observational study for hospitalized patients with CAP, HAP and VAP |
Coronavirus disease 19 infection, Pneumonia |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Nagoya University Hospital |
|
Japan |
2020-11-24 |
|
UMIN000042522 |
Phase Not Applicable |
Recruiting |
2 |
|
1500 |
Yuichiro Shindo |
2020-11-25 |
| Role Of Montelukast In Management Of COVID 19 |
Coronavirus disease 19 infection |
montelukast sodium alone, standard treatment alone |
Leukotriene D4 antagonist |
Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
All India Institute of Medical Sciences Patna |
|
India |
2020-11-25 |
|
CTRI/2020/11/029232 |
Phase 3 Clinical |
Not yet recruiting |
1 |
|
90 |
DR VIJAY KUMAR |
2020-11-25 |
| The effect of the online child birth preparation classes on pregnant women during COVID-19 pandemic |
Anxiety disorder, Coronavirus disease 19 infection |
online child birth preparation educational session alone |
|
Female |
Tehran University of Medical Sciences |
|
Iran |
2020-11-21 |
|
IR.TUMS.FNM.REC.1399.098, IRCT20190713044192N2 |
Phase Not Applicable |
Recruiting |
1 |
|
100 |
Farnaz Farnam, Mohammadali Sahraeian |
2020-11-26 |
| A clinical trial of Siddha drugs M V kashayam (internally) for the management and treatment of COVID-19 |
Coronavirus disease 19 infection |
MV kashayam intake alone |
|
Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) |
Arul Anandar College |
Madurai Herbal Market |
India |
2020-11-25 |
|
CTRI/2020/11/029289 |
Phase 2/Phase 3 Clinical |
Not yet recruiting |
1 |
|
130 |
Dr P Dharumarajan |
2020-11-25 |
| Impact of COVID-19 on screen time, physical activity, sleep pattern and food intake among students of 18 to 23 years |
Coronavirus disease 19 infection |
|
|
Healthy volunteers accepted, Young Adults (18-44 yrs) |
Manipal Academy of Higher Education, Welcomgroup Graduate School of Hotel Administration |
|
India |
2020-11-23 |
|
CTRI/2020/11/029235 |
Phase Not Applicable |
Not yet recruiting |
1 |
|
478 |
Pallavi Mahesh Shettigar, Reshma Mariam Santhosh |
2020-11-24 |
| Group CBT for Intolerance of Uncertainty |
Coronavirus disease 19 infection, Generalized anxiety disorder |
Cognitive-behavioral treatment alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University of Manitoba |
|
Canada |
2020-11-30 |
2021-08-31 |
H2019:412, NCT04512378 |
Phase Not Applicable |
Not yet recruiting |
1 |
9 Months |
20 |
Elizabeth Hebert, PhD |
2020-11-25 |
| Psychotherapy Strategies for the Treatment of Professionals and Students From Essential Services With High Levels of Emotional Distress in the Context of COVID-19 |
Anxiety disorder, Coronavirus disease 19 infection, Depression |
Brief Interpersonal Telepsychotherapy alone, Cognitive Behavioral Brief-Telepsychotherapy alone |
|
|
Hospital de Clinicas de Porto Alegre |
|
Brazil |
2020-11-05 |
2021-07-20 |
20200213_TREATMENT, NCT04635618 |
Phase Not Applicable |
Recruiting |
1 |
8 Months |
999 |
Giovanni Salum, MD, PhD |
2020-11-25 |
| ProneSpontCov: Awake Prone Position to Reduce Ventilation Inhomogeneity in COVID-19 Acute Respiratory Failure |
Coronavirus disease 19 infection, Respiratory failure |
Electrical impedance tomography (EIT) alone, lung ventilation in awake prone position alone, lung ventilation in dorsal decubitus alone, lung ventilation in ventral decubitus alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Assistance Publique Hopitaux De Marseille |
|
France |
2020-04-04 |
2021-01-31 |
2020-17, NCT04632602, ProneSpontCov |
Phase Not Applicable |
Recruiting |
1 |
9 Months |
20 |
Christophe GUERVILLY, Jean-Olivier ARNAUD |
2020-11-25 |
| Evaluation of the Effects of L-carnitine Supplementation on Patients with COVID-19 |
Coronavirus disease 19 infection |
Variable regimens including L-carnitine (Karen Company) , dexamethasone , favipiravir , interferon-beta |
RNA polymerase inhibitor |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) |
Hamadan University of Medical Sciences |
|
Iran |
2020-11-20 |
|
IR.UMSHA.REC.1399.650, IRCT20200921048794N1 |
Phase 3 Clinical |
Recruiting |
1 |
|
96 |
Dr Saman Talebi, Mehran Ghasemi, Rasool Haddadi, Saeed Bashirian |
2020-11-25 |
| A randomized, double-blind, placebo-controlled, phase III clinical trial of the effectiveness and safety of inoculation of recombinant new coronavirus vaccine (CHO cells) in the prevention of COVID-19 in people 18 years and older |
Coronavirus disease 19 infection |
ZF-2001 alone |
COVID19 Spike glycoprotein modulator |
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Hunan Province Centers for Disease Control and Prevention |
|
Ecuador, Pakistan, Indonesia, China, Uzbekistan |
2020-11-06 |
2021-12-31 |
ChiCTR2000040153 |
Phase 3 Clinical |
Recruiting |
5 |
13 Months |
29000 |
Li Fangjun, Zhong Zaixin |
2020-12-08 |
| A Phase II clinical trial of novel coronavirus pneumonia (COVID-19) mRNA Vaccine (BNT-162b2) in China |
Coronavirus disease 19 infection, Viral pneumonia |
BNT-162b2 alone |
COVID19 Spike glycoprotein modulator |
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over), Asian Ancestry |
Jiangsu Province Centers for Disease Control and Prevention |
Shanghai Fosun Pharmaceutical Industry Development Co Ltd |
China |
2020-11-23 |
2021-12-31 |
ChiCTR2000040044 |
Phase 2 Clinical |
Not yet recruiting |
2 |
13 Months |
960 |
Wang Wei, Zhu Fengcai |
2020-12-02 |
| A phase II, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of leronlimab as a treatment for COVID-19 patients suffering from long-hauler symptoms |
Coronavirus disease 19 infection |
leronlimab alone |
CCR5 chemokine antagonist |
|
CytoDyn Inc |
|
US |
|
|
|
Phase 2 Clinical |
Planned |
1 |
|
102 |
Dr Chris Recknor, Dr Kush Dhody, Dr Mahboob Rahman |
2020-11-27 |
| Pharmacokinetics, Safety, and Tolerability of CSL-760, an Anti-COVID-19 Hyperimmune Intravenous Immunoglobulin, in Healthy Adult Subjects |
Coronavirus disease 19 infection |
CSL-760 alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
CSL Behring LLC |
|
|
2020-12-31 |
2021-04-30 |
CSL760_1001, NCT04638634 |
Phase 1 Clinical |
Not yet recruiting |
0 |
4 Months |
24 |
Study Director, Trial Registration Coordinator |
2020-11-25 |
| Short- and Long-term Effects of Adding Oral L-arginine to Standard Therapy in Patients With COVID-19 (SARS-CoV-2) |
Coronavirus disease 19 infection, Viral pneumonia |
Bioarginina (L-arginine) alone, standard therapy alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University of Campania Luigi Vanvitelli |
|
Italy |
2020-11-18 |
2021-09-18 |
BIOARGININA, NCT04637906 |
Phase Not Applicable |
Not yet recruiting |
1 |
10 Months |
290 |
Giuseppe fiorentino |
2020-11-25 |
| A virtual global clinical trial to assess ePRO measures using Migraine Buddy mobile tracking app for an acute migraine medication in COVID-19 pandemic |
Coronavirus disease 19 infection, Migraine |
Migraine Buddy mobile tracking app alone |
|
|
Healint Pte Ltd |
|
|
2020-11-18 |
|
COVID19_IMPACT |
Phase Not Applicable |
Recruiting |
0 |
|
|
|
2020-11-23 |
| Questionnaire Regarding the Effect of Wearing Face Masks on Oral Health |
Coronavirus disease 19 infection, Halitosis, Xerostomia |
face mask alone |
|
Healthy volunteers accepted |
University of Gottingen |
University Medical Center Goettingen |
Germany |
2020-11-20 |
2021-07-01 |
FACEMASKS-ORALHEALTH, NCT04632004 |
Phase Not Applicable |
Recruiting |
1 |
7 Months |
3000 |
Philipp Kanzow, Dr. med. dent., Dr. rer. medic |
2020-11-26 |
| Effect of Home Exercise Activity on Cortisol and Depression in COPD During the Pandemic COVID |
Chronic obstructive pulmonary disease, Coronavirus disease 19 infection, Depression |
bicycle alone, moderate intensity home-exercise training alone, treadmill alone, upper and lower limb exercise alone |
|
Male, Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
Cairo University |
|
Egypt |
2020-11-19 |
2021-03-01 |
NCT04639349, P.T.REC/012/002897 |
Phase Not Applicable |
Recruiting |
1 |
3 Months |
40 |
Ali Ismail, lecturer, Ali Mohamed Ali ismail |
2020-11-26 |
| Testing Scalable, Single-Session Interventions for Adolescent Depression in the Context of COVID-19 |
Coronavirus disease 19 infection, Depression |
behavioral activation SSI alone, growth mindset SSI alone |
|
Adolescents (13-17 yrs) |
State University of New York at Stony Brook |
University of Denver |
US |
2020-11-19 |
2021-07-31 |
1505797-3, NCT04634903 |
Phase Not Applicable |
No longer recruiting |
1 |
8 Months |
2409 |
Jessica L Schleider, PhD |
2020-12-09 |
| COVID PLEX+CCP: Plasma Exchange (PLEX) and Convalescent Plasma (CCP) in COVID-19 Patients With Multiorgan Failure |
Coronavirus disease 19 infection, Hypoxia, Multiple organ failure |
centrifuge plasma exchange therapy alone, membrane plasma exchange therapy alone, standard care alone, Variable regimens including albumin , citrate , convalescent plasma , fresh frozen plasma , heparin |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Rigshospitalet |
Aalborg Hospital, Aarhus University Hospital, Odense University Hospital, Zealand University Hospital |
Denmark |
2020-11-16 |
2022-06-30 |
COVID PLEX+CCP, H-20041716, NCT04634422 |
Phase 2 Clinical |
Not yet recruiting |
1 |
19 Months |
220 |
Anders Perner, Prof, Nicholas Carlson, MD, Wladimir M Szpirt, MD, Wladimir Szpirt |
2020-11-25 |
| A Synthetic MVA-based SARS-CoV-2 Vaccine, COH04S1, for the Prevention of COVID-19 |
Coronavirus disease 19 infection |
COH-04S1 alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) |
City of Hope Medical Center |
National Cancer Institute |
US |
2020-11-25 |
2022-11-10 |
20447, NCI-2020-08335, NCT04639466, P30CA033572 |
Phase 1 Clinical |
Recruiting |
1 |
23 Months |
129 |
John Zaia |
2020-11-26 |
| Targeting the Health Care Provider (HCP) Burnout Crisis During the COVID-19 Pandemic |
Acute stress disorder, Coronavirus disease 19 infection |
Transcendental meditation alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Duke University |
|
US |
2020-11-30 |
2021-04-30 |
NCT04632368, PRO00106191 |
Phase Not Applicable |
Not yet recruiting |
1 |
5 Months |
80 |
Catherine Clinical Research Co-ordinator, Taylor Clinical Research Co-ordinator |
2020-11-26 |
| BRIDGE: Building Regulation in Dual Generations - Telehealth Model |
Coronavirus disease 19 infection, Depression |
BRIDGE therapy program alone, dialectical behavior therapy alone |
|
Healthy volunteers accepted, Female, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University of Manitoba |
Centre for Addiction and Mental Health, Research Manitoba, University of Oregon |
Canada |
2020-09-01 |
2021-05-31 |
BRIDGE, BRIDGEV2.0, NCT04639557 |
Phase Not Applicable |
Recruiting |
1 |
9 Months |
40 |
|
2020-11-23 |
| EUDOCO: Early Versus Delayed Intubation of Patients With COVID-19 |
Coronavirus disease 19 infection, Hypoxia, Respiratory failure |
endotracheal intubation alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Evangelismos Hospital |
|
Greece |
2020-11-18 |
2021-05-01 |
32635, 13-10-2020, EUDOCO, NCT04632043 |
Phase Not Applicable |
Not yet recruiting |
1 |
5 Months |
80 |
Ilias Siempos, MD, DSc |
2020-11-26 |
| Patient Centered Intervention to Prevent Tuberculosis Among Children < 5 Years Old |
Coronavirus disease 19 infection, Mycobacterium tuberculosis infection |
educational booklet alone, isoniazid alone, isoniazid preventive therapy alone, weekly SMS alone, weekly children storybook session alone |
|
Newborn Infants (up to 5 months), Infants (6-23 months), Preschool Children (2-5 yrs), Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Universidad Peruana Cayetano Heredia |
|
Peru |
2019-12-01 |
2023-12-15 |
103161, NCT03881228 |
Phase 2 Clinical |
Recruiting |
1 |
48 Months |
300 |
Larissa Otero, MD PhD, Larissa Otero, PhD |
2020-11-26 |
| Telepsychoeducation for the Prevention of Emotional Distress in Professionals and Students From Essential Services in the Context of COVID-19 |
Acute stress disorder, Coronavirus disease 19 infection |
telepsychoeducation with personalized videos alone |
|
|
Hospital de Clinicas de Porto Alegre |
|
Brazil |
2020-11-05 |
2021-07-20 |
20200213_PREVENTION, NCT04632082 |
Phase Not Applicable |
Recruiting |
1 |
8 Months |
2200 |
Giovanni Salum, MD, PhD |
2020-11-23 |
| The Effect of Ganglion Sphenopalatine Block (SPG-block) Versus Placebo on Persistent Headache Following Acute COVID-19 Infection |
Coronavirus disease 19 infection, Headache |
ganglion sphenopalatine block (SPG block) alone, lidocaine plus ropivacaine |
Sodium channel inhibitor |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University Hospital Bispebjerg and Frederiksberg |
|
Denmark |
2020-12-31 |
2021-11-30 |
GSPB-COVID-2020, NCT04636034 |
Phase 3 Clinical |
Not yet recruiting |
1 |
11 Months |
60 |
Christian S Meyhoff, PhD, Mads S Jespersen, MD, Mads Seit Jespersen |
2020-11-24 |
| COVID_CRC: The Impact of Covid-19 Pandemic on Colorectal Cancer Prevention Due to Delays in Diagnosis: a Global Study |
Colorectal tumor, Coronavirus disease 19 infection |
Colonoscopy alone |
|
|
Istituto Clinico Humanitas |
|
Italy |
2020-12-16 |
2021-03-31 |
100, COVID_CRC, NCT04637893 |
Phase Not Applicable |
Not yet recruiting |
1 |
3 Months |
1000 |
Alessandro Repici, MD, Roberta Maselli, MD |
2020-11-24 |
| Online Trial of Meditation and Behavior |
Coronavirus disease 19 infection |
Loving-Kindness Meditation training alone, Relaxation Meditation training alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) |
Georgetown University |
|
US |
2020-11-20 |
2021-11-20 |
2010-180-2, NCT04632875 |
Phase Not Applicable |
Recruiting |
1 |
12 Months |
68 |
Abigail A Marsh, PhD, Study Coordinator |
2020-11-23 |
| NeuroCovid Rehab and Recovery Related to COVID-19 Diagnosis |
Coronavirus disease 19 infection, Neurological disease |
Soterix taVNS model 0125-LTE stimulator alone, transcutaneous auricular vagus nerve stimulation alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
Medical University of South Carolina |
National Institute of General Medical Sciences, National Institutes of Health |
US |
2020-11-19 |
2021-06-30 |
00101270, NCT04638673, U54GM104941-08 |
Phase 2 Clinical |
Recruiting |
2 |
7 Months |
30 |
Mark S George, MD, Morgan Dancy, BA, Sarah Huffman, BA |
2020-12-08 |
| Prayer in Commbate to Corona Virus - COVID-19 |
Coronavirus disease 19 infection |
prayers by theologians alone, protcol treatment alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Hospital do Coracao |
|
Brazil |
2020-08-01 |
2021-01-31 |
NCT04631380, PRAYER-COVID19 |
Phase Not Applicable |
Recruiting |
1 |
6 Months |
200 |
Alexandre B Cavalcanti, MD, PhD, NATHAN V SOUBIHE JR, sabrina bernardez |
2020-11-24 |
| Video Home Visits for Dietary Counselling |
Coronavirus disease 19 infection, Urolithiasis |
urologist and dietitian virtual home visits alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University of California San Francisco |
|
US |
2021-01-01 |
2024-07-01 |
NCT04634851, UCSFUROVV |
Phase Not Applicable |
Not yet recruiting |
1 |
42 Months |
100 |
David Bayne, MD, MPH, Marshall Stoller, MD |
2020-11-24 |
| UNITED: At-Home Infusion Using Bamlanivimab in Participants With Mild to Moderate COVID-19 |
Coronavirus disease 19 infection |
bamlanivimab alone |
COVID19 Spike glycoprotein modulator |
Healthy volunteers accepted, Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
UnitedHealth Group Inc |
Eli Lilly & Co, Optum Inc |
|
2020-11-30 |
2021-05-31 |
2020-0081, NCT04639479, UNITED |
Phase 4 Clinical |
Not yet recruiting |
0 |
6 Months |
7500 |
Dan Griffin, MD PHD, Michelle Tanner, BA, Tracy Ziolek, MS |
2020-12-07 |
| Co-VIS: Benefits of Using a Transparent Visor to Replace the Face Mask in Speech Therapy Rehabilitation of Oral-Linguo-Facial Praxies in the Context of COVID-19: a Series of Cases |
Apraxia, Coronavirus disease 19 infection |
speech therapy rehabilitation alone, transparent covering visor alone, video sequence watching alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Assistance Publique Hopitaux de Paris |
|
France |
2020-11-30 |
2021-02-28 |
APHP200876, Co-VIS, IDRCB, NCT04639427 |
Phase Not Applicable |
Not yet recruiting |
1 |
3 Months |
4 |
Julie PAQUEREAU, MD |
2020-11-25 |
| NOSO-COR IMMUNO: COVID-19 - Multicenter Study on Nosocomial Transmission of SARS-CoV-2 Virus: an Ancillary Study |
Coronavirus disease 19 infection |
blood sampling alone, nasopharyngeal sampling alone, salivary sampling alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Hospices Civils De Lyon |
|
France |
2020-11-23 |
2021-11-01 |
69HCL20_0761, NCT04637867, NOSO-COR IMMUNO |
Phase Not Applicable |
Not yet recruiting |
1 |
11 Months |
200 |
MITRA ELAHI, PhD, Philippe VANHEMS, MD |
2020-11-25 |
| REHABCOVID: Organization of Pulmonary Rehabilitation of Post-COVID-19 Patient With Sequela |
Anxiety disorder, Coronavirus disease 19 infection, Depression, Dyspnea, Fatigue, Respiratory disease |
aerobic exercise alone, ergocycle alone, heart rate monitor alone, medical consultation alone, muscle strengthening exercise alone, occupational therapy alone, psychomotricity alone, respiratory tele-rehabilitation program alone, sophrology alone, walking exercise alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer |
|
France |
2020-11-30 |
2022-01-31 |
2020-A02838-31, 2020-CHITS-06, NCT04634318, REHABCOVID |
Phase Not Applicable |
Not yet recruiting |
2 |
14 Months |
118 |
Asmaa Jobic, Charles Simon, MD, Jean-Marc Vallier, MD, Nicolas Paleiron, MD |
2020-11-28 |
| Online Multi-component Psychological Intervention for Prevention of Grief Disorder Due to COVID-19 |
Anxiety disorder, Coronavirus disease 19 infection, Depression, Post traumatic stress disorder, Sleep disorder |
Multi-component psychological online intervention alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) |
Universidad Internacional de Valencia |
Universidad Autonoma de Ciudad Juarez, Universidad Nacional Autonoma De Mexico, University of Buenos Aires |
Mexico |
2020-12-15 |
2021-06-01 |
NCT04638842, VIU-GRIEF-COVID |
Phase Not Applicable |
Not yet recruiting |
1 |
5 Months |
42 |
Alejandro Dominguez Rodriguez, PhD, Anabel de la Rosa, Gómez, Carlos Armando Arzola, MD, Esteban Eugenio Esquivel Santoveña, PhD, Flor Rocío Ramírez Martínez, PhD, Luis Farfallini, PhD, María Jesús Hernández Jimenez, PhD, Paulina Arenas Landgrave, PhD, Rosa Olimpia Castellanos Vargas, MD, Sofía Cristina Martínez Luna, MD |
2020-11-25 |
| An observational, retrospective, propensity-matched study to evaluate the impact of famotidine use on clinical outcomes of hospitalized patients with COVID-19 |
Coronavirus disease 19 infection |
famotidine alone |
Histamine H2 receptor antagonist |
|
Hartford Hospital |
|
US |
|
|
|
Phase Not Applicable |
Status not specified |
1 |
|
878 |
|
2020-11-23 |
| CureCovid-2019: A Study to Compare the Efficacy of GNS-561 Versus Standard of Care in Patients With SARS-CoV-2 (COVID-19) Infection |
Coronavirus disease 19 infection |
GNS-561 alone, standard of care alone |
Autophagy protein inhibitor, Solute carrier family inhibitor |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Genoscience |
|
France |
2020-11-18 |
2021-10-30 |
CureCovid-2019, GNS561-CL-I-Q-0291, NCT04637828 |
Phase 2 Clinical |
Recruiting |
1 |
11 Months |
178 |
Christelle Ansaldi, Christelle Ansaldi, MD |
2020-11-25 |
| Polio Vaccine (IPV) for SARS-CoV-2 and Prevention of Coronavirus Disease (COVID-19) |
Coronavirus disease 19 infection |
polio vaccine, Sanofi Pasteur alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
|
|
US |
2020-11-15 |
2021-01-15 |
EMO-001, NCT04639375 |
Phase 4 Clinical |
Recruiting |
2 |
2 Months |
25 |
Brittany Comunale, John Andrews, John Andrews, PhD |
2020-11-28 |
| COVIFAT: Impact of Adipose Tissue in COVID-19 |
Coronavirus disease 19 infection, Inflammatory disease, Obesity |
adipose tissue sampling alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Assistance Publique Hopitaux de Paris |
|
France |
2020-11-23 |
2021-11-23 |
2020-A02403-36, APHP200983, COVIFAT, NCT04639440 |
Phase Not Applicable |
Not yet recruiting |
1 |
12 Months |
60 |
Fabienne FOUFELLE, Dr, Olivier BOURRON, Dr |
2020-12-02 |
| A phase III trial of AMY-101 for the treatment of severe COVID-19 patients |
Coronavirus disease 19 infection |
AMY-101 alone |
Complement C3 inhibitor |
|
University of Pennsylvania |
|
Brazil |
|
|
|
Phase 3 Clinical |
Planned |
1 |
|
|
|
2020-11-23 |
| The effect of massage training on the resilience of pregnant women |
Acute stress disorder, Anxiety disorder, Coronavirus disease 19 infection, Depression |
telemedicine-based massage training alone |
|
Female, Young Adults (18-44 yrs) |
Islamic Azad University |
|
Iran |
2020-11-04 |
|
IR.IAU.MSHD.REC.1399.159, IRCT20170607034378N2 |
Phase Not Applicable |
Recruiting |
2 |
|
120 |
Ali Asghar Mahmudi, Dr Saeed Khayat Moghadam, Fatemeh Jalal Marvi, Mahdi Sayad Kame Olya |
2020-11-24 |
| The role of hemoperfusion in COVID-19 |
Coronavirus disease 19 infection, Respiratory failure |
Standard of care treatment alone, hemoperfusion alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Shaheed Beheshti Medical University |
|
Iran |
2020-10-17 |
|
IR.SBMU.RETECH.REC.1399.582, IRCT20200608047686N2 |
Phase 2 Clinical |
Recruiting |
1 |
|
40 |
Afshin Zarghi, Muhanna Kazempour |
2020-11-24 |
| COVID-19 pandemic effects on depression, anxiety and help-seeking attitudes in college students |
Anxiety disorder, Coronavirus disease 19 infection, Depression |
SurveyMonkey platform alone |
|
Healthy volunteers accepted |
University of Porto |
|
Portugal |
2019-02-01 |
2021-06-01 |
ISRCTN63459073, PMHDS-1 |
Phase Not Applicable |
No longer recruiting |
1 |
28 Months |
500 |
Mrs Virginia Conceicao |
2020-11-25 |
| Qualitative Study: Issues Faced by Female Staffs During the Pandemic COVID-19 |
Coronavirus disease 19 infection |
|
|
|
Hospital Tuanku Fauziah |
|
Malaysia |
2020-11-23 |
2021-04-30 |
57017, NMRR-20-2507-57017 |
Phase Not Applicable |
Not yet recruiting |
1 |
5 Months |
|
Dr Noor Melissa Binti Nor Hadi |
2020-11-23 |
| TECOVID: Thrombotic Complications Among COVID-19 Patients: A Multicenter Study from a Malaysian Perspective |
Coronavirus disease 19 infection, Phlebothrombosis |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Universiti Teknologi Mara |
|
Malaysia |
2020-12-01 |
2021-11-30 |
56439, NMRR-20-2465-56439, TECOVID |
Phase Not Applicable |
Status not specified |
2 |
12 Months |
3035 |
Dr Hanis Hanum Zulkifly, Dr Lee Chew Kiok, Dr Leong Chee Loon |
2020-11-24 |
| Cross-Sectional Study: Factors Contributing to Burnout Among Healthcare Workers in Sabah |
Coronavirus disease 19 infection, Psychiatric disorder |
|
|
Healthy volunteers accepted |
Hospital Tuanku Fauziah |
|
Malaysia |
2020-12-01 |
2021-04-30 |
57139, NMRR-20-2494-57139 |
Phase Not Applicable |
Not yet recruiting |
3 |
5 Months |
|
Dr Noor Melissa Binti Nor Hadi |
2020-11-26 |
| Management of Depression and Anxiety in HF |
Anxiety disorder, Cardiac failure, Coronavirus disease 19 infection, Depression |
web-based COMPASS intervention alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
King's College London |
|
UK |
2020-10-02 |
2021-08-16 |
IRAS ID: 268951, NCT04636944 |
Phase Not Applicable |
Recruiting |
1 |
10 Months |
13 |
Annmarie Grealish, Catherine Evans, Sameera Helal, Silapiya Smith |
2020-11-24 |
| An observational, retrospective, cohort study to investigate the potential hepatotoxicity of lopinavir/ritonavir in severely ill patients for the treatment of COVID-19 infection |
Coronavirus disease 19 infection, Hepatotoxicity drug-induced |
lopinavir + ritonavir alone |
HIV protease inhibitor |
|
Centre Hospitalier Regional Universitaire de Lille |
|
|
|
|
|
Phase Not Applicable |
Status not specified |
0 |
|
42 |
|
2020-11-24 |
| Short Term Effects in Pulmonary Function Among COVID-19 Recovered Adult Patients in a Tertiary Hospital in Davao City |
Coronavirus disease 19 infection, Dyspnea |
|
|
|
Southern Philippines Medical Center |
|
Philippines |
2021-01-18 |
2021-04-18 |
PHRR201110-003113 |
Phase Not Applicable |
Not yet recruiting |
1 |
3 Months |
|
Benjo P. Ato, Christoper John Q. Quadra |
2020-11-23 |
| COVID-CMR: Prevalence of Myocardial Scars on CMR After COVID-19 Infection |
Coronavirus disease 19 infection, Myocardial disease |
Cardiac Magnetic Resonance Imaging alone, ECG monitoring alone, treadmill exercise test alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University Hospital, Bordeaux |
Universite de Bordeaux |
France |
2020-06-13 |
2021-04-13 |
CHUBX 2020/22, COVID-CMR, NCT04636320 |
Phase Not Applicable |
Recruiting |
1 |
10 Months |
240 |
Hubert COCHET, MD-PhD, Nathalie COTTIGNIES, Pierre JAïS, MD-PhD |
2020-11-23 |
| Phase I Trial of a Recombinant COVID-19 Vaccine (CHO Cell) |
Coronavirus disease 19 infection |
SARS-CoV-2 vaccine (CHO Cell) alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over), Asian Ancestry |
Jiangsu Province Centers for Disease Control and Prevention |
Chinese Academy of Medical Military Sciences, Liaoning Maokangyuan, Zhongyi Anke Biotechology Co Ltd |
China |
2020-10-30 |
2022-01-07 |
JSVCT096, NCT04636333 |
Phase 1 Clinical |
Recruiting |
1 |
14 Months |
216 |
Fanyue Meng, Doctor, Fengcai Zhu, Doctor, Mingwei Wei |
2020-12-02 |
| Effect of Vitamin D on Hospitalized Adults With COVID-19 Infection |
Coronavirus disease 19 infection |
cholecalciferol alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University of Liege |
Laboratoires SMB SA |
Belgium |
2020-11-12 |
2021-02-28 |
D-COVID, NCT04636086 |
Phase 4 Clinical |
Recruiting |
1 |
3 Months |
100 |
Anne-Françoise Rousseau, Anne-Françoise Rousseau, MD, PhD |
2020-11-23 |
| A retrospective, cohort study on safety, tolerability, and clinical outcomes of hydroxychloroquine for hospitalized patients with coronavirus 2019 disease |
Coronavirus disease 19 infection |
hydroxychloroquine alone |
|
|
National Center For Advancing Translational Sciences, National Institutes of Health, US Department of Health and Human Services |
|
US |
|
|
|
Phase Not Applicable |
Status not specified |
1 |
|
153 |
|
2020-12-08 |
| PEACE: Perceptions, Experiences, and Activity in Cancer Survivors During COVID-19 |
Cancer, Coronavirus disease 19 infection |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University of Nebraska |
|
US |
2020-12-01 |
2021-06-30 |
768-20, NCT04637295, PEACE |
Phase Not Applicable |
Not yet recruiting |
1 |
7 Months |
1000 |
Diane K Ehlers, PhD, Lindsey Page, MS, Nicholas J Foggia, MS |
2020-11-23 |
| A clinical trial of light activated photodynamic compound vaccine (COVID-19 infection), Theralase Technologies/University of Manitoba for the potential treatment of COVID-19 infection |
Coronavirus disease 19 infection |
light activated photodynamic compound vaccine (COVID-19 infection), Theralase Technologies/University of Manitoba alone |
|
|
Theralase Technologies Inc |
|
|
|
|
|
Phase Not Applicable |
Planned |
0 |
|
|
|
2020-11-23 |
| Methylene Blue Treatment of COVID-19 |
Coronavirus disease 19 infection |
methylene blue alone, standard therapy alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Epatocentro Ticino Foundation |
|
Switzerland |
2020-11-30 |
2022-12-31 |
MB TREATMENT OF COVID19, NCT04635605 |
Phase 2 Clinical |
Not yet recruiting |
1 |
25 Months |
64 |
Andreas Cerny, Prof, Maurizia Bissig |
2020-11-24 |
| MEDEAS: Methylprednisolone Versus Dexamethasone in COVID-19 Pneumonia |
Coronavirus disease 19 infection, Viral pneumonia |
methylprednisolone alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
L'Universita Degli Studi di Trieste |
Centro Di Riferimento Oncologico (CRO Aviano), Istituto Nazionale Per Le Malattie Infettive "Lazzaro Spallanzani" |
Italy |
2020-11-25 |
2021-04-30 |
MEDEAS, MEDEAS1, NCT04636671 |
Phase 3 Clinical |
Not yet recruiting |
1 |
5 Months |
680 |
Francesco Salton, MD, Marco Confalonieri, MD |
2020-11-24 |
| KORANIT: Serological Diagnostics of COVID-19 in Health Care Workers |
Coronavirus disease 19 infection |
blood test alone, nasal swab test alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
University Medical Centre Ljubljana |
|
Slovenia |
2020-11-30 |
2021-01-31 |
KOAIT-1-2020, KORANIT, NCT04635592 |
Phase Not Applicable |
Not yet recruiting |
1 |
2 Months |
300 |
Marko Zlicar, MD, PhD, Peter Poredos, Assist. prof, Peter Poredos, MD, PhD |
2020-11-27 |
| An observational comparative study on the effects of second week methylprednisolone pulses in patients with severe coronavirus disease 2019 pneumonia |
Coronavirus disease 19 infection, Pneumonia |
methylprednisolone alone |
|
|
Hospital de Cruces |
|
Spain |
|
|
|
Phase Not Applicable |
Status not specified |
1 |
|
242 |
|
2020-11-23 |
| Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults |
Coronavirus disease 19 infection |
MT-2766 alone |
TLR-9 agonist |
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Medicago Inc |
GlaxoSmithKline plc |
Canada, Europe, North America, US |
2020-11-19 |
2022-04-30 |
CP-PRO-COVLP-021, NCT04636697 |
Phase 2/Phase 3 Clinical |
Recruiting |
6 |
17 Months |
30612 |
Andre Frechette, Brian Ward, MD, Guy Tellier, Jean-Sebastien Gauthier, Jean-Sebastien Paquette, Mary Hardison |
2020-12-01 |
| Personalized Phage Treatment in COVID-19 Patients With Bacterial Co-Infections Microbials for Pneumonia or Bacteremia/Septicemia |
Acinetobacter baumannii infection, Bacterial infection, Coronavirus disease 19 infection, Pseudomonas aeruginosa infection, Sepsis, Staphylococcus aureus infection, Viral pneumonia |
Phage Therapy alone, anti-microbial therapy alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Adaptive Phage Therapeutics Inc |
|
|
|
|
APT.APS.001, NCT04636554 |
Phase Not Applicable |
Recruiting |
0 |
|
|
Robert J Hopkins, MD, MPH&TM, FACP, FIDSA, Stephanie Holland |
2020-11-24 |
| Burden of COVID-19 Infection in Populations With High or Low Risk of Infection |
Coronavirus disease 19 infection, Post traumatic stress disorder |
app alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Neuromed IRCCS |
|
Italy |
2020-12-15 |
2022-06-15 |
DEP_032020, NCT04636203 |
Phase Not Applicable |
Not yet recruiting |
1 |
18 Months |
3500 |
Chiara Cerletti, MS, Licia Iacoviello, MD, PhD |
2020-11-24 |
| A large clinical diagnostic study to assess COVID-19 in exhaled breath condensate (EBC) using CoronaCheck diagnostic test |
Coronavirus disease 19 infection |
CoronaCheck diagnostic test alone |
|
|
Exhalation Technology Limited |
|
UK |
2020-11-02 |
|
|
Phase Not Applicable |
Recruiting |
1 |
|
300 |
Anoop Chauhan |
2020-11-25 |
| Immune Profiling with Antibody-based COVID-19 Testing |
Coronavirus disease 19 infection, Multiple myeloma |
Antibody-based COVID-19 Testing alone |
|
African Ancestry |
Quest Diagnostics Inc |
Dana-Farber Cancer Institute Inc |
US |
|
|
|
Phase Not Applicable |
Status not specified |
1 |
|
1000 |
Irene Ghobrial, MD |
2020-11-20 |
| Vital Sensor Monitors for CV19 Detection |
Coronavirus disease 19 infection |
ANNE One wireless vital sign monitoring device alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Northwestern University |
US Department of Defense |
US |
2020-11-05 |
2022-10-30 |
NCT04635787, STU00213040 |
Phase Not Applicable |
Recruiting |
1 |
23 Months |
300 |
Shuai (Steve) Xu |
2020-11-23 |
| An observational, retrospective, US cohort study to evaluate the COVID-19 disease severity in patients with multiple sclerosis (MS) treated with ocrelizumab |
Coronavirus disease 19 infection, Multiple sclerosis |
ocrelizumab alone |
B-lymphocyte antigen CD20 inhibitor |
|
Roche Holding AG |
|
US |
|
|
|
Phase 4 Clinical |
Status not specified |
0 |
|
357 |
|
2020-12-09 |
| RECIPE: Restoring Non-Emergent Cardiovascular Care in the Peri- COVID-19 Era |
Coronavirus disease 19 infection |
cardiac procedures alone |
|
Healthy volunteers accepted |
Pinnacle Health |
|
US |
2020-08-01 |
2022-06-30 |
NCT04636021, RECIPE, UPMCP- 20-007 |
Phase Not Applicable |
Recruiting |
1 |
23 Months |
1000 |
William Bachinsky MD, William Bachinsky, MD |
2020-11-23 |
| INHALE-HEP: Inhaled Heparin for Hospitalized COVID-19 Patients |
Coronavirus disease 19 infection |
standard care alone, unfractionated heparin alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
The Australian National University |
Helwan University |
Egypt, Argentina |
2020-06-01 |
2021-06-01 |
INHALE-HEP, INHALE-HEP META-TRIAL, NCT04635241 |
Phase 2/Phase 3 Clinical |
Recruiting |
2 |
12 Months |
656 |
Alicia B Vilaseca, PhD, Frank MP van Haren, MD, PhD, Frank van Haren, Tarek I Ismail |
2020-11-24 |
| H2Covid: Hydrogen Therapy in Patients With Moderate Covid-19 |
Coronavirus disease 19 infection |
conventional oxygen therapy alone, hydrogen therapy alone, nasal cannula alone, Variable regimens including hydrogen , nitrogen , oxygen |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University Hospital, Grenoble |
|
France |
2020-12-01 |
2021-09-30 |
38RC20.277, H2Covid, NCT04633980 |
Phase 1 Clinical |
Not yet recruiting |
1 |
10 Months |
10 |
BOUCHER François, PhD, Jean Paul Brion, MD, Saber TOUATI, PhD |
2020-11-23 |
| Impact of Social Distancing on Bariatric Versus Non-Surgical Obese Patients During COVID-19 Pandemic |
Coronavirus disease 19 infection, Obesity |
bariatric surgery alone, medical weight management alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
Singapore General Hospital Pte Ltd |
|
Singapore |
2020-06-01 |
2020-07-30 |
HENRYLEW, NCT04633941 |
Phase Not Applicable |
Completed |
1 |
1 Month |
272 |
Chin Hong Lim, FRCS |
2020-11-27 |
| Borderline COVID-19 PCR Test Result |
Coronavirus disease 19 infection |
PCR test alone |
|
|
Jessa Hospital |
|
Belgium |
2020-08-01 |
2020-12-30 |
F/2020/166, NCT04636294 |
Phase Not Applicable |
No longer recruiting |
1 |
4 Months |
30000 |
|
2020-11-23 |
| The Impact of COVID-19 Pandemic on Thyroid Surgery in Italy: Results From a Nation-wide, Multicentric Study |
Coronavirus disease 19 infection, Thyroid disease |
Thyroidectomy alone |
|
|
University of Cagliari |
|
Italy |
2020-03-10 |
2020-11-12 |
NCT04635813, THYCOVIT |
Phase Not Applicable |
Completed |
1 |
8 Months |
3800 |
Fabio Medas |
2020-11-23 |
| PallPan AP 4: COVID-19: National strategy for palliative care during times of a pandemic - generalst palliative care in hospitals |
Coronavirus disease 19 infection |
focus group interview alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Universitätklinikum Düsseldorf |
Bundesministerium für Bildung und Forschung |
Germany |
2020-12-01 |
|
2020-1119, DRKS00023595, PallPan AP 4 |
Phase Not Applicable |
Not yet recruiting |
1 |
|
30 |
Martin Neukirchen |
2020-11-23 |
| A phase I clinical trial of TNX-1800 for the potential prevention of COVID-19 infection |
Coronavirus disease 19 infection |
TNX-1800 alone |
COVID19 Spike glycoprotein modulator |
|
Tonix Pharmaceuticals Holding Corp |
|
|
|
|
|
Phase 1 Clinical |
Planned |
0 |
|
|
|
2020-11-20 |
| A phase III trial of PegiHep for the treatment of COVID-19 |
Coronavirus disease 19 infection |
peginterferon alfa-2b follow-on-biologic, Zydus-Cadila alone |
Interferon alpha 2 ligand |
|
Zydus-Cadila Group |
|
India |
|
|
|
Phase 3 Clinical |
Planned |
1 |
|
250 |
|
2020-12-09 |
| Effect of Ivermectin in treatment of COVID-19 |
Coronavirus disease 19 infection |
Variable regimens including Lopinavir/Ritonavir , hydroxychloroquine sulfate , interferon beta-1a follow-on biologic (intramuscular), CinnaGen , ivermectin |
Chloride channel modulator, Interferon beta ligand |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Bandare-abbas University of Medical Sciences |
|
Iran |
2020-11-15 |
|
IR.HUMS.REC.1399.410, IRCT20200506047323N6 |
Phase 3 Clinical |
Recruiting |
1 |
|
120 |
Mahdi Hasani Azad, Mohammad Fathalipour |
2020-11-26 |
| Phase I Clinical Trial on NK Cells for COVID-19 |
Coronavirus disease 19 infection |
natural killer cells alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Hospital de Clinicas de Porto Alegre |
|
Brazil |
2021-01-02 |
2021-03-30 |
20200210, NCT04634370 |
Phase 1 Clinical |
Not yet recruiting |
1 |
2 Months |
24 |
Annelise Pezzi, PhD, Lucia Silla, MD, PhD, Lucia Silla, Md, PhD |
2020-11-23 |
| COV-HD: Antibody Response in Hemodialysis and Non-dialysis Patients Diagnosed With COVID-19 |
Coronavirus disease 19 infection |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Saint Petersburg State University |
|
Russian Federation |
2020-11-30 |
2021-08-31 |
COV-HD, COVID, NCT04633915 |
Phase Not Applicable |
Not yet recruiting |
1 |
9 Months |
40 |
Ekaterina Parshina |
2020-11-23 |
| An observational study on the factors associated with prolonged viral shedding and impact of lopinavir/ritonavir treatment in hospitalized non-critically ill patients with SARS-CoV-2 infection |
Coronavirus disease 19 infection |
lopinavir + ritonavir alone |
HIV protease inhibitor |
|
Zhengzhou University |
|
China |
|
|
|
Phase Not Applicable |
Status not specified |
1 |
|
120 |
|
2020-11-19 |
| Ezrin Peptide (HEP-1) for Treatment of Coronavirus Disease (COVID-19) Infection |
Coronavirus disease 19 infection |
Gepon alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
Shaheed Beheshti Medical University |
praxisgemeinschaft für zelltherapie |
Iran |
2020-12-20 |
2021-04-01 |
IR.SBMU.REC.1399.023, NCT04627233 |
Phase 1 Clinical |
Not yet recruiting |
1 |
3 Months |
20 |
Farzad Ashrafi |
2020-11-23 |
| A Study Evaluating the Efficacy and Safety of CKD-314 in Hospitalized Adult Patients Diagnosed With COVID-19 Pneumonia |
Coronavirus disease 19 infection, Viral pneumonia |
nafamostat (COVID-19 infection), Institut Pasteur Korea alone, standard of care alone |
Serine protease inhibitor, Transmembrane serine protease 2 inhibitor |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Chong Kun Dang Pharmaceutical Corp |
|
South Korea |
2020-11-20 |
2021-06-30 |
A108_01CVD2013, NCT04628143 |
Phase 2 Clinical |
Not yet recruiting |
1 |
7 Months |
100 |
Dongho Kim, MD |
2020-11-24 |
| The Severity of COVID-19 in Diabetes and Non-diabetes Patients (COVID-19) |
Coronavirus disease 19 infection, Non-insulin dependent diabetes |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over), Asian Ancestry |
Dr. A. Ramachandran's Diabetes Hospitals, India Diabetes Research Foundation |
|
India |
2020-11-16 |
2021-05-16 |
CTRI/2020/12/029454, IDRFARH015, IDRFARH015 Version 2.0, NCT04634214 |
Phase Not Applicable |
Not yet recruiting |
4 |
6 Months |
1050 |
Ambady Ramachandran, M.D,PhD,DSc, Dr A Subair Khan, Dr Ambady Ramachandran, Dr Sruti Chandrasekaran, Dr Su Thillai Vallal, Dr T Palaniappan, Palaniappan T, M.D, Sruti Chandrasekaran, M.D.,D.M, Su Thillai Vallal, M.D, Subair Khan, M.S |
2020-12-02 |
| STOP Severe COVID-19: Study To antagonize Plasminogen Activator Inhibitor-1 in Severe COVID-19 |
Coronavirus disease 19 infection |
TM-5614 alone, standard of care alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Northwestern University |
|
US |
2020-11-16 |
2022-06-30 |
NCT04634799, STOP Severe COVID-19, STU00213262 |
Phase 1/Phase 2 Clinical |
Recruiting |
1 |
19 Months |
80 |
Anna Huskin, RN, Douglas E Vaughan, MD, Lyndsay Christensen, MSN, Sanjiv J Shah, MD, Sanjiv Shah, MD |
2020-11-23 |
| MP-COVID: The MentalPlus for Assessment and Rehabilitation of Cognitive Function After Remission of the Symptoms of COVID-19 |
Cognitive disorder, Coronavirus disease 19 infection |
MentalPlus digital game alone |
|
Healthy volunteers accepted, Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University of Sao Paulo |
|
Brazil |
2020-11-08 |
2023-12-29 |
MENTALPLUS, MP-COVID, NCT04632719 |
Phase Not Applicable |
Recruiting |
1 |
37 Months |
200 |
Julia S Valentin, Fellow, Julia S. Valentin, Fellow, Julia SS Valentin, Bacharel, Livia S. Valentin, Ph.D, Livia S. Valentin, Ph.D., Livia SS Valentin, Ph.D, Livia Stocco S Valentin, Ph.D, Luiz Antonio M Cesar, Ph.D, Luiz Aparecido Bortolotto, Ph.D |
2020-11-25 |
| EpiSARS2: Prevalence and Risk Factors of COVID-19 in the Upper Silesian Agglomeration |
Coronavirus disease 19 infection |
|
|
Healthy volunteers accepted |
Slaski Uniwersytet Medyczny w Katowicach |
|
Poland |
2020-06-22 |
2021-04-22 |
2020/ABM /COVID19/0044, EpiSARS2, NCT04627623 |
Phase Not Applicable |
Recruiting |
1 |
10 Months |
6000 |
Grzegorz M Brozek, Prof, Jan E Zejda, Prof, Prof. Grzegorz Brożek,, Rafał Trela |
2020-11-23 |
| Assessment of Stress, Depression and Anxiety in Healthcare Caring for Patients With COVID-19 |
Acute stress disorder, Anxiety disorder, Coronavirus disease 19 infection, Depression, Sleep disorder |
Beck's Test alone, COPE test alone, Test PSS alone, Test STAI alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
Jagiellonian University |
|
Poland |
2020-07-01 |
2021-12-31 |
1072.6120.161.2020, NCT04631497 |
Phase Not Applicable |
Recruiting |
1 |
18 Months |
100 |
Tomasz Skladzien, Ph.D. M.D, Tomasz Skladzien, Ph.D. M.D., Tomasz Skladzien, PhD |
2020-11-23 |
| Exploratory Phase I Trial of the Active IMP in Healthy Volunteers in Relation to COVID-19 |
Coronavirus disease 19 infection |
ivermectin (extended release/sc/BEPO, COVID-19), MedinCell alone |
|
Healthy volunteers accepted, Male, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) |
MedinCell SA |
MAC Clinical Research |
UK |
2020-09-22 |
2021-05-31 |
MDC-TTG-CT-001, NCT04632706 |
Phase 1 Clinical |
Recruiting |
1 |
8 Months |
24 |
Chief Development Officer, Joel Richard, L Cheung, P M Leung, R Kelshaw |
2020-11-24 |
| An European clinical study to assess RLF-100 in the treatment of patients with COVID-19 induced lung injury |
Coronavirus disease 19 infection, Lung injury |
aviptadil (inhaled, sarcoidosis/acute lung injury/acute respiratory distress syndrome associated COVID-19), Relief Therapeutics Holding alone |
Adrenergic receptor antagonist, VIP receptor agonist |
|
Relief Therapeutics Holding AG |
Syneos Health Inc |
Europe |
2021-03-31 |
|
|
Phase Not Applicable |
Planned |
0 |
|
|
|
2020-11-19 |
| MEDIC-LAUMC: Managing Endothelial Dysfunction in COVID-19: A Randomized, Controlled Trial at LAUMC |
Coronavirus disease 19 infection, Dyspnea, Respiratory distress syndrome, Vascular disease |
anticoagulation therapy alone, Variable regimens including L-arginine , atorvastatin , dexamethasone , folic acid , nebivolol , nicorandil , vitamin C , zinc |
Beta 1 adrenoceptor antagonist, Beta 3 adrenoceptor agonist, HMG CoA reductase inhibitor, Potassium channel stimulator |
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
LAU Medical Center |
|
Lebanon |
2020-11-10 |
2021-05-01 |
LEBANESE AMERICAN UNIVERSITY, MEDIC-LAUMC, NCT04631536 |
Phase 0 Clinical |
Not yet recruiting |
1 |
5 Months |
80 |
Kamal Matli, Matli Kamal, MD |
2020-11-23 |
| A phase IIb, confirmatory study of Zofin in the treatment of patients with COVID-19 infection |
Coronavirus disease 19 infection |
Zofin alone |
|
|
Organicell Regenerative Medicine |
|
|
2021-03-31 |
|
|
Phase 2b Clinical |
Planned |
0 |
|
|
|
2020-11-19 |
| IvermecPrev-Brazil: Study on the effects of using ivermectin to prevent COVID-19 in an adult population in Brazil |
Coronavirus disease 19 infection |
ivermectin alone |
Chloride channel modulator |
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Universidade Federal de Pernambuco |
University of Toronto |
Brazil |
2020-04-10 |
2021-06-30 |
ISRCTN90437126, IVERMECPREV-BRAZIL SCINETN001.2020, IvermecPrev-Brazil |
Phase 3 Clinical |
Recruiting |
1 |
14 Months |
800 |
Prof Denia Fittipaldi-Duarte, Prof deCastro |
2020-11-24 |
| EAVE II: Early Pandemic Evaluation and Enhanced Surveillance of the coronavirus COVID-19 |
Coronavirus disease 19 infection |
vaccine programmes alone |
|
|
Academic and Clinical Centre Office for Research and Development [ACCORD], UK |
|
UK |
2020-03-01 |
2021-09-30 |
EAVE II, IRAS 114474, ISRCTN40292537 |
Phase Not Applicable |
Recruiting |
2 |
19 Months |
5400000 |
Prof Sheikh |
2020-11-25 |
| Cash transfers to stimulate school re-enrollment among vulnerable adolescent girls in urban informal settlements as Kenya responds to COVID-19 |
Coronavirus disease 19 infection |
one-time cash transfer alone |
|
Healthy volunteers accepted, Female |
Population Council - Kenya |
Bill & Melinda Gates Foundation, Department for International Development, Echidna Giving |
Kenya |
2020-10-02 |
2021-06-30 |
ISRCTN12792822, P661 |
Phase Not Applicable |
Not yet recruiting |
1 |
8 Months |
1700 |
Dr Austrian |
2020-11-25 |
| COVID-19 - Administration of the SARS-CoV-2-Neutralizing Monoclonal Antibody DZIF-10c (Inhalation) |
Coronavirus disease 19 infection |
DZIF-10c (iv, COVID-19), University of Cologne/Boehringer Ingelheim alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
University of Cologne |
Boehringer Ingelheim International GmbH, The Clinical Trials Centre Cologne |
Germany |
2020-11-23 |
2021-06-30 |
NCT04631705, UNI-KOELN-4370 |
Phase 1/Phase 2 Clinical |
Not yet recruiting |
1 |
7 Months |
69 |
Florian Klein, Univ.Prof., Gerd Fätkenheuer, Henning Gruell, Dr. med. |
2020-11-30 |
| APEL-COVID: Apelin; ACE2 and Biomarkers of Alveolar-capillary Permeability in SARS-cov-2 (COVID-19) |
Adult respiratory distress syndrome, Coronavirus disease 19 infection, Viral pneumonia |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Universite de Sherbrooke |
University Hospital, Angers |
Canada |
2020-10-26 |
2021-12-01 |
2021-3862-APEL-COVID, APEL-COVID, NCT04632732 |
Phase Not Applicable |
Recruiting |
1 |
13 Months |
140 |
Frédéric Chagnon, MSc, Olivier Lesur, MD PhD |
2020-11-23 |
| An observational study to evaluate the pharmacokinetics and safety of lopinavir in COVID-19 patients |
Coronavirus disease 19 infection, SARS coronavirus infection |
lopinavir + ritonavir alone |
HIV protease inhibitor |
|
CHU De Nantes |
|
France |
|
|
|
Phase Not Applicable |
Status not specified |
1 |
|
12 |
|
2020-11-19 |
| Physical Activity and the Risk of COVID-19 Infection and Mortality |
Coronavirus disease 19 infection |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over), Asian Ancestry |
Wonju Christian Hospital |
|
South Korea |
2014-01-01 |
2020-07-31 |
2020AN0292, NCT04631861 |
Phase Not Applicable |
Completed |
1 |
79 Months |
132069 |
Dong-Hyuk Cho |
2020-11-23 |
| A retrospective, single-center, case-control, comparative analysis on the safety and efficacy of anti-IL6 tocilizumab in patients with COVID-19 |
Coronavirus disease 19 infection |
tocilizumab alone |
|
|
Osped Niguarda Ca Granda |
|
|
|
|
|
Phase Not Applicable |
Status not specified |
0 |
|
222 |
|
2020-11-19 |
| Sleep and Covid19: Sleep Behavior in Athletes During Home Confinement Due to the Covid-19 Outbreak |
Coronavirus disease 19 infection |
|
|
Healthy volunteers accepted, Young Adults (18-44 yrs) |
Istituto Ortopedico Galeazzi Spa |
|
Italy |
2020-05-22 |
2021-02-28 |
NCT04632615, SLEEP&COVID19, Sleep and Covid19 |
Phase Not Applicable |
Recruiting |
1 |
9 Months |
230 |
Jacopo Antonino Vitale, PhD, Stefano Borghi, MSc |
2020-11-19 |
| PROPEL: Intravenous Zotatifin in Adults With Mild or Moderate COVID-19 |
Coronavirus disease 19 infection |
zotatifin alone |
Eukaryotic initiation factor 4A-I inhibitor |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
University of California San Francisco, eFFECTOR Therapeutics Inc |
Medpace Inc |
|
2020-11-16 |
2021-07-01 |
EFT226-0003, NCT04632381, PROPEL |
Phase 1b Clinical |
Not yet recruiting |
0 |
7 Months |
36 |
Mark Densel, Neil Sankar, MD, MPH, Rhonda Petsch |
2020-11-24 |
| COVID-19 - Administration of the SARS-CoV-2-Neutralizing Monoclonal Antibody DZIF-10c (Infusion) |
Coronavirus disease 19 infection |
DZIF-10c alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
University of Cologne |
Boehringer Ingelheim International GmbH |
Germany |
2020-11-23 |
2021-06-30 |
NCT04631666, UNI-KOELN-4288 |
Phase 1/Phase 2 Clinical |
Not yet recruiting |
1 |
7 Months |
69 |
Florian Klein, Univ.Prof., Gerd Faetkenheuer, Univ.-Prof., Gerd Fätkenheuer, Henning Gruell, Dr. med. |
2020-11-30 |
| A Phase II Clinical Trial of Recombinant Corona Virus Disease-19 (COVID-19) Vaccine (Sf9 Cells) |
Coronavirus disease 19 infection |
SARS-CoV-2 vaccine (Sf9 Cell, COVID-19), Jiangsu Province Centers for Disease Control and Prevention alone |
COVID19 Spike glycoprotein modulator |
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Jiangsu Province Centers for Disease Control and Prevention, West China Hospital |
|
China |
2020-11-17 |
2021-11-18 |
ChiCTR2000039994, JSVCT099, NCT04640402 |
Phase 2 Clinical |
Recruiting |
1 |
12 Months |
960 |
Fanyue Meng, Doctor, Fengcai Zhu, Doctor, Wei Wang |
2020-11-24 |
| Evaluation of respiratory Tele-rehabilitation in patient with COVID-19 |
Coronavirus disease 19 infection |
Diaphragmatic breathing exercise alone, Incentive spirometry exercise alone, Seated arm reaches alone, Sit to stand squats alone, Standing heel raises alone, Standing marching alone, Wall pushups alone, respiratory tele-rehabilitation alone, video conferencing program alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Mashhad University of Medical Sciences |
|
Iran |
2020-11-21 |
|
IR.MUMS.NURSE.REC.1399.052, IRCT20200711048077N1 |
Phase Not Applicable |
Recruiting |
1 |
|
60 |
Ali khorsand vakilzadeh, Fateme Rangani, Mohsen Tafaghodi |
2020-11-23 |
| Quality of life in post covid affected patients |
Coronavirus disease 19 infection |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Sri Ramachandra University |
|
India |
2020-11-17 |
|
CTRI/2020/11/029188 |
Phase Not Applicable |
Not yet recruiting |
1 |
|
500 |
Suja Lakshmanan |
2020-11-27 |
| Psychological effect of COVID 19 on Positive female patient |
Anxiety disorder, Coronavirus disease 19 infection, Psychiatric disorder |
|
|
Female, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
All India Institute of Medical Sciences Patna |
|
India |
2020-11-25 |
|
CTRI/2020/11/029200 |
Phase Not Applicable |
Not yet recruiting |
1 |
|
25 |
Dr Poonam Kumari |
2020-11-23 |
| LATTICE: To determine the impact of latent tuberculosis on severity and outcomes in patients with suspected SARS-COV-19 infection |
Coronavirus disease 19 infection, Mycobacterium tuberculosis infection |
Interferon gamma release assay alone, Mantoux test alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
All India Institute of Medical Sciences |
|
India |
2020-11-30 |
|
CTRI/2020/11/029203, LATTICE |
Phase Not Applicable |
Not yet recruiting |
1 |
|
300 |
Dr Pawan Tiwari, Dr Randeep Guleria, Dr Shweta Bhopale |
2020-11-27 |
| An observational study to determine the association of vaccine coverage with the prevalence of SARS-CoV-2 infection |
Coronavirus disease 19 infection |
BCG vaccine alone |
|
|
Utano National Hospital |
|
Japan |
|
|
|
Phase Not Applicable |
Status not specified |
1 |
|
|
|
2020-11-18 |
| A clinical study to assess repurposed niclosamide in the treatment of patients with COVID-19 |
Coronavirus disease 19 infection |
repurposed niclosamide (oral/tablet, COVID-19), Hyundai Bioscience/CNPharm alone |
|
|
CNPharm Co Ltd |
|
|
|
|
|
Phase Not Applicable |
Planned |
0 |
|
|
|
2020-11-18 |
| HERODOTUS: Head and Neck cancers International Covid-19 collaboration |
Coronavirus disease 19 infection, Head and neck tumor, Nasal cancer, Salivary gland cancer, Thyroid tumor, Viral pneumonia |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Hellenic Cooperative Oncology Group |
Emory University, Fondazione IRCCS Istituto Nazionale Tumori, Grupo Español de Tratamiento de Tumores de Cabeza y Cuello, National Cancer Centre of Singapore, The University of Birmingham, University of Queensland, University of Toronto |
Greece |
2020-12-01 |
2021-06-30 |
HERODOTUS, HERODOTUS, NCT04632173 |
Phase Not Applicable |
Not yet recruiting |
1 |
7 Months |
750 |
Amanda Psyrri, Amanda Psyrri, MD, Evita Fragou, Lisa Licitra, MD |
2020-11-19 |
| NUEVA: BCG Vaccination to Prevent COVID-19 |
Coronavirus disease 19 infection |
BCG vaccine, Organon alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) |
Henry M Jackson Foundation for the Advancement of Military Medicine |
Defense Health Agency, Harvard Medical School, US Department of Defense, Uniformed Services University of the Health Sciences |
US |
2020-11-30 |
2023-04-30 |
NCT04632537, NUEVA, USUHS.2020-062 |
Phase 3 Clinical |
Not yet recruiting |
3 |
29 Months |
550 |
Ansley Adams, BS, Dan Steigelman, MD, David Hrncir, MD, Dutchabond Shaw, RN, Kimberly Murphy, MSN, Marianne Spevak, BSHS, Naomi E Aronson, Thomas G Oliver, Thomas Oliver, MD |
2020-12-03 |
| RHEA-COVID19: Effectiveness and Safety of Rhea Health Tone as add-on Therapy for COVID-19 in Hospitalized Adults in Indonesia |
Coronavirus disease 19 infection |
Rhea Health Tone alone, Standard of Care alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) |
Universitas Padjadjaran |
PT. Rhea Pharmaceutical Sciences Indonesia, Prodia Clinical Laboratory |
Indonesia |
2020-12-01 |
2021-02-15 |
NCT04627519, PHARM-202010.01, RHEA-COVID19 |
Phase 2 Clinical |
Not yet recruiting |
1 |
2 Months |
69 |
Haig YH Babikian, Keri Lestari, Keri Lestari, PhD |
2020-11-25 |
| High GRP78 Levels in Covid-19 Infection: A Case-Control Study |
Coronavirus disease 19 infection |
ELISA kit, Sun Long alone, Serum protein level analysis alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Kafkas University |
Acibadem University, Pamukkale University |
Turkey |
2020-04-16 |
2020-10-10 |
CLINICAL-2, NCT04628637 |
Phase Not Applicable |
Completed |
1 |
5 Months |
144 |
Ramazan Sbirli, Dr. |
2020-12-03 |
| Curaneum 20 for Covid 19 |
Coronavirus disease 19 infection |
Curaneum 20 alone, standard management alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
|
|
India |
2020-12-01 |
|
CTRI/2020/11/029166 |
Phase 3 Clinical |
Not yet recruiting |
1 |
|
200 |
Arunaloke Chakrabarti, Prof Pradip Bhattaharyya |
2020-11-23 |
| Study to evaluate the knowledge, attitude and mental health of in-hospital front-line warriors of operation theatre |
Coronavirus disease 19 infection, Psychiatric disorder |
|
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
Government Medical College and Hospital,Chandigarh |
|
India |
2020-11-20 |
|
CTRI/2020/11/029159 |
Phase Not Applicable |
Not yet recruiting |
1 |
|
200 |
Sukanya Mitra |
2020-11-20 |
| Clinical Study Spartan COVID-19 V2 System (Canada Alternate) |
Coronavirus disease 19 infection |
Spartan COVID-19 v2 System alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Spartan Bioscience Inc |
|
Canada, US |
2020-11-17 |
2021-01-31 |
NCT04628208, VNV-00635 |
Phase Not Applicable |
Recruiting |
3 |
2 Months |
60 |
Poppy MacPhee, Tara Linseman |
2020-12-03 |
| Covid19-Pain: Musculoskeletal Pain In Patients With COVID-19 Who Have Hospital Care |
Coronavirus disease 19 infection, Musculoskeletal pain |
|
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Fondazione Don Carlo Gnocchi - Onlus |
|
Italy |
2020-12-01 |
2021-07-31 |
COVID19-PAIN, Covid19-Pain, NCT04632355 |
Phase Not Applicable |
Not yet recruiting |
1 |
8 Months |
100 |
Jorge H Villafañe, Jorge H Villafañe, Ph.D |
2020-11-20 |
| Covid-19 Anxiety And Phobia Levels Of The Parents |
Anxiety disorder, Coronavirus disease 19 infection, Phobia |
|
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Selcuk University |
|
Turkey |
2020-05-01 |
2020-10-15 |
FARUKCICEKCI, NCT04631172 |
Phase Not Applicable |
Completed |
1 |
5 Months |
150 |
Faruk Cicekci |
2020-11-20 |
| CMR Findings in COVID-19 Patients Presenting With Myocardial Infarction |
Coronavirus disease 19 infection, Myocardial infarction |
cardiac magnetic resonance imaging alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Assiut University |
|
Egypt |
2021-01-01 |
2023-10-31 |
CMR IN MYOCARDIAL INFARCTION, NCT04628104 |
Phase Not Applicable |
Not yet recruiting |
1 |
34 Months |
60 |
Mohamed Ahmed Abdallah Hamada, hosam hasan, master, mohamed ahmed, Master |
2020-11-19 |
| mHealth Intervention for Increasing COVID-19 Prevention Practices With Urban Refugee and Displaced Youth in Uganda |
Coronavirus disease 19 infection |
Kukaa Sala mHealth intervention alone, face mask and soap provision alone |
|
Healthy volunteers accepted, Adolescents (13-17 yrs), Young Adults (18-44 yrs) |
University of Toronto |
|
Uganda |
2021-02-01 |
2021-09-20 |
IDRC_COVID, NCT04631367 |
Phase Not Applicable |
Not yet recruiting |
1 |
7 Months |
404 |
Carmen H Logie, PhD, Moses Okumu, PhD |
2020-11-19 |
| ANCOR: What can the investigators learn from the implementation of a novel point-of-care antigen-based SARS-CoV-2 rapid diagnostic test to screen incoming patients in a large university hospital? (COVID-19) |
Coronavirus disease 19 infection |
novel point-of-care antigen-based SARS-CoV-2 rapid diagnostic test alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University Hospital Heidelberg |
|
Germany |
2020-11-20 |
|
ANCOR, DRKS00023584, S-811/2020 |
Phase Not Applicable |
Recruiting |
1 |
|
44 |
Claudia Denkinger |
2020-12-02 |
| Characteristics of COVID-19 Patients in Kazakhstan in Early 2020 |
Coronavirus disease 19 infection, Respiratory distress syndrome, Sepsis, Septic shock, Viral pneumonia |
|
|
|
Semey State Medical University |
|
Kazakhstan |
2020-02-20 |
2020-12-01 |
76.29.31_48.04.06-01, NCT04627194 |
Phase Not Applicable |
No longer recruiting |
1 |
9 Months |
1000 |
Maiya Goremykina, M.D, C.M.S, Raifa Ivanova, MD, D.M.S., Sergey Yegorov, Ph.D., Yersin Zhunussov, MD, D.M.S. |
2020-11-19 |
| Efficacy and safety of pentoxifylline in treatment and recovery of patients with COVID-19 |
Coronavirus disease 19 infection |
Variable regimens including hydroxychloroquine , pentoxifylline , sofosbuvir + daclatasvir |
Phosphoric diester hydrolase inhibitor |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Iran University of Medical Sciences |
|
Iran |
2020-08-17 |
|
IR.IUMS.REC.1399.458, IRCT20170809035597N2 |
Phase 3 Clinical |
No longer recruiting |
2 |
|
86 |
Azadeh Goodarzi, Azadeh Goodarzi, Simin Almasi |
2020-11-20 |
| AntagoBrad-Cov: Evaluation of the effects of bradykinin antagonists on pulmonary manifestations of COVID-19 infections |
Coronavirus disease 19 infection, Lung disease |
CE-1145 plus icatibant |
Bradykinin B2 receptor antagonist, Complement C1s subcomponent inhibitor |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
GCS Ramsay Santé pour l’Enseignement et la Recherche |
|
France |
2020-11-12 |
|
2020-002225-29, AntagoBrad-Cov, AntagoBrad-Cov |
Phase 2 Clinical |
Recruiting |
1 |
|
45 |
SAHBANE |
2020-11-20 |
| AspCOVID-19 study: Fungal infection of the airways in severe COVID-19 pneumonia |
Aspergillus infection, Coronavirus disease 19 infection, Viral pneumonia |
standard laboratory parameters alone, standard microbiological testing alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Technical University of Munich |
|
Germany |
2020-03-11 |
2020-07-31 |
AspCOVID-19 study, ISRCTN14810048 |
Phase Not Applicable |
Completed |
2 |
4 Months |
32 |
Dr Lahmer |
2020-12-02 |
| Prospective research for early detection of COVID-19 pneumonia using mobile CT vehicle at specialized accommodation facilities |
Coronavirus disease 19 infection, Viral pneumonia |
mobile CT vehicle alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Yokohama City University |
Japan Agency for Medical Research and Development |
Japan |
2020-11-17 |
|
UMIN000042477 |
Phase Not Applicable |
Recruiting |
1 |
|
150 |
Tsuneo Yamashiro |
2020-11-19 |
| Japanese health and safety information for international visitors: a randomized controlled trial |
Coronavirus disease 19 infection |
sa-chan game alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University of Human Environments, University of Tokyo |
Japan Science and Technology Agency |
Europe, North America, Australia |
2020-12-15 |
|
UMIN000042483 |
Phase Not Applicable |
Not yet recruiting |
1 |
|
1000 |
Mariko Nishikawa |
2020-11-20 |
| Antiinflammatory and anticoagulative agents in COVID-19 pneumonia treatment |
Coronavirus disease 19 infection, Viral pneumonia |
Dexamethasone plus enoxaparin sodium |
Low molecular weight heparin |
|
IM Sechenov Moscow Medical Academy |
|
Europe, Russian Federation |
2020-04-08 |
|
UMIN000042489 |
Phase Not Applicable |
Completed |
1 |
|
157 |
Petr Tkachenko, Vladimir Ivaashkin |
2020-11-19 |
| A retrospective study to analyze the impact of influenza A virus (IAV) exposure on COVID-19 |
Coronavirus disease 19 infection, Influenza virus A infection |
oseltamivir alone |
Exo-alpha sialidase inhibitor |
|
Peking University First Hospital |
|
China |
|
|
|
Phase Not Applicable |
Status not specified |
1 |
|
70 |
|
2020-11-18 |
| Does emergency orthopedic surgery in the pandemic era increase the risk of developing COVID-19? A combined analysis of retrospective and prospective study at a national tertiary hospital in Jakarta, Indonesia |
Coronavirus disease 19 infection, Surgical procedure |
orthopedic surgery alone |
|
Preschool Children (2-5 yrs), Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
Cipto Mangunkusumo Hospital, University of Indonesia |
|
Asia, Indonesia |
2020-04-01 |
|
UMIN000042453 |
Phase Not Applicable |
Completed |
2 |
|
14 |
Achmad Kamal, I Wayan Arya Mahendra Karda |
2020-11-20 |
| DemStepCare: General practitioner-based dementia care with coordinated cooperation and risk-stratified use of specialized nurses |
Coronavirus disease 19 infection, Dementia |
DemStepCare intervention alone |
|
|
Klinikum der Albert-Ludwigs Universitaet Freiburg |
Dlr Deutsches Zentrum Für Luft- Und Raumfahrt Ev |
Germany |
2019-10-17 |
|
2019-14427, DRKS00023560, DemStepCare |
Phase Not Applicable |
Recruiting |
1 |
|
2400 |
Erik Farin-Glattacker, Teresa Weber |
2020-11-20 |
| Clinical profiles and outcomes of COVID patients given with remdesivir: A single centre experience |
Coronavirus disease 19 infection |
remdesivir alone |
COVID19 non structural protein 8 modulator, COVID19 replicase polyprotein 1ab inhibitor, RNA polymerase modulator |
|
Southern Philippines Medical Center |
|
Philippines |
2020-03-01 |
|
PHRR201111-003148 |
Phase Not Applicable |
Not yet recruiting |
1 |
|
|
Ranillo V Gamutan Jr |
2020-11-20 |
| Sero-surveillance for Dengue, Chikungunya and COVID |
Chikungunya virus infection, Coronavirus disease 19 infection, Dengue virus infection |
|
|
Preschool Children (2-5 yrs), Children (6-12 yrs), Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
International Clinical Epidemiology Network (INCLEN) TRUST |
|
India |
2020-12-01 |
|
CTRI/2020/11/029141 |
Phase Not Applicable |
Not yet recruiting |
1 |
|
5000 |
Divya Nair, Shikha Dixit |
2020-11-20 |
| Role of Heparin inhalation in reducing the duration the patient is breathing with the help of a ventilator |
Coronavirus disease 19 infection |
Heparin alone, Standard care alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
All India Institute of Medical Sciences Patna |
|
India |
2020-12-01 |
|
CTRI/2020/11/029175 |
Phase 2 Clinical |
Not yet recruiting |
1 |
|
58 |
Shagufta Naaz |
2020-11-19 |
| Validation of immune booster potential of Kabasura Kudineer |
Coronavirus disease 19 infection |
Kabasura Kudineer alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
Central Council for Research in Siddha, Ministry of Ayush |
|
India |
2020-11-18 |
|
CTRI/2020/11/029137 |
Phase Not Applicable |
Not yet recruiting |
1 |
|
100 |
Dr Aiswarya M Nair, Dr Parameswari RP, Prof SP Thyagarajan |
2020-11-19 |
| Difficulties encountered with respiration while providing analgesia for surgeries to patients who had recovered from Covid-19 infection |
Coronavirus disease 19 infection, General anesthesia |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) |
SRM University |
|
India |
2020-11-20 |
|
CTRI/2020/11/029148 |
Phase Not Applicable |
Not yet recruiting |
1 |
|
50 |
Dr CR Saravanan, Dr Parameshwaran M |
2020-11-19 |
| Use of a new breathing device for covid 19 patients |
Coronavirus disease 19 infection |
InVicto alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Royal Brompton Hospital |
|
India |
2020-11-23 |
|
CTRI/2020/11/029146 |
Phase Not Applicable |
Not yet recruiting |
1 |
|
240 |
Dr Alben Sigamani, Dr Vimal Bharadwaj |
2020-11-19 |
| Impact of COVID 19 on Guillain-Barre Syndrome in India |
Coronavirus disease 19 infection, Guillain Barre syndrome |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
All India Institute of Medical Sciences |
|
India |
2020-12-01 |
|
CTRI/2020/11/029143 |
Phase Not Applicable |
Not yet recruiting |
1 |
|
300 |
Vishnu VY |
2020-11-20 |
| Effect of Covid19 work from home on musculoskeletal disorders |
Coronavirus disease 19 infection, Musculoskeletal disease |
|
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) |
Manipal Academy of Higher Education |
|
India |
2020-12-01 |
|
CTRI/2020/11/029142 |
Phase Not Applicable |
Not yet recruiting |
1 |
|
498 |
Dr G Arun Maiya, Garima Gupta |
2020-11-19 |
| The effects of aromatherapy on the anxiety and sleep quality of the patients with COVID-19 |
Anxiety disorder, Coronavirus disease 19 infection |
aromatherapy alone, lavender essential oil (Zardband company) alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
Kerman University of Medical Sciences |
|
Iran |
2020-11-05 |
|
IR.KMU.REC.1399.423, IRCT20201020049088N1 |
Phase 2 Clinical |
Recruiting |
1 |
|
60 |
Abbas Pardakhti, Behnaz Bagherian, Mohammad Hossein Mehrolhassani |
2020-11-20 |
| TS-COVID: Prevention With Chloroquine in Health Personnel Exposed to Infection With Coronavirus Disease 2019 (COVID-19) |
Coronavirus disease 19 infection |
chloroquine alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Fundacion Clinica Valle del Lili |
|
Colombia |
2020-03-28 |
2021-02-14 |
FVL-1567, NCT04627467, TS-COVID |
Phase 2 Clinical |
No longer recruiting |
1 |
10 Months |
3217 |
Juan D Velez, MD |
2020-11-19 |
| Baseline Vitamin D Deficiency and COVID-19 Disease Severity |
Coronavirus disease 19 infection, Vitamin D deficiency |
|
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Parkview Medical Center |
|
US |
2020-10-27 |
2022-04-14 |
NCT04628000, PIRB78 |
Phase Not Applicable |
Recruiting |
1 |
17 Months |
50 |
Doug Duffee, Doug Duffee, MD, Stephaine Lucas, MD, Stephanie Lucas, MD |
2020-11-18 |
| Mothers view on the impact of increased screen time on the overall health of school going children during COVID-19 |
Coronavirus disease 19 infection |
survey alone |
|
Female, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) |
Welcomgroup Graduate School of Hotel Administration |
|
India |
2020-11-22 |
|
CTRI/2020/11/029171 |
Phase Not Applicable |
Not yet recruiting |
1 |
|
261 |
Humaira Fatima Shah, Mrs Swathi Acharya K |
2020-11-18 |
| Efficacy of Yoga Based Self-Management Program for Chronic Pain |
Coronavirus disease 19 infection, Pain |
Yoga based self-management alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Aarogyam UK |
Patanjali Yog Peeth (UK) Trust |
UK |
2020-09-17 |
2020-11-09 |
AU0211, NCT04628130 |
Phase Not Applicable |
Completed |
2 |
1 Month |
42 |
Deepa Modi, Neha Sharma, Sunita Poddar, Vishwesh Kulkarni |
2020-11-18 |
| A phase I/Ii clinical trial of PDS-0203 for the potential prevention of COVID-19 infection |
Coronavirus disease 19 infection |
PDS-0203 alone |
Coronavirus spike glycoprotein inhibitor |
|
PDS Biotechnology Corp |
|
|
2021-06-30 |
|
|
Phase 1/Phase 2 Clinical |
Planned |
0 |
|
|
|
2020-11-17 |
| Covid19 Antibody prevalence and sustainability. A retrospective, longitudinal, mono-centered, observational study in Covid-19 PCR positive hospital workers |
Coronavirus disease 19 infection |
|
|
Adolescents (13-17 yrs), Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
Ernst von Bergmann Clinic |
|
Germany |
2020-11-20 |
|
DRKS00023561, S 30(bB)/2020 |
Phase Not Applicable |
Recruiting |
1 |
|
207 |
Maria Biersack |
2020-11-18 |
| Comparison of the Surgical Facemask With the Double-trunk Mask on Oxygenation in COVID-19 |
Coronavirus disease 19 infection |
Double-Trunk Mask alone, Surgical Mask alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Clinique Universitaires Saint-Luc |
|
Belgium |
2020-11-13 |
2021-11-13 |
DTM-003, NCT04629989 |
Phase Not Applicable |
Recruiting |
1 |
12 Months |
27 |
William Poncin, William Poncin, PT, PhD |
2020-11-20 |
| A Smartphone Intervention for Relational and Mental Well Being |
Coronavirus disease 19 infection, Depression |
daily text messages alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University of Washington |
|
US |
2020-04-04 |
2020-08-03 |
NCT04629755, STUDY00009897 |
Phase Not Applicable |
Completed |
1 |
4 Months |
1765 |
Jonathan W Kanter, PhD |
2020-11-21 |
| A case-control study to assess safety and efficacy of lenzilumab in the treatment of patients with severe COVID-19 and acute respiratory distress syndrome (ARDS) |
Coronavirus disease 19 infection, Respiratory distress syndrome |
lenzilumab alone |
GM-CSF ligand inhibitor, Immunoglobulin G1 modulator, Immunoglobulin kappa modulator |
|
Humanigen Inc |
|
US |
|
|
|
Phase Not Applicable |
Status not specified |
1 |
|
39 |
|
2020-11-17 |
| LAUREL: Chronic Lung Disease and COVID-19: Understanding Severity, Recovery and Rehabilitation Needs |
Coronavirus disease 19 infection |
Rehabilitation-focused program alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
VA Office of Research and Development |
|
US |
2021-11-01 |
2024-10-31 |
1 I01 RX-003666-01, F3666-R, LAUREL, NCT04628039 |
Phase Not Applicable |
Not yet recruiting |
1 |
36 Months |
506 |
John R Kundzins, BS, Kristina A Crothers, MD |
2020-11-20 |
| General Psychological Distress, PTSD, and Co-Morbidities in Healthcare Workers Consequent to COVID-19 |
Acute stress disorder, Coronavirus disease 19 infection, Post traumatic stress disorder |
Interpersonal Psychotherapy alone, Medical Music alone, Narrative Writing alone, Prolonged Exposure Therapy alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Weill Medical College of Cornell University |
|
US |
2020-11-30 |
2021-09-30 |
20-04021913, NCT04626050 |
Phase Not Applicable |
Not yet recruiting |
1 |
10 Months |
120 |
JoAnn Difede, PhD, Mariel Emrich, BS |
2020-11-20 |
| PASSION: Proximal Effects of Alcohol on Same-Sex Intimate Partner Violence |
Acute stress disorder, Coronavirus disease 19 infection |
CBT Text Messaging alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Georgia State University |
University at Buffalo |
US |
2020-11-30 |
2022-09-30 |
NCT04625465, PASSION, R01AA025995 |
Phase Not Applicable |
Recruiting |
1 |
22 Months |
480 |
Dominic J Parrott, Ph.D., Konrad Bresin, Ph.D. |
2020-11-19 |
| M3Epilepsy: Making Mindfulness Matter in Children With Epilepsy |
Coronavirus disease 19 infection, Epilepsy |
Making Mindfulness Matter (M3) alone |
|
Preschool Children (2-5 yrs), Children (6-12 yrs) |
Lawson Health Research Institute |
Canadian Institutes of Health Research |
Canada |
2019-12-02 |
2022-12-20 |
6558, M3Epilepsy, NCT04020484 |
Phase Not Applicable |
Recruiting |
1 |
36 Months |
100 |
Karen Bax, Ph.D., Kathy Nixon Speechley, Ph.D, Kathy Nixon Speechley, Ph.D., Mary Secco, MSc cand. |
2020-11-24 |
| Effect of the globally spread Covid-19 on the diet and lifestyle of adults (25 to 60 years) |
Coronavirus disease 19 infection |
questionnaire alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) |
Welcomgroup Graduate School of Hotel Administration |
|
India |
2020-11-23 |
|
CTRI/2020/11/029172 |
Phase Not Applicable |
Not yet recruiting |
1 |
|
200 |
Deeksha Lobo, Jasmine Tamak, Mrs Pallavi Mahesh Shettigar |
2020-11-20 |
| What does Covid 19 do to patients with long standing Kidney disease and the impact of treatment on their course in hospital - a tertiary care hospital study |
Coronavirus disease 19 infection, End stage renal disease |
hemodialysis alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Kasturba Medical College |
|
India |
2020-12-01 |
|
CTRI/2020/11/029173 |
Phase Not Applicable |
Not yet recruiting |
1 |
|
62 |
Dr B A SHASTRY, MAHAD HASAN KHAN |
2020-11-21 |
| Impact of COVID 19 on domestic responsibilities in physicians |
Coronavirus disease 19 infection |
questionnaire alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Tata Memorial Hospital |
|
India |
2020-11-30 |
|
CTRI/2020/11/029174 |
Phase Not Applicable |
Not yet recruiting |
1 |
|
2000 |
Sabita Jiwnani |
2020-11-19 |
| Lignocaine nebulization in covid pneumonia |
Coronavirus disease 19 infection, Viral pneumonia |
lignocaine alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
All India Institute Of Medical Sciences, Rishikesh |
|
India |
2020-11-20 |
|
CTRI/2020/11/029170 |
Phase 2 Clinical |
Not yet recruiting |
1 |
|
60 |
Dr Praveen Talawar |
2020-11-20 |
| A phase II clinical study to assess STI-2099 either as a stand-alone nasal application or as a combination nasal and intravenous administration in both mild and moderate COVID-19 patients |
Coronavirus disease 19 infection |
STI-2099 alone |
|
|
Sorrento Therapeutics Inc |
Defense Advanced Research Projects Agency, Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense, SmartPharm Therapeutics |
US |
|
|
|
Phase 2 Clinical |
Planned |
1 |
|
|
|
2020-12-01 |
| A phase I safety and pharmacokinetic study of STI-2099 in healthy subjects and outpatients with mild COVID-19 disease with or without a simultaneous intravenous injection of COVI-AMG |
Coronavirus disease 19 infection |
STI-2099 alone, COVI-AMG plus STI-2099 |
COVID19 Spike glycoprotein inhibitor |
Healthy volunteers accepted |
Sorrento Therapeutics Inc |
|
|
|
|
|
Phase 1 Clinical |
Planned |
0 |
|
|
|
2020-11-17 |
| A Phase II Clinical Trial of MW-33 Injection in Patients With COVID-19 |
Coronavirus disease 19 infection |
MW-33 alone |
COVID19 Spike glycoprotein inhibitor |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Mabwell (Shanghai) Bioscience Co Ltd |
|
|
2020-11-30 |
2021-09-30 |
MW33-2020-CP201, NCT04627584 |
Phase 2 Clinical |
Not yet recruiting |
0 |
10 Months |
150 |
Bei ZHAO, Master, Song LU, Master |
2020-11-18 |
| Echo-COVID: Cardiac Performance in Mechanically Ventilated COVID-19 Patients |
Coronavirus disease 19 infection, Respiratory failure, Viral pneumonia |
Mindray M9 (Bio-Medical Electronics Co) alone, Philips CX 50 (Philips Healthcare) alone, Vivid i echocardiography system (GE Medical Systems) alone, echocardiography alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Pontificia Universidad Catolica De Chile |
Clinica Alemana de Santiago, Hospital Barros Luco Trudeau, University of Chile |
Chile |
2020-04-01 |
2020-08-01 |
200422002, Echo-COVID, NCT04628195 |
Phase Not Applicable |
Completed |
1 |
4 Months |
100 |
Emilio Valenzuela, M.D |
2020-11-18 |
| Expanded Evaluation of the Survivorship Wellness Group Program in the Context of COVID-19 and Telehealth |
Anxiety disorder, Coronavirus disease 19 infection, Depression |
Survivorship Wellness Group Program alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
University of California San Francisco |
|
US |
2020-08-31 |
2023-12-31 |
20805, NCI-2020-08530, NCT04630015 |
Phase Not Applicable |
Recruiting |
1 |
40 Months |
250 |
Alison Chang, Diane Shumay, PhD, Margaret Chesney, MD, Margaret Chesney, PhD, cancertrials@ucsf.edu |
2020-11-19 |
| A retrospective cohort study to examine outcomes among patients who were treated anakinra or tocilizumab for COVID-19 -related cytokine storm |
Coronavirus disease 19 infection |
anakinra alone, tocilizumab alone |
Type I IL-1 receptor antagonist |
|
University of California Los Angeles |
|
US |
|
|
|
Phase Not Applicable |
Status not specified |
1 |
|
93 |
|
2020-11-17 |
| Face Masks to Reduce COVID-19 in Bangladesh |
Coronavirus disease 19 infection |
Face mask alone, face mask awareness alone |
|
Healthy volunteers accepted, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Yale University |
Innovation for poverty action, North South University, Stanford University |
Bangladesh |
2020-11-15 |
2021-02-28 |
2000028482, NCT04630054 |
Phase Not Applicable |
Recruiting |
1 |
3 Months |
450000 |
Jason Abaluck, PhD, Md. Alamgir Kabir, BA, Mohammad Ashraful Haque, BA, Stephen P Luby, MD |
2020-11-19 |
| Effect of Covid-19 on Outcomes of Pregnancy |
Coronavirus disease 19 infection |
PCR test alone |
|
Healthy volunteers accepted, Female, Young Adults (18-44 yrs) |
Assiut University |
|
Egypt |
2020-09-01 |
2021-12-01 |
12789, NCT04629001 |
Phase Not Applicable |
No longer recruiting |
1 |
15 Months |
1000 |
Armia Michael |
2020-11-19 |
| A real-world study to evaluate T-Detect COVID for past infection |
Coronavirus disease 19 infection |
T-Detect COVID alone |
|
|
Adaptive Biotechnologies Corp |
Ospedale San Raffaele, University of Padua |
Italy |
|
|
|
Phase Not Applicable |
Status not specified |
1 |
|
|
|
2020-11-19 |
| COVID-19 Infection Rate in the Construction- and Cleaning Industry |
Coronavirus disease 19 infection |
Spirometry alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Arbeitsmedizinischer Dienst der BG BAU GmbH |
Berufsgenossenschaft der Bauwirtschaft |
Germany |
2020-11-22 |
|
BO/40/2020, DRKS00023558 |
Phase Not Applicable |
Not yet recruiting |
1 |
|
3000 |
Thomas Solbach |
2020-11-20 |
| A retrospective case-control study to evaluate the impact of tocilizumab on mortality and/or invasive mechanical ventilation requirement in a cohort COVID-19 patients |
Coronavirus disease 19 infection |
Invasive mechanical ventilation alone, tocilizumab alone |
|
|
Hôpital Nord Franche-Comté |
|
France |
|
|
|
Phase Not Applicable |
Status not specified |
1 |
|
206 |
|
2020-11-17 |
| Verification of stress relief by introducing online visits to the restrictions on visits of COVID-19 |
Acute stress disorder, Coronavirus disease 19 infection |
online visit alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Jinseikai Kohnan Hospital |
|
Japan |
2020-11-16 |
|
UMIN000042384 |
Phase Not Applicable |
Not yet recruiting |
1 |
|
100 |
Hiroshi Yamamoto |
2020-11-18 |
| Maternal Attachment and Depression Anxiety Score Evaluation in COVID-19 Positive Pregnant Women |
Anxiety disorder, Coronavirus disease 19 infection, Depression |
|
|
Healthy volunteers accepted, Female, Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs) |
Istanbul Bakirkoy Maternity and Children Diseases Hospital |
|
Turkey |
2020-08-01 |
2020-11-20 |
MATERNALATTACHMENTCOVID, NCT04629638 |
Phase Not Applicable |
No longer recruiting |
1 |
3 Months |
500 |
Pınar Yalcin bahat |
2020-11-21 |
| RECOVER: Regenerative Medicine for COVID-19 and Flu-Elicited ARDS Using Longeveron Mesenchymal Stem Cells (LMSCs) |
Adult respiratory distress syndrome, Coronavirus disease 19 infection, Influenza virus infection |
allogeneic human mesenchymal stem cells (aging frailty/Alzheimer's disease/metabolic syndrome/hypoplastic left heart syndrome), Longeveron alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Longeveron LLC |
|
US |
2020-07-24 |
2025-07-31 |
00-006, NCT04629105, RECOVER |
Phase 1 Clinical |
Recruiting |
3 |
60 Months |
70 |
Andrew Quartin, MD, Anthony Oliva, PhD, Carl Shanholtz, MD, Freshta Akbari, MS, Gisel Urdaneta, MD, John P Galliard, MD, Kevin N Ramdas, MD, MPH, Kristopher Deatrick, MD, Mary- Clare Day, RN, BSN, CCRC, Roland Schein, MD, Sunjay Kaushal, MD, PhD |
2020-11-20 |
| CODED: Risk Stratification of COVID-19 Patients Discharged From the Emergency Department |
Coronavirus disease 19 infection |
chest radiography alone, lung ultrasonosgraphy alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Azienda Ospedaliera Citta della Salute e della Scienza di Torino |
University of Turin |
Italy |
2020-11-01 |
2021-07-31 |
CODED, COVID-ED-INTRISK, NCT04629183 |
Phase Not Applicable |
Recruiting |
5 |
9 Months |
400 |
Emanuele E Pivetta, MD, PhD, Enrico Lupia, MD, PhD, Franco Aprà, MD, Fulvio Morello, MD, PhD, Giuseppe Lauria, MD, Peiman Nazerian, MD, Stefano Podio, MD |
2020-11-19 |
| LAVA: The LAVA (Lateral Flow Antigen Validation and Applicability) Study for COVID-19 |
Coronavirus disease 19 infection |
Innova Lateral Flow Device alone, RT-PCR alone |
|
Newborn Infants (up to 5 months), Infants (6-23 months), Preschool Children (2-5 yrs), Children (6-12 yrs), Adolescents (13-17 yrs) |
Alder Hey Children's NHS Foundation Trust |
|
UK |
2020-11-05 |
2020-11-19 |
290989, LAVA, NCT04629157 |
Phase Not Applicable |
Recruiting |
2 |
|
400 |
Beatriz Larru, MD, Christopher Kelly, Laura Rad, Lucy Cooper, Rachel Harwood, MB BS, Richard Kirk |
2020-11-19 |
| Evaluation of a new adhesive system for orthodontic braces for a 6-month period |
Coronavirus disease 19 infection, Tooth disease |
conventional bracket system (CS) alone, flash-free adhesive system alone, pre-coated bracket system (PS) alone |
|
|
Ondokuz Mayis University |
|
Turkey |
2018-06-08 |
2019-06-18 |
ISRCTN26731749, OMÜ KAEK 2018/416 |
Phase Not Applicable |
Completed |
2 |
12 Months |
30 |
Prof Elekdag-Turk |
2020-11-26 |
| A phase II trial of BNT-162b2 for the treatment of COVID-19 |
Coronavirus disease 19 infection |
BNT-162b2 alone |
COVID19 Spike glycoprotein modulator |
|
Shanghai Fosun Pharmaceutical (Group) Co Ltd |
|
China |
|
|
|
Phase 2 Clinical |
Not yet recruiting |
1 |
|
|
|
2020-11-17 |
| Double-Blind, Randomized, Placebo-Controlled, Adaptive-Design, Multicenter, Phase III Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects |
Coronavirus disease 19 infection |
fostamatinib disodium alone, standard of care alone |
Syk tyrosine kinase inhibitor |
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Rigel Pharmaceuticals Inc |
|
|
2020-12-31 |
2021-10-31 |
C-935788-061, NCT04629703 |
Phase 3 Clinical |
Not yet recruiting |
0 |
10 Months |
308 |
|
2020-11-24 |
| EST-OBS-OZO-BIOPLA-SARS-COV 2: Observational study benefits rectal ozone therapy and BIOPLA as complementary therapy in convalescent patients SARS-COV-2 |
Coronavirus disease 19 infection |
BIOPLA alone, rectal ozone therapy alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
National Center for Scientific Research, Cuba |
BioCubaFarma |
Cuba |
2020-06-08 |
2020-08-15 |
EST-OBS-OZO-BIOPLA-SARS-COV 2, RPCEC00000342 |
Phase Not Applicable |
No longer recruiting |
1 |
2 Months |
40 |
Mario Slim War, Zullyt Zamora Rodriguez |
2020-11-20 |
| A clinical trial to evaluate the safety and pharmacokinetics of COVI-AMG in healthy subjects |
Coronavirus disease 19 infection |
COVI-AMG alone |
COVID19 Spike glycoprotein inhibitor |
Healthy volunteers accepted |
Sorrento Therapeutics Inc |
|
US |
|
|
|
Phase Not Applicable |
Not yet recruiting |
1 |
|
|
|
2020-11-17 |
| A retrospective study of zinc sulfate in combination with a zinc ionophore may improve outcomes in hospialized COVID-19 patients |
Coronavirus disease 19 infection |
Variable regimens including azithromycin , hydroxychloroquine , zinc sulphate |
|
|
New York University School of Medicine, US |
|
US |
|
|
|
Phase Not Applicable |
Status not specified |
1 |
|
932 |
|
2020-11-17 |
| Tracheobronchitis in Respiratory Involvement on the Lung SPECT/CT Images of COVID-19 Patients |
Coronavirus disease 19 infection, Dyspnea, Tracheobronchitis |
perfusion lung scintigraphy alone, ventilation alone |
|
|
Central Hospital, Nancy, France |
|
France |
2020-03-11 |
2020-07-23 |
2020PI154, NCT04629222 |
Phase Not Applicable |
Completed |
1 |
4 Months |
10 |
Pierre Yves MARIE, PhD |
2020-11-18 |
| Clinical trial to evaluate superiority of anti-SARS-CoV-2 convalescent plasma versus standard-of-care in hospitalized patients with mild COVID-19 |
Coronavirus disease 19 infection |
Fresh frozen plasma alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
Hannover Medical School |
German Federal Ministry of Health |
Germany |
2020-10-19 |
|
2020-001936-86, COMET |
Phase 2 Clinical |
Recruiting |
1 |
|
340 |
Institute of Transfusion Medicine |
2020-11-20 |
| A retrospective study of machine learning models that predict the likelihood of critical events and mortality in COVID-19 patients within clinically relevant time windows |
Coronavirus disease 19 infection |
machine learning model alone |
|
|
Mount Sinai School of Medicine |
|
US |
|
|
|
Phase Not Applicable |
Status not specified |
1 |
|
4000 |
Benjamin Glicksberg |
2020-11-18 |
| NOTICE: A retrospective chart review study,to collect real-world data on the use of Inomax (nitric oxide) gas, for inhalation therapy in patients with respiratory complications associated with the novel coronavirus SARS-CoV-2 (COVID-19) |
Coronavirus disease 19 infection, Hypoxia, Respiratory disease |
nitric oxide (inhaled), Ikaria alone |
Hemoglobin modulator |
|
Mallinckrodt plc |
Pharmerit International |
|
|
|
NOTICE |
Phase 4 Clinical |
Status not specified |
0 |
|
|
|
2020-11-16 |
| IPCO: Prospective, open-label, randomized, controlled, phase IIb clinical study in parallel groups for the assessment of efficacy and safety of immune therapy with COVID-19 convalescent plasma plus standard treatment versus standard treatment alone of subjects with severe COVID-19 |
Coronavirus disease 19 infection |
convalescent plasma alone, standard treatment alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs), Elderly Adults (80 and over) |
Universitatsklinikum Erlangen |
|
Germany |
2020-06-12 |
|
2020-002122-82, IPCO, UKER-COV2-01 |
Phase 2b Clinical |
Recruiting |
1 |
|
58 |
Transfusionsmedizinische Abteilung |
2020-11-18 |
| The lying in prone position effect on oxygen saturation in patients in early stage and not intubated having mild to moderate Lung Disease with COVID-19 |
Coronavirus disease 19 infection, Lung disease, Respiratory distress syndrome, Viral pneumonia |
Prone positionioning alone |
|
Young Adults (18-44 yrs), Middle-aged Adults (45-64 yrs), Aged Adults (65-79 yrs) |
All India Institute of Medical Sciences Patna |
|
India |
2020-11-16 |
|
CTRI/2020/11/029130 |
Phase Not Applicable |
Not yet recruiting |
1 |
|
48 |
Shagufta Naaz |
2020-11-20 |
| A retrospective observational cohort study of clinical characteristics and predictors of survival in adults with coronavirus disease 2019 receiving tocilizumab |
Coronavirus disease 19 infection |
tocilizumab alone |
|
|
Henry Ford Health System |
|
US |
|
|
|
Phase Not Applicable |
Status not specified |
1 |
|
81 |
|
2020-11-17 |